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Abstract 
This research explores the relationship between risk factors associated with cannabis use in young 
people.  This thesis addresses the assessment of cannabis use and its association with risk factors 
and implicit associations, and the suitability of these for targeting at-risk cannabis users, and how 
theories of drug instrumentalization and normalization frame cannabis use behaviour in young 
people in contact with drug services using a mixed-methods approach.  Additionally, this research 
addresses the implications for indicated prevention and the targeting of young people considered at 
risk for developing problematic cannabis use behaviours.   
This PhD reviews the scientific literature on cannabis use, with an emphasis on prevalence 
and use behaviours alongside associated risk and protective factors.  Cannabis markets and potency, 
along with policy implications, are also explored.  Furthermore, this PhD aims to understand how 
cannabis use behaviour assessment impacts on the identification of risk, and the subsequent 
implications for identifying those who might benefit from further support.  Frequent, habitual 
cannabis users and their relationship with risk factors, including implicit cognitions, and use 
behaviour assessment are explored.  Additionally, cannabis users in touch with drug services and 
their use behaviour are explored through frameworks of drug use instrumentalization and 
normalization.  Lastly, the main findings of this dissertation are surmised and future research and 
policy implications are discussed. 
  This PhD illustrates the importance of cannabis use behaviour assessment in identifying 
young people at-risk for developing problematic use behaviours.  This thesis provides evidence that 
suggests that psychopathology, and the over-instrumentalization of use as a self-medication, coping 
mechanism may be associated with the development of problematic use outcomes.  These findings 
are contextualised within the current cultural and political environments in the United Kingdom and 
discussed in regards to their suitability for indicated prevention. 
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Chapter 1 
Background and literature review 
1.1  Introduction 
The aim of this literature review is to understand important characteristics of cannabis use in young 
people, and its relationship to the development of prevention research efforts.  The review provides 
a general overview; how the properties of cannabis might contribute to specific outcomes for users 
and how the current cannabis market influences these outcomes.  Next, cannabis use behaviour 
(including epidemiology and prevalence estimates), both internationally and in the UK, and the 
potential problems associated with use will be discussed.  Following this, a review of prevention 
research will be presented with a particular focus on indicated prevention.  Finally, a review of the 
risk and protective factors associated with cannabis use and young people will be presented, 
specifically evaluating their usefulness in developing indicated prevention programs, as well as the 
theoretical underpinnings linking health behaviour and cannabis prevention. 
1.2 Cannabis 
Cannabis is obtained from the plant Cannabis Sativa and some of its subspecies, although debate 
regarding the taxonomy of cannabis amongst botanists still exists (see Watts, 2006).  It is used in a 
variety of ways but is usually obtained from the dried leaves, stalks, flowers and seeds of the 
plant.  Most commonly, the flowering tops or leaves of the plant are dried to prepare cannabis and it 
is smoked with a joint (often mixed with tobacco), pipe, or waterpipe; orally ingested (usually 
prepared in tea or a pastry); or inhaled using a vaporiser.  Other ways of using cannabis include 
compressing the resin secreted from the plant to prepare hashish, or extracting the psychoactive 
component of the plant in oil to create hash oil. Cannabis is unsuitable for intravenous use due to its 
water-insolubility. 
The cannabis plant produces unique chemicals known as cannabinoids along with 
approximately 500 other chemical compounds.  Although over cannabinoids have been identified, 
the pharmacology of most of these substances is still unknown (Radwan et al., 2009).  The most 
potent psychoactive agent and cannabinoid, and widely considered to be the most important when 
studying recreational use of cannabis, is ∆9-tetrahydrocannabinol (THC).  THC is largely responsible 
for the intoxication (“high”) experienced when using cannabis and the majority of psychological and 
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physical effects (Iversen, 2000).  High doses of THC produce hallucinogenic-like effects (Johns, 
2001).  Cannabidiol (CBD) is also considered to be an important cannabinoid when studying the 
effects of cannabis use due to its pharmacological antagonistic effect on THC (Pertwee, 2008).  The 
antagonistic effect results because CBD is a sedative compound.  The ratio of CBD to THC in the 
cannabis plant is significant in determining the level of psychoactivity experienced (Schubart et al., 
2011; Potter, Clark, & Brown, 2008; Mechoulam & Parker, 2013).   In addition to the cannabinoids 
and chemicals found in cannabis, smoke produced from a cannabis combustion (notwithstanding the 
products of mixing with tobacco directly) contains carbon monoxide and the same tars, irritants and 
carcinogens that are present in tobacco smoke, some of them in greater concentration (Ashton, 
2001). 
1.2.1 International data on cannabis use by young people 
The Health Behaviour in School-aged Children study (HBSC) World Health Organization collaborative 
cross-national study provides comprehensive data on young people and their health 
behaviours.  THE HBSC sample comprises school-aged children, aged 11, 13, and 15, from 43 
countries in Europe and North America (although only 39 countries supplied suitable data for 
inclusion in the report) (Currie et al., 2012). This survey focuses on health inequalities specifically 
age, gender, geographical and socioeconomic dimensions.   Questions on cannabis use were 
administered only to the 15 year-old age group, and not administered to students from Turkey due 
to cultural sensitivity.  A minimum sample size of 1500 pupils was set; however most countries far 
exceeded these recommendations.   
In addition to looking at prevalence, HBSC data looked specifically at health inequalities: age, 
sex, geography and family socioeconomic status.  Health inequalities related to age were not 
included in cannabis related activity because only 15 year-old participants responded to questions 
relating to cannabis use.  Socioeconomic status was evaluated using the Family Affluence Scale.  The 
Family Affluence Scale (FAS) is a set of questions evaluating the material conditions of a young 
person’s home (car ownership, bedroom occupancy, holidays and home computers), and was used 
due to its relative ease for young people to answer and its tendency to produce lesser missing data 
than other measures, such as parental occupation.  The 2009/10 survey showed that the proportion 
of 15 year-olds across all HBSC countries who had used cannabis at least once during their lives was 
17% (15% for females and 20% for males) and 13% reporting use in the last 30 days.   Stark 
differences were reported in lifetime cannabis use of young people between countries, with as little 
as 3% reporting use in Romania and as much as 34% reporting use in Canada.  A statistically 
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significant association between cannabis use and high family affluence was only shown in a few 
countries and mainly among boys; however, weekly cannabis smoking was more prevalent among 
boys and girls from low-affluence families in most countries, with a significant relationship 
demonstrated in 9 countries for boys and 13 for girls, while weekly smoking and family affluence was 
significantly positively associated only in Romania. 
Respondents who had used cannabis at least once in their lives were placed into one of four 
categories: discontinued user (those who have used cannabis in their lifetime but not within the past 
30 days or 12 months); experimenter (those who have used cannabis 1-2 times in the past 12 
months); regular user (those who have used cannabis 3-39 times in the past 12 months); and heavy 
user (those who have used cannabis 40 or more times in the past 12 months).  Of all HBSC 
respondents, 4 % were classified as discontinued users, 6% experimenters, 5% regular users and 2% 
heavy users.  Additionally, results indicated higher prevalence of cannabis use among boys, with sex 
difference greater than 10% in some countries, including Lithuania, Poland and Switzerland (Currie 
et al., 2012).  There were, however, substantial variations between countries and regions, attributed 
to cross-national differences in country wealth, perceived availability of cannabis, and perceived risk 
(Currie et al., 2012).  In the UK, 9% of 15 year-olds reported using cannabis in the past 30 days and 
no sex differences were reported. 
In addition to the international comparison provided by HBSC, many other studies have 
investigated the use of cannabis in the general population and its associations with psychosocial 
harm.  In a systematic review of longitudinal, general population studies of cannabis use in young 
people and the corresponding psychosocial harms (including educational attainment, use of other 
drugs, anti-social behaviour, social problems) over 200 publications from 48 longitudinal studies 
were reviewed (MacLeod et al., 2004).  Of the 16 studies considered to be of a ‘higher 
methodological quality’, 12 were conducted in the USA or Canada and one in the United 
Kingdom.  The authors concluded that the evidence did not provide a strong support for a causal 
relationship between cannabis use by young people and psychosocial harm (MacLeod et al., 
2004).  Despite being consistently associated with reduced educational attainment, the use of other 
drugs, and a greater likelihood of problems with low age of initiation, cannabis was inconsistently 
associated with psychological problems and antisocial and other problematic behaviour. Three 
alternative explanations are given for the association between cannabis use by young people and 
psychosocial harm: reverse causation, in which cannabis use is a result of psychosocial factors; bias, 
in which the association found is a consequence of social methodology; and confounding factors, in 
which cannabis use is associated with other factors that are determinant of psychosocial harm. 
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More recently, a systematic review investigated whether cannabis could cause psychotic or 
affective symptoms beyond acute intoxication (Moore et al., 2007).  Results indicated that lifetime 
cannabis use was associated with an increased risk of any psychotic outcome, and that this 
association demonstrated a dose-response relationship, with greater risk for those who more 
frequently use cannabis.  Notably, the authors point out that although arguments linking early 
exposure to cannabis and increased risk of psychotic or affective symptoms, evidence does not 
support this and that the link may be, in fact, a result of more frequent exposure to cannabis 
opposed to a specific age group associated with increased vulnerability.  This contributes to the 
growing evidence that suggests that although cannabis and psychosocial harms are linked, a causal 
relationship between use frequency and affective outcomes is unlikely to be determined at this 
time. 
One of the greatest challenges in interpreting epidemiological cannabis data is discounting 
confounding, as adverse psychosocial outcomes and cannabis use are likely to share common 
predictive factors (Smith & Ebrahim, 2003; MacLeod et al., 2004).  Furthermore, when looking at the 
relationship between specific affective psychotic outcomes, like schizophrenia, and cannabis use, a 
simple causal explanation is unlikely, as incidence of schizophrenia is associated with exposure to 
cannabis, yet as rates of cannabis have increased, the rates of schizophrenia have stabilized 
(MacLeod et al., 2004).  In this regard, it has become increasingly apparent that simple measures of 
cannabis do not adequately describe the variations of use behaviour within the population.  In order 
to parcel out the complexities of cannabis use and psychosocial outcomes, a more detailed 
measurement of cannabis use is required.  As antecedents related to psychosocial outcomes and 
cannabis use are likely related and with a large proportion of the general population reporting at 
least experimental use, it is important to understand the ways in which use may be related to 
psychosocial outcomes, and when other antecedents may be more likely the root of these 
outcomes. 
In addition to the epidemiology of cannabis use, it is important to note the prevalence of 
cannabis use disorders and the treatment seeking population as well.  Cannabis dependence, or 
Cannabis use disorder, are controversial within the academic literature, with some researchers 
doubting the ability of cannabis to cause a withdrawal symptom, a prime element of other drug 
disorders, despite research into the endogenous cannabinoid system that suggests the potential for 
withdrawal mechanisms (Budney et al., 2004). Additionally, the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-5), has added cannabis withdrawal to previous classifications of cannabis use 
disorder and cannabis abuse (American Psychiatric Association, 2013).  In contrast, cannabis use is 
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viewed generally as an irregular and experimental activity that typically increases with use over 
adolescence (Coffey et al., 2000) before declining in the mid-20s (Chen & Kandel, 1995; Copeland & 
Swift, 2009).   
1.2.2 Cannabis use in the United Kingdom 
Cannabis is the most widely used illegal drug in the world with an estimate between 2.7 and 4.5 
percent of the population aged 15-64 years having used cannabis (UNODC, 2014).  Of particular 
concern is use by young people, with 17% of 15/16 year-olds in Europe reporting lifetime cannabis 
use (Hibell et al., 2012).  In 2013-2014 in England and Wales, 29.2% of the general population (16-59 
year-olds) reported lifetime cannabis use, and 10.4% of young people (16-24 year-olds) reported use 
in the last year (Home Office, 2015).  This represents a trend in lowering rates of cannabis use by 
young people since 1999, when the Crime Survey of Britain and Wales reported 26.0% of young 
people using cannabis in the last year (Home Office, 2015).  In 2013, over a quarter (26.8%) of 
treatment presentation in the UK were for cannabis, with the number of people entering structured 
drug treatment (including inpatient, outpatient and treatment through a GP) for the first time 
reporting cannabis as the primary drug representing 48.6% of admissions (Burton et al., 
2014).  Furthermore, of the 18,349 under 18s in the UK accessing specialist substance misuse 
services, 73% reported cannabis as the primary substance, more than any other drug including 
alcohol (Public Health England, 2015).  
Prevalence data in the UK suggests that use by the general population has stabilised, if not 
declined, in recent years (Home Office, 2015; Burton et al., 2014).  Despite this trend, cannabis is still 
the most commonly used illicit drug.  Although the majority of cannabis users engage in recreational, 
experimental, and intermittent use, and are unlikely to develop dependence, they still may 
experience problematic use outcomes.  In moving forward in reducing cannabis-related problems 
and harms, it is important to develop a better understanding the nuances of cannabis use behaviour 
and how it relates to use outcomes.  Standard use measures, like frequency of use, do not provide a 
complex enough representation of use behaviour, and must be developed in order to unravel the 
relationship between use and affective and problematic outcomes.   
UK data collected for the European School Survey Project on Alcohol and other Drugs 
(ESPAD) was used to examine different use-clusters that emerge in heavy cannabis users (Miller and 
Plant, 2002).  In the sample of 2641 UK school students aged 15-16 years, those who reported using 
cannabis more than 40 times (7.6% of the sample) were identified.  Three clusters emerged among 
those identified as heavy cannabis users: antisocial (24.9%), unhappy (33.8%), and ordinary 
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(41.3%).  The antisocial cluster was the smallest and reported relative ease in receiving money from 
their parents, a large group of friends, being male, and scored highest on levels of aggression against 
others, and thieving and destruction of property.  The unhappy cluster found difficulty in obtaining 
money, caring, warmth or mental support from their parents; reported lax parental control and poor 
relationship and support from friends and parents; and had substantially lower levels of self-esteem 
and higher levels of depressed mood. Furthermore, they were generally dissatisfied with their own 
health and financial state.  The final cluster, coined the ‘ordinary’ cluster, scored low on 
delinquency-aggression measures and had obedience to Society’s rules.  They also held a belief that 
life is stable and predictable.  Although cross-sectional in design, these results highlight the different 
types of users and how this might influence the reasons for their use, and how they use.  There are 
several potential hypotheses that may be derived: 1) the antisocial cluster is engaged in general 
deviant behaviour; 2) the unhappy cluster may engage in use as a form of self-medication or 
escapism; 3) the ordinary cluster may be engaging in typical use associated with young people and 
drug exploration.  In acknowledging the different types of users, it becomes clear that looking at 
who uses, how they use, and why they use cannabis may inform researchers on the ways in which 
use outcomes may be reflected by use behaviour. 
In another UK study looking at cannabis use, risk and protective factors and social 
functioning, results indicated, similarly to prevalence data, that a 24% of 14-16 year-olds in a sample 
of over 2000 students from 7 different state schools in London had used cannabis in their lifetime 
(Best et al., 2005).  Additionally, those who had used cannabis were far more likely than their 
abstaining peers to have used, alcohol, tobacco and other drugs.  Results indicated that of those who 
initiated cannabis use in the past 2 years, roughly 10% escalated to daily use, consistent with 
previous longitudinal data in Australia (Best et al., 2005; Coffey et al., 2000).  However, when looking 
at cannabis use measures and risk and protective factors and social functioning, only time spent with 
friends involved in drug use indicated frequency of use.  These results indicate that social 
functioning, particularly engaging in a network of friends that use drugs, is an important 
determinant of the frequency of cannabis use.  Although this research highlights the importance of 
social networks and use behaviour, it does not provide a complete picture of the context within 
which this use is occurring.  In the context of the previously discussed clusters of cannabis users, it 
would be useful to know whether these behaviours took place in instances of general drugs 
experimentation, delinquent behaviour, or as a coping mechanism for dealing with unhappiness.  It 
is with this knowledge that we would be able to apply more detailed information for prevention 
work on how to prevent individuals from engaging in cannabis use that is likely to lead to 
problematic outcomes.   
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In a study of young people, alcohol and illicit drug use was measured in university students 
(mean age 20.9 years) (Webb et al., 1996).  Cannabis was the most widely reported illicit drug used 
by students, with 20% of the sample reporting regular use (weekly or more often).  This is higher 
than prevalence data among adults (aged 16-59 years) in the general population which report less 
than 10% last year use since 1996 (Burton et al., 2014), suggesting that university students may be 
more likely to engage in frequent use of cannabis than the general population.  However, based on 
UK Focal Point prevalence data, it would appear that the majority of uses would begin to discontinue 
or lessen their cannabis use between their mid-20s and 30s.  A longitudinal analysis was conducted 
with UK dental students (with a medical student comparison group) examining their use of alcohol 
and illicit drugs (Newbury-Birch, Lowry & Kamali, 2002).  Dental students responded to a 
questionnaire at the end of their second year, final year, and after a year of being a qualified 
dentist.  In measuring current use of cannabis (although current use is not explicitly defined) 8% of 
dental students reported cannabis in their final year and 16% as dentists.  Similarly, medical students 
reported 22% in the final year of their degree and 24% as Pre-Registration House Officers 
(PRHO).  This longitudinal data provides insight into the cannabis use consumption by young people 
in university, and their transition into their professional career.  This data suggests that current use 
of cannabis use may increase as they transition from student to the first years of employment.  In 
keeping in mind UK prevalence data, it is likely that this stabilisation would deteriorate over time, 
unless there are specific mechanisms of use that are different for those in medical 
professions.  More longitudinal analysis in the UK of how cannabis use evolves, prior to initiation, 
until later age (when cannabis use tends to taper off) would be helpful in ascertaining how and why 
users continue to engage in use when use by their peers tails off. 
Some research has looked at the positive and negative experiences of heavy use, and aimed 
to differentiate between frequent use and problematic use (Hammersley & Leon, 
2006).  Investigating cannabis users in South East England, researchers interviewed (using extensive 
structured questionnaires) 172 university students who had used cannabis at least once in their 
lifetime, and used snowball sampling to recruit their participants.  The researchers identified four 
groups based on their patterns of use:  those who used casually and had no reason to control or 
manage their use; users who had deliberately given up using; users who regularly used, but saw this 
as largely positive, despite some negative effects; and users who bought cannabis regularly, but 
restricted their use based on the day of the week or due to other commitments (Hammersley & 
Leon, 2006).  Most commonly, users reported that they titrated their use of cannabis, with 37% 
reporting ‘I take a bit, get a bit high, take a bit more and so on for a few hours’; 35% reporting ‘just 
take a little bit and get a bit high’; 19% ‘quite a lot at once and got wasted for a few hours’; and 9% 
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‘kept on taking it until it was all gone or they had passed out’.  Additionally, the authors suggest that 
dependence was not predictive of the extent of cannabis use, where cannabis dependence was 
assessed with questions regarding positive experiences of cannabis use to counterbalance questions 
regarding negative experiences.  Although heavy users and those who reported daily/near-daily use 
of cannabis scored highest on levels of dependence, they still reported more positive than negative 
experiences.  This study, however, did not include a standard measure of dependence, only the 
frequency of negative problems associated with use behaviour, which makes it difficult to compare 
this to other data exploring cannabis use behaviour. 
Despite the limitations to this study, including a non-random sampling procedure, these 
results provide evidence that a more detailed understanding of the mechanisms of use behaviour 
are informative in explaining use outcomes.  Additionally, the researchers highlight how concerns 
with negative experiences of cannabis may be warranted, but more so in an analogy with alcohol 
than other illicit drugs (Hammersley & Leon, 2006).  Longitudinal analysis and understanding how 
the patterns of use and frequency of use, change over time, and how these changes affect use 
outcomes is needed.  Furthermore, as this research was exploratory in nature, it is important to 
develop more research investigating the patterns of use, their mechanisms, and the prevalence and 
stability of these patterns within the population of young people. 
1.2.3 Problems associated with cannabis use 
Adolescent cannabis use is associated with a number of social, health and judicial 
problems.  Adverse effects of cannabis include dependence disorder, increased risk of motor vehicle 
accidents, impaired respiratory function and cardiovascular disease, lower educational attainment, 
in addition to maladaptive adolescent psychosocial development and putative mental health 
problems with chronic use (Hall & Degenhardt, 2009; Lynskey et al., 2003; McGee et al, 2000; 
Fergusson et al., 2002). However, there are problems in determining causality of other cannabis 
related health problems, particularly pulmonary disorders, due to the high prevalence of concurrent 
tobacco use (Advisory Council on the Misuse of Drugs, 2008).  Although not all use is dysfunctional, a 
high rate of young people initiate cannabis use at an early age and the increased number of 
cannabis-related treatment presentations indicate that preventative interventions need to focus not 
only on use initiation, but also targeting individuals most at-risk for abusing cannabis prior to use 
initiation, and decreasing cannabis use and associated problems among cannabis users who have yet 
to develop, but may be more susceptible to, developing dependence.  
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1.2.4 Cannabis potency 
Cannabis potency is defined as the concentration (percentage) of cannabinoids in the cannabis plant, 
most commonly that of THC (∆9-tetrahydrocannabinol).  The percentage of THC is often considered 
to the most important factor in determining the potency of cannabis due to its strong psychoactive 
effect.  Although the THC content is most commonly used as a measure of cannabis potency, the 
psychoactive effect of cannabis may also depend on other cannabinoids, including cannabidiol (CBD) 
which has become increasingly important in recreational cannabis research due to its believed anti-
psychotic properties, and other cannabinoids (i.e., cannabichromene, tetrahydrocannabivarin, 
cannabigerol) considered to have additive effects. 
The plant variety (species), the part of the plant used, geographical origin, preparation for 
administration, and cultivation techniques are also major components in the determination of 
cannabis potency.  Generally, cannabis and cannabis resin have between 2-8% THC content, while 
cannabis grown for fibre production (hemp) generally contains lower levels of THC (less than 0.3%) 
and higher levels of CBD compared to cannabis grown for recreational use (EMCDDA, 2008). The 
crossbreeding and genetic modification of cannabis has resulted in hybrid subspecies with higher 
levels of THC, with many of these hybrids originating from the Netherlands and the seeds readily 
available for purchase on the internet (Adams and Martin, 1996; Hall and Swift, 2000).   The 
flowering tops (‘buds’) of cannabis have the highest THC content of the plant, followed by the 
leaves, stems, and seeds, while the cannabis preparations of hash oil generally have the highest THC 
content, followed by resin and herbal cannabis (McClaren et al., 2008).  THC content degrades over 
time and the means by which cannabis is stored (airtight storage preserves the THC content) affects 
potency.  Cultivation techniques, such as the growing of female plants in isolation so they are 
seedless (‘sinsemilla’, popularly referred to as ‘skunk’) producing higher levels of potency as 
fertilisation and seed production reduces THC level, also affect the potency of cannabis.  In addition, 
the use of hydroponic or other methods facilitating the growth of cannabis indoors under artificial 
conditions yields higher concentrations of THC (Adams & Martin, 1996; Poulsen & Sutherland, 2000). 
1.2.5 Cannabis potency trends 
Recent political discussion and media coverage of cannabis potency has suggested that the THC 
concentration of cannabis is significantly higher than in previous years.  These assertions, in addition 
to growing evidence that illustrates the potential increased likelihood of developing psychosis and 
psychotic symptoms as a result of high potency cannabis use, has led to increased interest and 
governmental funding for the appraisal of cannabis potency in the market.  In the United States, 
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seizures of confiscated cannabis showed an increase of  THC concentration levels from 2.0% in 1980 
to 4.5% in 1997 (ElSohly, 2002), and 8.5% in 2006 (Office of National Drug Control Policy, 
2007).  However, data from New Zealand analysing seizures between 1976 and 1996 did not 
demonstrate an increase in cannabis potency (Poulsen & Sutherland, 2000).  Although data 
measuring the potency of cannabis through seizures between 1997 and 2004 increased from 2.5% to 
15%, this dramatic increase in potency could be explained by the large increase in proportion of 
seizures that were of cannabis buds between 2000 and 2004 (Licata et al., 2005)  Evidence 
synthesised in reports by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
conclude that the potency of cannabis has not increased significantly over time and especially not at 
levels 10 times greater than in earlier years as some have suggested (Walters, 2002), with the 
exception of the Netherlands where cannabis potency has increased largely due to the production of 
domestic cannabis indoors (EMCDDA, 2004; EMCDDA, 2008).  Data from the Netherlands indicates 
the THC content of cannabis has doubled between 2000 and 2004, but has since dropped off, with 
similar patterns being reported for hash (van Laar et al., 2007; Niesink et al., 2007).  Samples 
measured in the Netherlands, however, were from ‘coffee shops’-businesses that are permitted to 
sell small amounts of cannabis to the public-and were chosen based on their most popular sellers 
(generally sinsemilla), compared to police seizures used in other countries which contain a mixture 
of sinsemilla, buds, leaves, stems and seeds (Niesink et al., 2007).  
1.2.6 Cannabis potency in the United Kingdom  
In the United Kingdom, as part of the reclassification of cannabis, the Advisory Council on the Misuse 
of Drugs (ACMD) recommended research investigations to evaluate the different types of cannabis 
and their potencies in the market (ACMD, 2006).  The average potency of herbal cannabis varied 
between 3% and 5% from 1975 to 1989 (Baker et al., 1980; Baker et al., 1982, EMCDDA, 2004), and 
increased from 8% to 13% between 1998 and 2004 (Eaton et al., 2005).  Despite the suggestion that 
cannabis potency has increased in the UK, methodological issues such as inadequate or undisclosed 
sampling strategies, loose definitions of type of cannabis analysed, and lack of knowledge regarding 
cultivation techniques make it difficult to ascertain if and how these measured increases in cannabis 
are representative of the wider UK market (McClaren et al., 2008).  More recent studies have 
attempted to measure the market share of types of herbal cannabis (imported herbal cannabis and 
‘sinsemilla’) separately, due to their varying degrees of cannabis potency.  In 2004/5, an 
investigation evaluating police seizures of five constabularies in England, with the majority being 
collected “on the street” with the remainder collected during property searches, found that 
sinsemilla accounted for 55% of samples seized, although considerable differences were found 
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among regions (Potter et al., 2008).  Evidence also showed that herbal cannabis (median THC: 2.14%; 
median CBD: <.10%) and sinsemilla (median THC: 13.98%; median CBD: <.10%) had different 
cannabinoid profiles to cannabis resin (median THC: 3.54%; median CBD: 4.17%) especially with 
regards to CBD content (Potter et al., 2008).  In 2008, police seizures collected from twenty-three 
polices forces across England and Wales, with 80% of samples being collected “on the street”, found 
that herbal cannabis (81% sinsemilla; 3% traditional imported herbal cannabis) accounted for 80.8% 
of the sample, cannabis resin accounted for 15.3%, and the rest of the sample was found to be 
either indeterminate or not cannabis (Hardwick and King, 2008).  The evidence demonstrates a 
further increase in the market share (55% to 81%) and potency (13.98% to 15.0%) of sinsemilla since 
2004/5, and continued low levels of CBD content with 97% of herbal cannabis containing less than 
0.1% (Hardwick and King, 2008).  Similarly to results produced in 2004/5, significant regional 
variations in market share of herbal cannabis existed, and cannabis resin (median THC: 5.0%; mean 
CBD: 3.5%) had a much different cannabinoid profile compared to herbal cannabis (Hardwick & King, 
2008). 
1.2.7 Cannabis contamination 
In addition to cannabis potency, interest and concern regarding the possible contamination of 
cannabis, in particular contamination caused by cultivation and storage (both naturally occurring 
contaminants, like fungi, and ‘unnatural’ products such as growth enhancers and pest control) and 
substances added for marketing purposes (for example, substances used to ‘bulk’ up the weights of 
the product), has increased in recent years (McLaren et al., 2008).  Evidence from Australia shows 
that a sizeable portion (25%) the general population believes that hydroponic cannabis poses a 
greater potential health risk because of greater potency and contamination (StollzNow, 2006), while 
medicinal cannabis users tend to avoid hydroponic cannabis because of the perceived adverse side 
effects caused by contamination (Swift et al., 2005).  Despite these documented concerns regarding 
the potential harmful effects of hydroponic cannabis, the perception that cannabis is a less harmful 
product than manufactured drugs such as amphetamines and heroin, and products such as 
cigarettes which contain chemicals and additives, because it is a ‘natural’ product persists (Hall & 
Nelson, 1995). 
Naturally occurring moulds (A. Flavus), fungi (Aspergillus), and bacteria have been implicated 
in respiratory illness in cannabis users.  Aperguillus is known to cause aspergillosis (a fatal lung 
disease), and an association between patients with compromised immune systems and the use 
cannabis and the development of the disease was found (Denning et al., 1991; Marks et al., 1996).  A 
study investigating the relationship between cannabis contamination with fungi and bacteria found 
  
12 
 
that 13 out of 14 cannabis samples contained fungi, the majority of cannabis smokers (13 of 23) 
were exposed to Aspergiluus, while the only one of the controls (n =10) was exposed (Kagen et al., 
1983).  More recent investigations have supported the suggestion of cannabis contamination.  One 
study found cannabis examples to be contaminated with mould, most commonly Penicillium 
(Verweij et al., 2000), while cannabis tested from coffee shops in a Dutch study found that cannabis 
contained levels of fungi and bacteria at levels considered to be unsafe for consumption (Hazekamp, 
2006).  Although evidence suggests that cannabis contamination exists, there is thus far no evidence 
that suggests the use of contaminated cannabis leads to disease in healthy individuals (McLaren et 
al., 2008).  In addition to naturally occurring contaminants, concerns regarding the potential risks 
associated with pesticides and chemicals used in the cultivation of cannabis have been addressed 
(McLaren et al., 2008).  Although strict guidelines are in place regarding the use of pesticides 
commercially and domestically (Australian Pesticides and Veterinary Medicines Authority, 2004), due 
to the illegal nature of cannabis production it is not known what products are used in cultivation, 
and what effects these pesticides may have on a product that is smoked (McLaren et al., 
2008).  There is little research on the contamination of cannabis from growth enhancers and pest 
controls, as well as the effects that these contaminations may have on people.  A Dutch study found 
traces of pesticides in cannabis, but not at levels considered to be harmful to users (Niesink et al., 
2006).  Indoor-grown cannabis is perceived to be more contaminated with pesticides and growth 
enhancers than naturally grown cannabis (Swift et al., 2005; StollzNow, 2006), however there is no 
evidence to suggest the extent to which these claims exist (McLaren et al., 2008). 
The use of substances to ‘bulk up’ the weight of cannabis or to make it appear more potent 
is cause for concern regarding the contamination of cannabis.  In the United Kingdom, the 
Department of Health estimated that roughly 5-10% of cannabis seized between January and March 
2007 was contaminated with glass beads (Department of Health, 2007).   These glass beads were 
believed to be used to add bulk and to resemble the crystalline appearance of the THC-rich resin 
glands (McLaren et al., 2008).  The corresponding public health alerts that were issued suggest that 
smoking contaminated cannabis could result in sore mouth, mouth ulcers, chesty persistent coughs 
and tightness in the chest (Department of Health, 2007), although it is unknown how many people 
were actually exposed to such products.  Other reports have claimed that other substances such as 
phencyclidine and tobacco have been used to ‘bulk up’ cannabis (McPartland, 2002), but there has 
been no systematic research to support these claims. 
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1.2.8 Cannabis potency and market trends 
The vast majority of research investigating high-potency cannabis and its effects on use outcomes is 
associated with drug-induced psychosis and mental health disorders, particularly schizoaffective 
disorders.   A review of epidemiological studies looking at the causal link between cannabis and 
adults psychosis reported that use of cannabis yielded a twofold increase in likelihood of psychosis, 
and determined that a population level cessation of cannabis would lead to an 8% reduction in 
psychotic illness (assuming a causal relationship) (Arseneault et al., 2004).  These results, however, 
should be interpreted with caution as the authors’ point out that cannabis is not a direct causal link, 
but rather a part of a causal constellation of factors.  Furthermore, results are reliant on data from a 
small group of individuals, and more extensive long-term, longitudinal studies are 
needed.  Investigations of UK patients with first episode psychosis found that patients presenting a 
first episode psychosis were not more likely to have used cannabis compared to healthy controls, 
but were more likely to use cannabis more frequently and for a longer period of time (Di Forti et al., 
2009; Di Forti et al., 2015).  Furthermore, compared to controls, patients presenting first time 
psychosis reported a greater preference for using sinsemilla compared to herbal cannabis or resin 
(Di Forti et al., 2009; Di Forti et al., 2015).  Daily users of high-potency cannabis, however, had earlier 
onset of first episode psychosis than those who never used cannabis (Di Forti et al., 2014),   There 
are many limitations to this body of work, including: non-random recruitment that may have skewed 
towards mild cannabis users; inability to ascertain causality due to a cross-sectional design; 
confounding factors, including the use of cannabis to ameliorate psychotic symptoms; and use of 
self-reported cannabis use, especially the ability of participants to discern the type of cannabis they 
use, opposed to biological markers of use (Di Forti et al., 2009; Di Forti et al., 2014; Di Forti et al., 
2015).  Despite these limitations, this works highlights that differences in cannabis type, duration 
and frequency may lead to different outcomes for users.   
A similar study was conducted in the Netherlands, which included the examination of the 
properties of the cannabis participants reported using because of the toleration of use in the Dutch 
market.  Specifically, researchers asked participants which types of cannabis they usually consumed 
from a list provided by the Trimbos Institute (Niesink et al., 2007), thus verifying the concentration 
of THC and CBD in the type of products they reported with the participant’s self-reported 
response.  In this non-clinical, cross-sectional, web-based study, results indicated that use of 
cannabis with CBD present was inversely related to self-reported positive psychiatric symptoms, but 
not with negative or depressive psychiatric symptoms (Schubart et al., 2011).  Despite 
demonstrating a small effect size, this provides further evidence of the antipsychotic properties of 
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CBD.  The authors note that this small effect size (compared to previous studies including Zuardi et 
al., (2006)) may be because the concentration of CBD used for cannabis smoking is less compared to 
that of purified oral form (Schubart et al., 2011).  In addition to similar studies, it is difficult to 
ascertain the causality of cannabis use and psychiatric symptoms, and longitudinal studies 
investigating how cannabis potency may affect psychiatric outcomes is needed.  Nevertheless, this 
research further illustrates the need to develop further research investigating how the properties of 
cannabis influence use outcomes. 
Although the majority of research investigating cannabis and the influence of cannabinoid 
properties on use outcomes focuses on psychiatric-related factors, some research has investigated 
its relationship with other factors.  A recent study investigated the impact of cannabinoids, 
particularly THC and CBD, on memory impairment and psychological well-being (in addition to 
psychotic-like symptoms) (Morgan et al., 2012).  Results indicated that higher levels of THC present 
were associated with higher levels of anxiety and depression, as well as greater memory 
impairment.  Conversely, high levels of CBD were associated with lower psychosis-like symptoms, 
but only in recreational users (used less than 25 times per month).  The use of biological markers 
determining the concentrations of CBD and THC found in participants provides the best indicator of 
cannabinoids present.  However, because the mechanisms in which cannabinoids are deposited in 
hair are not well understood, in this study the presence of cannabinoids, opposed to the 
concentration of cannabinoids, was used.  Despite the limitations of the biological testing, this study 
provides further evidence of an association between cannabis potency and psychiatric 
outcomes.  More importantly, it illustrates that the association between cannabis potency and 
mental health factors, and that research looking at the effects of potency on behavioural outcomes 
and other factors is needed.   
In unravelling the complicated constellation of factors associated with problematic cannabis 
use outcomes, it is increasingly apparent that looking more closely at cannabis type, duration and 
frequency in a more detailed manner may provide greater insight and help to inform drug 
prevention public health initiatives.  As knowledge regarding cannabis, its properties, and the market 
continue to grow, researchers develop strategies for evaluating cannabis use behaviour.  The varying 
cannabinoid concentrations in cannabis, as well as their availability both by country and regionally, 
may have an impact on outcomes of cannabis users.  If cannabis users are in a country or region in 
which sinsemilla is a prominently distributed product, then there may be corresponding 
effects.  Additionally, if users are seeking out and predominantly using sinsemilla, this could also 
have an effect on their cannabis use outcomes.  It is therefore important for researchers to not only 
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evaluate the ‘knowledge’ of cannabis users, but how their knowledge of the cannabis and the 
market affects their decision making.  Do cannabis users seek out sinsemilla because it helps them 
achieve their intended use experience?  Are cannabis users making the decision to use sinsemilla 
despite possessing knowledge that it may have potentially negative mental health outcomes?  How 
does cannabis knowledge influence consumption behaviour? Simple measures of frequency, like 
number of joints or days of use per week, do not adequately inform researchers of the use 
behaviour of cannabis users, and as a result provide very little insight into how the mechanisms of 
use are related to outcomes. 
Although there are an increasing number of studies focusing on the relationship between 
cannabis use, drug-induced psychosis, and mental health disorders, it is important to note that these 
are not the only potential problematic outcomes associated with cannabis use.  It is important to 
understand specifics of cannabis use, especially in frequent users, and how these factors correspond 
to both positive and negative outcomes.  Understanding how the mechanisms of cannabis use 
behaviour relate to other problematic outcomes, like problems in relationships, finances, meeting 
commitments (school/work), is important.  By comparison, in determining the consequences of 
alcohol consumption, there is a distinction between users who have a glass of wine an evening, and 
a person who drinks 10 units an evening; however, this type of distinction is not as apparent in 
cannabis research, where period prevalence of use is often used as a substitute for levels of use.  As 
explored above, the type of cannabis, and the ratio of THC and CBD present in the species, and the 
way in which it is used is likely to have a great effect on outcomes in cannabis users.  Additionally, it 
is important to understand the degree to which users are involved within their own use behaviour, 
and the degree to which their knowledge of the cannabis they use, the desired outcomes of their 
use, and their ability to negotiate between these two factors, play a role in their use 
outcomes.  Furthermore, it is important to understand the contexts for which people are choosing to 
use cannabis, and how/why use is initiated and how this has affects their use outcomes. 
1.3 Theoretical foundation 
The social development model was the theoretical framework used to guide these studies and 
helped to understand the relationship between cannabis use outcomes and prevention 
interventions in young people. The social development model is an amalgamation of control theory 
(Hirschi, 1969) and social learning theory (Bandura, 1971), but for these studies the concept of 
instrumentalization of drug use was also considered (Müller and Schumann, 2011).  The social 
development model emphasises the development of prosocial bonds to significant groups such as 
community (including peers) and family as a means of protection from the development of 
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maladaptive behaviours such as drug abuse (Hawkins et al., 1992).  In addition, elements of other 
theories, including Problem Behavior Theory (Jessor, 1987), and theories implicating personality and 
interpersonal characteristics (Comeau et al., 2001; Howard et al., 1997) inform this research and 
subsequent factors believed to increase the susceptibility of cannabis related use and problems.  The 
theoretical background describes antecedents and risk factors and their association with the 
development of substance use behaviours.  Knowledge regarding risk and protective factors and 
their subsequent utility in predicting substance use (specifically cannabis) is paramount in designing 
and implementing prevention efforts.  Furthermore, the theoretical background seeks to explain the 
association between risk and protective factors and substance use is critical in the development of 
such intervention efforts and how to target individuals who may be more likely to initiate or develop 
problematic use. 
Previous research on cannabis use in the context of social development theory has 
supported the influence of peers and family factors on the initiation of cannabis use and the 
subsequent development of use trajectories and behaviours.  Peer influence has been associated 
with substance use involvement at different stages of development (Windle, 2000; Brook et al., 
2001); cannabis-using high school students with fewer cannabis-using friends were less likely than 
their peers to increase their cannabis use frequency six months later (White et al., 2006).  Familial 
factors, including parental monitoring, are associated with use initiation, early substance use, and 
drug use disorders (Chilcoat & Anthony, 1996; Kosterman et al., 2000; Reinherz et al., 
2003).  Additionally, research has provided evidence that interpersonal and personality variables are 
important risk factors associated with cannabis initiation and use among young people, including: 
aggression (Reinherz et al., 2000; Unger et al., 2003), risk perception (von Sydow et al., 2002; 
McCambridge & Strang, 2004), and sensation seeking (Martin et al., 2002). 
The consideration of instrumental drug use provides a framework for understanding non-
addictive psychoactive drug use, including the use of cannabis (Müller & Schumann, 2011).  This 
framework highlights that most people who are regular consumers of psychoactive drugs are not 
dependent and will never become dependent (O’Malley & Johnston, 2002). The concept of 
instrumental drug use suggests that there are specific mechanisms for which psychoactive drugs are 
indirectly used in order to achieve particular mental states such as improved social interaction; 
facilitated sexual behaviour; improved cognitive performance and counteracting fatigue; facilitated 
recovery from and coping with psychological stress; self-medication for mental problems; sensory 
curiosity; euphoria; hedonia, and high; and improved physical appearance and attractiveness (Müller 
& Schumann, 2011).  Under this framework, there may be ‘over-instrumentalization’ of drug use, 
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which leads to increasing risk of transitioning to dependent and/or problematic use of drugs’ (Müller 
& Schumann, 2011).  Although frequency of use is often attributed to problematic outcomes of use 
and dependency (Coffey et al., 2003), under this framework the ‘loss of control’ over drug 
instrumentalization would contribute to the development of problematic or dependent use 
behaviours. 
These theories were chosen in order to allow for the consideration of the fluidity of drugs 
use behaviour, and to reflect that use often matures and changes over time.  Furthermore, the 
intersection of these theories provides context to use behaviour that is influenced by social 
relationships and personality constructs.  Thus, although having peers who use cannabis may 
influence one’s own use behaviour, it is important to also contextualize use behaviour, including 
how use is facilitated and the instrumentalization of use.  Previous research has investigated the role 
of social relationships and personality constructs and their associations with cannabis use and other 
illicit drugs, but there is a paucity of work that has looked at these associations in the context of 
which use is administered using detailed analysis of the mechanisms of use. 
1.4 Prevention 
Prevention interventions seek to identify strategies that might avert the development of 
dysfunctional behaviour before it occurs.  The identification of risk factors associated with an 
increased probability of developing the dysfunctional behaviour and protective factors that reduce 
the probability of the development of the dysfunctional behaviour are the key elements of 
prevention research.  Once these factors have been identified, appropriate interventions can be 
devised to prevent the development of problematic use behaviours (Springer & Phillips, 
2007).  Universal intervention techniques dominate the realm of substance misuse prevention 
research.  However, the majority of universal substance misuse interventions, including those 
focusing on cannabis, have been found to be ineffective, and those demonstrating promise in 
addressing substance misuse often require extensive time and financial commitments while yielding 
minimal results (Foxcroft et al., 2002; Gates et al., 2006).  In contrast, indicated prevention is an 
individualised prevention approach that targets individuals at a higher risk for substance abuse or 
dependence later on in life and is considered to be the last point in prevention services for those at 
the border of developing substance use dependence.  Although indicated services offer the highest 
probability of reaching those who are responsible for some of the greatest individual burdens on 
health, criminal justice and social services, and are at risk for the greatest individual harm due to 
substance abuse, little research exists that has investigated it.  Indicated prevention is considered to 
be the most neglected prevention service among the three categories (universal, selective and 
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indicated) in the Institute of Medicine framework (Springer & Phillips, 2007).  Limited funding, 
recruitment difficulty, high costs, and complexities of co-occurring problems are all factors 
considered to be barriers to indicated prevention implementation.   
The Institute of Medicine (Springer & Phillips, 2007) concluded that where delivered 
indicated prevention strategies should: prevent progression to a dependence disorder (DSM-IV 
[currently DSM-V]); target harmful use and associated harms, not initiation of use; indicators of use 
should be more correlated with substance use compared to universal and selective interventions; a 
screening instrument should be used to identify at-risk individuals.  Family, peer, or community level 
indicators are not suitable, and so screening tools should include individual indicators (e.g. school 
failure, involvement in the criminal justice system, health or mental health problems, violence or 
aggression, heavy alcohol use) (EMCDDA, 2009).  In addition, best practice guidelines (which 
provides recommended, but not gold standard practice advice) suggest similar strategies and that 
indicated prevention should focus on those individuals with small, but detectable signs of substance 
abuse or similar behaviours; target individuals with high-risk indicators of substance abuse, but not 
dependence (according to diagnostic criteria); individuals must be identified prior to 
intervention;  the aim of the intervention should not be to stop the initiation of use, but to prevent 
the progression to dependence and reduce the length and frequency of harmful use; indicators 
should contain a higher level of association with the targeted behaviour than selective interventions; 
and individual risk and protective factors need to be known in order to determine a specific 
intervention (NIDA, 1997). 
Despite being an under researched field of substance misuse prevention, some indicated 
prevention interventions have shown promise.  One study from the UK found that a single 
motivational interviewing session delivered to young (aged 16-20 years) drug users recruited by 
peers, especially those considered to be vulnerable or high-risk (defined as higher cannabis use 
frequency, men, those on benefits, those with psychosocial vulnerability) to be effective in reducing 
frequency of cannabis use at a 3 month follow-up (McCambridge & Strang, 2004). However, effect 
sizes diminished at one-year follow-up suggesting either a tapering off effect or spontaneous 
improvement in control subjects (McCambridge & Strang, 2005). Despite a lack of long-term 
effectiveness, this study suggested that indicated prevention targeting young people at a higher risk 
of developing cannabis use dependence has the potential to change behaviour, at least in the short-
term.    
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Preliminary investigations using an indicated prevention approach have focused on targeting 
personality risk factors for substance misuse (Conrod et al., 2000a; Conrod et al, 2000b; Conrod et 
al., 2006; Conrod, Castellanos, & Mackie, 2008).  In particular, the personality factors of sensation 
seeking, trait anxiety, anxiety sensitivity and hopelessness have been targeted in indicated 
prevention interventions that seek to prolong use initiation and decrease propensity for problematic 
use. One personality-based targeted intervention in the UK comprised two 90 minute manual-driven 
group sessions led by a counsellor and co-facilitator, and prevented the growth of binge drinking 
behaviour among sensation seeking adolescents (mean age 14) compared to a control group (no 
intervention) (Conrod et al., 2006).  Additionally, evidence from personality-targeted indicated 
prevention intervention suggested that matching participants to interventions based on their 
personality, and the cannabis-use motivations that are predicted by such personality factors, are 
more effective in reducing frequency and severity of problematic alcohol and drug use (cannabis) 
compared to motivational control interventions (Conrod et al., 2000).  These results suggest that 
screening for use motivation and tailoring interventions based on these motivations is one direction 
in which prevention research should proceed.  Although the majority of indicated preventions using 
targeted personality interventions have focused predominantly on alcohol use and binge drinking, 
other research has shown that high anxiety sensitivity predicted conformity motives for cannabis use 
(Comeau et al., 2001).  Thus, personality-targeted brief interventions may look to focus on the high 
anxiety sensitivity as a motivational predictor for cannabis use and seek to design targeted 
interventions surrounding this personality construct. 
Despite the promise of targeting individual risk and protective factors to create more 
individualised approaches to preventing harmful substance misuse, the intervention models used 
have typically been based on traditional intervention techniques such as motivational interviewing 
(e.g. McCambridge & Strang, 2004), family based (e.g. Kamon et al., 2005), cognitive therapy (e.g. 
Zonnevylle-Bender et al., 2007) and school-based programmes (e.g. Conrod, Constellanos-Ryan & 
Strang, 2010; Conrod et al., 2013)).  Additionally, indicated prevention research has tended to rely 
largely on traditional modes for enrolling population groups most at-risk for developing substance 
misuse problems and dependence (although see Palmgreen et al., 2002 who used television 
advertisements with targeted content to recruit high sensation seekers).   Attention to creating more 
individualised approaches to preventing harmful substance misuse needs to not only focus on 
creating innovative ways to design interventions for high-risk populations, but also in developing 
innovative ways in recruiting and reaching target populations.  One innovative indicated prevention 
strategy in schools has used personality-targeted interventions to match high risk individuals with 
individualised interventions based on anticipated motivations for use based on personality profiles 
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(Conrod et al., 2006).  Implementation of similar innovative techniques in community settings, 
especially utilising existing public health frameworks and systems, is needed. 
1.5 Policy context 
In response to disparities in health outcomes and expectancies around drug use, the UK government 
has published its Drugs Strategy and subsequent annual reports detailing plans for reducing health 
inequalities (Home Office, 2010). The key principles of the current UK Drugs Strategy are to reduce 
demand, restrict supply and build recovery, which will be measured by the reduction of illicit drug 
use and its harms, and increasing the number of individuals recovering from dependence (Home 
Office, 2010).  Unlike previous strategies employed by the UK government, this strategy focuses not 
only on eliminating harms related to drug use, but providing opportunities to choose recovery.   
Furthermore, approaches will be oriented towards locally designed and delivered services.  The most 
recent update on the UK Drugs Strategy emphasises the continued use of universal and targeted 
approaches to reducing drug demand (Home Office, 2015). Indicated prevention provides a more 
individualised approach of preventative medicine and the utilisation of local services allow for 
services to be designed and delivered based on the specific vulnerabilities and needs of 
communities.  Although targeted approaches around vulnerable youth (particularly around 
resilience across the life course and parental drinking), men who have sex with men, and the 
identification of vulnerable young people and their subsequent referral to local services, the types of 
services, particularly around indicated approaches to the identification and dissemination of 
targeted prevention, are not specifically addressed (Home Office, 2015).  The types of targeted 
approaches used by local services, thus, are up to the discretion of the communities themselves.  
Thus, research exploring targeted approaches to drug prevention is needed to provide local 
communities with resources to deliver the most suitable targeted prevention interventions. 
1.6 Mixed Methods Approach 
This PhD employed a mixed-methods approach, using both quantitative and qualitative 
methodologies to answer the research questions posited in this thesis. Quantitative research utilises 
statistical and mathematical techniques to investigate observable phenomena in an attempt to 
generalise to a larger population, while qualitative traditionally asks broad questions to identify 
themes and patterns exclusive to the population used in the study.  The first two studies of this 
thesis employ quantitative methodologies to ascertain the relationship between risk factors 
associated with cannabis use outcomes.  The use of quantitative methods is important for the 
identification of factors that may be suitable for targeting in an indicated prevention intervention. 
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Additionally, the third study of this PhD employed qualitative methods in order to contextualize and 
explore the relationship identified in the previous studies.  This was critical in order to identify and 
explore the nuances of this relationship and the suitability for the previously identified risk factors 
for indicated prevention efforts.  Thus, the research methods used are informed by the research 
questions, and the research objectives in this piece of work are best met by the use of both 
quantitative and qualitative methods.  
The utilisation of mixed methods has been discussed in the academic literature (Bryman, 
2007; Bardley & Bishop, 2015).  One of the main issues in mixed-methods research is the importance 
of integration of research techniques and findings to be mutually enlightening, and similarly, mixed 
methods research is weakened by the lack of integration of data.  In this thesis work, each study 
were designed, implemented and informed by a consistent understanding of previous literature 
(through the literature review) and the emerging findings of studies.  As a result, the most suitable 
methods were chosen based on the research objectives and emerging evidence.  Thus, although 
findings were not concurrently analysed due to time available for the PhD, the studies were 
informed by consistent objectives and research questions. 
1.7 Conclusions 
Indicated prevention is a tool for which public health interventions can target individuals with 
specific vulnerabilities to developing problematic use outcomes.  This technique provides an 
opportunity for a cost-effective way to deliver interventions.  In contrast to universal interventions 
which are targeted at the entire population regardless of level of risk, this allows interventions to 
focus specifically on the mechanisms which are most likely to lead to problematic 
outcomes.  Although this provides an opportunity for public health to focus on the most vulnerable 
population groups, it is first important that researchers understand the mechanisms of use between 
cannabis use and risk and protective factors.  Many of the risk and protective factors associated with 
cannabis use have numerous confounding factors and it is important before designing indicated 
interventions that these factors are, in fact, strong predictors of problematic use, and that the 
mechanisms of use that predict use outcomes are understood so interventions targeting these 
individuals can be developed.  This literature provides a review of the cannabis and prevention, and 
highlights the need for more investigative work informing indicated prevention efforts.  This PhD will 
investigate the relationship between risk factors and their linkages with cannabis, and how 
understanding this relationship may provide an understanding of how indicated interventions for 
young people and cannabis use can be designed and delivered. 
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Chapter 2 
Cannabis use measures and associated risk 
factors 
 
2.1 Introduction 
Prevention science research seeks to avert the development of dysfunctional use behaviour before it 
occurs.  The identification of risk factors associated with an increased probability of developing the 
dysfunctional behaviour and protective factors that reduce the probability of the development of the 
dysfunctional behaviour are the key elements of prevention research.  Once these factors have been 
identified, appropriate interventions can be devised to prevent the development of problematic use 
behaviours.  
The majority of focus on cannabis prevention work has been on the initiation of cannabis use 
and abstinence (Porath-Waller, Beasley & Beirness, 2010; Norberg, Kezelman, & Lim-Howe, 2013).  
Although cannabis use in the United Kingdom has decreased in recent years, the prevalence of recent 
and frequent cannabis use is still the greatest amongst all illicit drugs (Burton et al., 2014).  Although 
prevention work seeks to prevent the initiation of cannabis use, it also works to prevent cannabis 
users from graduating to dependent and/or problematic use.  It is therefore important to understand 
whether or not the risk and protective factors associated with cannabis initiation are similar to other 
cannabis use outcomes, including frequency and self-reported cannabis use-related problems.  
A multitude of risk and protective factors have been implicated in the development of 
cannabis and other drug-related behaviours.  Although there is a complicated web of factors 
associated with the development of drug-related and cannabis, this research focuses specifically on 
factors that are most suitable for community and school-based interventions.  Thus, factors that are 
appropriate for large-scale screening and amenable to change are considered.   
This research has two main objectives: 
1) To assess outcome measures of cannabis use and how they are predicted by risk and 
protective factors, and the feasibility of developing indicated prevention efforts based on 
these factors. 
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2) To assess how sub-clinical levels of psychopathology affect use outcomes, and if this is an 
appropriate avenue for future indicated prevention work. 
In assessing the first research objective, it is important to differentiate the relationship between 
frequency and problematic outcomes in order to better understand how these two outcomes interact.  
In alignment with the drugs as instruments framework (see section 1.2), we cannot make the 
assumption that the frequency of use is directly related to problems associated with cannabis use.  
Rather, the over-instrumentalization of drugs and lack of control regarding use precedes problematic 
outcomes.   Thus, although users of drugs may be considered recreational, infrequent users, these 
individuals, if they are engaging in abusive or ‘binge’ use, may still experience problematic use 
outcomes, even if these problematic outcomes are not considered as indicators of dependence.  It is 
important that these individuals are not discounted when assessing and estimating prevalence of 
problematic users, and that interventions designed to prevent problematic use would be appropriate 
and available for this population.  Furthermore, it is necessary in defining interventions to assess which 
individuals are most likely to have problematic outcomes due to their use, and not just the individuals 
who are susceptible of progressing to dependent use.  In looking at young people, it is of importance 
to note that while many young people acutely engage in problematic alcohol behaviours, both 
delinquent and hazardous, most of these people will not advance to dependent use, yet these 
individuals may still benefit from targeted interventions (Johnstone et al., 1996; Zakrajsek & Shope, 
2006; McCambridge, McAlaney & Rowe, 2011) .This same approach needs to be adopted for cannabis 
and other drug use behaviour (Sargent et al., 2010; Conrod, Castellanos-Ryan & Strang, 2010). 
In the second research question, sub-clinical levels of psychopathology and its relationship with 
cannabis use outcome are investigated.  The reasoning for this is two-fold: 1) psychopathology is one 
of the factors most attributed to cannabis and other drug use outcomes (Moore et al., 2007); and 2) 
the comorbidity of mental health and problematic drug use is a great public health concern (Jané -
Liopis & Matytsina, 2006).  Depression, anxiety, and aggression have all been linked to cannabis and 
other drug use behaviour (Crippa et al., 2009; Ostrowsky, 2011; Lev-Ran et al., 2013).  The direction 
of causality amongst psychopathology and drug use is often presented with conflicting theories. Some 
suggest that psychopathology leads to increased drug use, while others purpose that drug use leads 
to increased levels of psychopathology (Harris & Edlund, 2005; van Laar et al., 2007; Schneider, 2008; 
Degenhardt et al., 2013).  It is likely that there is a bi-directional relationship between 
psychopathology and drug use, where one factor exacerbates the condition of the other (McGee et 
al., 2000; Ferdinand et al., 2005; Pacek, Martins & Crum, 2013).  Thus, psychopathology would be an 
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appropriate risk factor for the development of indicated prevention in potentially curbing the 
development of both problematic cannabis use and mental health outcomes. 
2.2 Risk and protective factors associated with drug use 
Research has identified numerous risk and protective factors associated with the use of licit and 
illicit substances including, but not limited to: genetics (Lynskey et al., 2002; Verweij et al., 2010), sex 
and sexuality (Guxens et al., 2007; Corliss et al., 2010), age (Young et al., 2002; Beckett et al., 2004; 
Ljubotina et al., 2004; Palmer et al., 2009 ), life events (Turner & Lloyd, 2003), self-esteem (Hoffman 
& Cerbone, 2002; Bitancourt et al., 2016), impulsivity/sensation seeking (Martin et al., 2002; 
Crawford et al., 2003), mental health disorders (Höfler et al, 1999; Hoffman and Cerbone, 2002; 
Ilomaki, 2004), early onset of substance use (Höfler et al., 1999; von Sydow et al., 2002), drug-
related attitudes and cognitions (von Sydow et al., 2002; McCambridge & Strang, 2004), aggression 
(Reinherz et al., 2002; Unger et al., 2001),  family structure (Reinherz et al., 2002; Lynskey et al., 
2002), parental monitoring (Case and Haines, 2003; Wu et al., 2004), peer behaviour and use (Höfler 
et al., 1999; von Sydow et al., 2002; Beckett et al., 2004), social norms (Kosterman et al., 2000) 
educational performance (Hallfors et al., 2002) socio-economic status (Höfler et al., 1999; Reinherz 
et al., 2002; Poulton et al., 2002); and drug availability (von Sydow et al., 2002).   The large number 
of factors associated with substance misuse has led to difficulties for researchers and public health 
practitioners to identify which are most predictive of harmful outcomes or are most suitable for 
targeting through intervention.  Furthermore, each factor is also likely to be differentially amenable 
to change through intervention (e.g. sex is resistant to change, parental monitoring is easier to 
change, whilst improving socio-economic status is difficult but amenable to change through long 
term policy investment), and the effect of changing the indicator on drug use behaviour also varies. 
As the majority of this area of research has been conducted in international populations (typically 
the USA) it is also important that the transferability of existing findings is investigated. Research is 
therefore needed that not only identifies amenable factors but that also assesses whether they may 
be targeted through local (or national) health service structures and systems. 
The risk and protective factors at the forefront of this PhD research are 
impulsivity/sensation seeking, aggression/externalising behaviours, anxiety sensitivity, 
depression/depressive symptoms, and risk perception/time perspective.  For these factors, there is 
an emerging body of literature examining their relationship with substance use behaviours (Windle 
& Wiesner, 2004; Bonn-Miller et al, 2007; Comeau et al., 2001; Hampson et al., 2008; Korhonen et 
al., 2008; Kilmer et al., 2007).  Evidence from indicated prevention research also suggests that 
targeting these factors may provide an effective means of recruiting participants into interventions, 
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(e.g. Palmgreen et al., 2001), and such interventions may also be effective at reducing substance use 
in young people of previous indicated prevention interventions targeting these factors (Conrod et 
al., 2006; Conrod et al., 2010; McCambridge & Strang, 2004; Zonnevylle-Bender, 2007).   
2.2.1 Genetic factors associated with cannabis use 
Genetic factors associated with cannabis use are largely unsuitable for indicated prevention, 
although interventions targeting phenotypes, specifically looking at the interaction of genes and the 
influence of environmental factors may be suitable for future prevention work.  However, in 
assessing which risk and protective factors are suitable to interventions, it is important to assess the 
degree to which genetic factors contribute to use behaviour and outcomes.  A recent meta-analysis 
of environmental, such as family environment, parental style, prenatal influences, socio-economic 
status, and genetic factors associated with cannabis use evaluated the links between cannabis 
initiation and dependence in twin studies by sex (Verweij et al., 2010).  This study presented findings 
into three categories: genetic factors; factors from a shared environment; and environmental factors 
not shared by twin pairs.  As with most attempts to amalgamate multiple studies of cannabis use, 
there was a lack of consistency with the measurement of problematic cannabis use in the primary 
studies used for analysis.  For this study, problematic cannabis was ‘operationally defined’ as having 
‘one or more symptoms of abuse or dependence in their lifetime’ as defined by the primary authors, 
although most used the DSM-IV (Verweij et al., 2010).  For males, genetic factors contributed the 
most to models explaining both initiation of use and problematic use, while shared and unshared 
environmental factors contributed significantly to the model, but to a lesser extent.  For females, the 
results showed a strong association between genetic factors and problematic cannabis use, and 
shared environmental factors and initiation of cannabis use.  These results indicate that both 
cannabis initiation and problematic use are hereditable, although the strong contributions of shared 
and unshared environmental factors suggest that non-genetic factors play a substantial role.  A 
particular insight of this meta-analysis is the importance these factors may play at different points in 
cannabis use trajectories.  For females, the extent to which environmental factors contributed to 
initiation of use and biological factors to problematic use suggested that use initiation is more 
strongly related to availability of cannabis and the use by peers.  Additionally, this would suggest 
that the biological factors related to cannabis may be more important in understanding the 
development of problematic use outcomes.  In developing cannabis use interventions, it is important 
to note that for females, in particular, initiation of use may be a critical point of intervention, and 
environmental factors associated with initiation of use may be most suitable in designing targeted 
prevention. 
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2.2.2 Mental health and cannabis 
Substantial research focus has been placed on the relationship between cannabis and psychotic and 
affective mental health outcomes (Moore et al., 2007; Degenhardt et al., 2013; Lev-Ran et al., 
2013).  Despite these efforts, the relationship between mental health and cannabis remains unclear 
(Moore et al., 2007).  One of the main difficulties in unravelling the relationship between mental 
health outcomes and cannabis use is elucidating causality (McLaren et al., 201.).  Despite frequent 
assertions of comorbidity and correlation between mental health factors and cannabis use 
outcomes, paradoxical theories of self-medication hypothesis and cannabis use as a contributing 
factor to the development of mental health outcomes have been frequently demonstrated and 
refuted in the literature (Lazereck et al., 2012).  Furthermore, there are considerable difficulties in 
ascertaining cannabis use outcomes and the suitability of frequency and dependence as appropriate 
measures (Zeisser et al., 2012; van der Pol et al., 2013b; Hughes et al., 2014).  The measurement of 
amount of cannabis use specifically is difficult due complexities of use sharing in cannabis culture 
and the variability in cannabis content, including the percentage of THC present.  Despite the 
limitations of current research on the relationship between mental health and cannabis, 
considerable progress has been made in understanding this relationship. 
The association between cannabis use and mental health outcomes and disorders has been 
well documented.  Heavy use of cannabis is associated with the onset of acute psychotic episodes 
for those without previous history of psychotic symptoms and the exacerbation of symptoms for 
those with established psychosis (Linszen, Dingemans, & Lenoir, 1994; van Os et al., 2002; van Os et 
al., 2009).  The relationship between affective mental health disorders and cannabis use is more 
equivocal, although research suggests that depressed individuals are more likely to use cannabis, 
and that use associated with an increased likelihood of anxiety, depression and suicide attempts 
(Johns, 2001).  In a systematic review of longitudinal studies of cannabis and mental health 
disorders, a consistent increase in incidence of psychotic mental health outcomes, independent of 
acute intoxication, was found in addition to a dose-response effect with risk of incidence increasing 
from 40% to 50-200% for heavy using participants (Moore et al., 2007).  While the relationship 
between psychotic mental health outcomes and cannabis was consistent, the link between cannabis 
use and affective mental health outcomes, including anxiety and depression, was less strong. 
A cohort study in Australia that followed adolescent students (aged 14-15 years-old) for 7 
years found an association between frequent cannabis use and the development of anxiety and 
depression (Patton et al., 2002).  While 60% of participants had used cannabis by the age of 20, as 
frequency of cannabis use increased so did the prevalence of anxiety and depression.  This effect 
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was particularly strong for female participants, with female daily users of cannabis having an over 
fivefold increase in odds of anxiety or depression than in non-users.  In this sample, no prospective 
relationship between anxiety and depression in adolescence and later frequent cannabis use was 
found, repudiating the self-medication hypothesis and suggesting that pharmacological or 
psychosocial mechanisms underlie the relationship between cannabis and mental health.   
Although the self-medication hypothesis has been disputed in the development of anxious 
and depressive affective disorders, evidence supported that cannabis is used as a means of self-
medication for aggression (Arendt et al., 2007).  In a sample of cannabis dependent (ICD-10 criteria) 
young adults (aged 16-30 years), participants that reported problems controlling violent behaviour 
tended to use cannabis to decrease aggression and suspiciousness, and for relaxation, despite 
reacting with more aggression when intoxicated.   This study had several limitations, including the 
use of a crude measure of aggression as the recurrent tendency to either harm people physically and 
the retrospective evaluation of behaviour.  Despite these limitations, these results suggest self-
medication of aggression.  In addition, this study investigated the relationship between depression, 
cannabis dependence and the self-medication hypothesis.  Results indicated that depressive 
participants did not retroactively self-report happiness or euphoria after acute cannabis use; 
suggesting that self-medicating for depression by the use of cannabis is unlikely, consistent with 
previous research (Degenhardt, Hall & Lynskey, 2003).  
The relationship between cannabis and mental health is complex and similar factors are 
associated with the development of both the initiation of cannabis use and the development of 
mental health problems.  The direction of causality is contentious, but most assertions suggest that 
cannabis use generally predisposes the development of mental health disorders (Richardson, 
2010).  However, the complexities of reviewing such research are highlighted by one longitudinal 
study following adolescents (aged 15 years-old) until early adulthood (aged 21 years-old) that 
indicated that mental disorders at the age of 15 led to a small, but significant elevated risk of 
cannabis use at the age of 18, while cannabis use at age 18 led to an elevated risk of a mental 
disorder at age 21 (McGee et al., 2000).  Realistically, there are likely to be several different 
pathways and trajectories relating to cannabis use and mental health disorders, and it may be that 
there is a bi-directional relationship between cannabis and mental health.   
2.2.3 Anxiety sensitivity 
Although correlated and similar to trait anxiety, anxiety sensitivity is a conceptually and distinct 
construct (McNally & Eke, 1996).  Anxiety sensitivity corresponds to a specific fear of anxiety-related 
  
28 
 
bodily sensations as a result of a fear that such sensations will lead to negative outcomes such as 
physical illness, social embarrassment or loss of mental control (Reiss et al., 1986), while trait anxiety 
refers to the tendency to react anxiously to potentially anxiety provoking stimuli. Anxiety sensitivity 
is believed to be related to cannabis use, particularly for individuals for whom coping is a motivation 
for cannabis use (Bonn-Miller et al., 2007).  Anxiety sensitivity is considered to be a malleable trait in 
psychosocial interventions, meaning that interventions targeting anxiety sensitivity could change 
cannabis use, or other substance use outcomes (Otto & Reilly-Harrington, 1999; Smits et al., 
2008).  Interventions that have decreased anxiety sensitivity, such as moderate-intensity exercise, 
have been shown to decrease levels of anxiety sensitivity as well as decreased motivations to use 
cannabis for coping reasons (Smits et al., 2011).  This evidence supports the need to further 
investigate how the reduction of anxiety sensitivity through moderate-intensity exercise as a 
potential intervention tool for reducing cannabis problems. 
Other research has investigated the potential links between anxiety sensitivity and cannabis, 
and its potential for public health interventions. The Substance Use Risk Profile Scale is an 
instrument used to assess four distinct, independent personality trails (anxiety sensitivity, 
hopelessness, sensation seeking, and impulsivity) believed to be associated with problematic 
substance use (Krank et al., 2011).  In one study of Dutch adolescents, results indicated that 
hopelessness and sensation seeking were strongly associated with using alcohol, cannabis and 
tobacco, while high anxiety sensitivity individuals were less likely to use alcohol at a younger age 
(Malmberg et al., 2010).  It is important to note that this research focused specifically on age of 
onset, and suggested only that hopelessness and sensation seeking individuals are more likely to 
engage in use at a younger age.  This is not surprising considering characteristics of sensation 
seeking and hopelessness would be more likely to coincide with engaging in deviant or hedonic 
behaviour.  It is likely that anxiety sensitivity would not be associated with the initiation of use, but 
that it may affect use outcomes if one begins to use cannabis. An analysis of the role of anxiety 
sensitivity and cannabis use and how it influences use behaviour across the course of use trajectory 
is needed.  For example, individuals with high levels of anxiety sensitivity are likely to engage in 
substance use to relieve negative affective states, while high sensation seeking individuals are more 
likely to engage in use for the positive hedonic effects (Brunelle et al., 2004; Conrad, Pihl & Vassileva, 
1998).  Thus, while individuals with high anxiety sensitivity may not have an earlier age of onset for 
cannabis use, they still may be more likely to develop problematic use outcomes.  Research looking 
at the effects of internalising behaviour (anxiety, depression, and suicidal tendencies) and 
externalizing behaviour (hyperactivity, aggression) and cannabis dependence symptoms found that 
high levels of internalising behaviour problems were associated with high number of dependence 
  
29 
 
problems, regardless of the coping motive level (Fox et al., 2011).  The mechanisms for this 
relationship were different than hypothesised.  The researchers predicted that experiencing higher 
levels of internalising behaviours would result in levels of negative consequences that exceeded 
predictor variables; however, using cannabis to cope with negative affects was most problematic for 
users without internalising behaviours (Fox et al., 2011).  The mechanisms between anxiety 
sensitivity and cannabis use in young people still need considerable more research to untangle the 
web of factors underlying the relationship; however, the linkages between anxiety sensitivity and 
the development of cannabis use problems as well it’s malleability in an intervention setting suggest 
that this may be a suitable construct for indicated prevention. 
2.2.4 Aggression and problem behaviour 
Aggression and problem behaviour have been shown to be major risks factors for drug use.  The self-
medication hypothesis postulates that individuals who experience negative emotional stress tend to 
seek out specific substances in order to assuage specific symptoms (Khantzian, 1985).  In a study of 
clinically dependent cannabis users in Denmark, for example, evidence suggested that cannabis use 
could be used as a means of self-medication for controlling aggression and problem behaviour, 
defined as difficulty in controlling violent behaviour (Arendt et al., 2007).  Furthermore, evidence 
suggests that cannabis use, in moderate to high doses, is linked with the suppression of aggressive 
behaviour (Hoaken & Stewart, 2003).  Although the self-medication theory refers specifically to 
controlling violent behaviour, the research in this PhD intends to focus on both violent and non-
violent behaviour and distinguish these from anger and aggression.  This will provide a more 
appropriate and inclusive measure of aggression suitable for a general population sample. 
Research has investigated how the relationship between cannabis and aggression was 
mediated in a clinical sample of young people (under 26 years-old) with first-episode psychosis 
(Harris et al., 2010). The results indicated that patients who exhibited physically aggressive 
behaviour were more likely to be regular users of cannabis.  Although it is not clear whether or not 
cannabis use is a direct cause of violent/aggressive behaviour, or if confounding factors of 
personality type and deviant behaviour are the cause (Harris et al., 2010).  The authors propose that 
a potential mechanism for which cannabis may increase aggressive behaviour is the effect of ‘go-no 
go’ functions on the brain which play a role in the ability to inhibit behaviour (Harris et al., 
2010).  The self-medication hypothesis would suggest that using cannabis may serve to inhibit 
violent or aggressive behaviour, and that cannabis is unlikely to cause aggressive or violent 
behaviour, which is supported within the literature (Abel, 1977).  It is important, however, to 
understand if aggression is a suitable construct for targeting individuals who are likely to become 
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problematic users of cannabis, or whether aggression is linked to other confounding factors that are 
associated with problematic cannabis use outcomes. 
2.2.5 Depression 
Psychopathology, particularly depression, has been implicated in the development of cannabis use 
and related problems (Degenhardt, Hall & Lynskey, 2003; Degengardt et al., 2013).  There are three 
main theories in research regarding the relationship between cannabis and psychopathology, 
including depression: a causal link of cannabis increasing the risk of psychopathology (cannabis 
causing depression); reverse causation where cannabis use is caused or influenced by 
psychopathology (depression causing cannabis); and the association between cannabis and 
psychopathology is due to other factors (confounding factors increase the risk of both cannabis use 
and depression), like socioeconomic status and personality factors, and the measured association is 
due to confounding factors and other bias (Johns, 2001; Arseneault et al., 2004; Macleod et al., 
2004; Arendt et al., 2007).  A study of cannabis-dependent young people (under 30 years-old) looked 
to investigate the self-medication hypothesis for depression and aggression (Arendt et al., 
2007).  Results indicated that while there did not appear to be evidence supporting the self-
medication hypothesis and cannabis and depression, those with reported depressive symptoms 
were more likely to report lifetime history of problems (Arendt et al., 2007).  Furthermore, prior 
depression was associated with less positive effect outcomes reported while under the influence of 
cannabis (Arendt et al., 2007).  Thus, although evidence suggests that depression may not be used to 
assuage depressive symptoms, depressive symptoms may lead to less positive cannabis use 
outcomes and in turn problematic use. 
A review of the evidence exploring the association between cannabis use and depression 
found that heavy cannabis use and depression were correlated, and that longitudinal data suggests 
that heavy cannabis use may increase depressive symptoms in some users (Degenhardt, Hall & 
Lynskey, 2003).  Furthermore, as evidenced by longitudinal studies, the authors highlight that early 
onset regular or problematic cannabis use is associated with later onset of depression.  This is likely 
because a) cannabis causes changes in neurotransmitter systems that lead to a more depressed 
mood, or b) that effects of cannabis use are socially mediated, whereas reduced educational 
attainment, unemployment and crime, and other factors associated with regular and problematic 
cannabis use lead to depressive symptoms (Degenhardt, Hall & Lynskey, 2003).  This evidence 
suggests that there may be a bidirectional relationship between cannabis and depression, whereas 
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some early onset and subsequent regular cannabis use may lead to depressive symptoms, and 
depressive symptoms may lead to more problematic use outcomes in others. 
In an effort to better understand the mechanisms that underlie the association between 
depression and cannabis, research has examined those factors that may mediate this 
relationship.  In one study of University undergraduates, researchers investigated how distress and 
discomfort intolerance mediates the relationship between depression and cannabis use and related 
problems (Simons & Gaher, 2005).  Discomfort intolerance assesses the ability to tolerate physical 
states of discomfort, and distress intolerance is the ability to tolerate negative and physical 
sensations, which have been previously linked to substance misuse (Simons & Gaher, 2005). The 
results indicated that distress intolerance was associated with problematic cannabis use, including 
cannabis problems and cannabis frequency (Buckner, Keough, & Schmidt, 2007).  Discomfort 
intolerance mediated the relationship between cannabis and depression whereby individuals with a 
greater capacity to tolerate discomfort were more likely to have cannabis-related problems 
(Buckner, Keough, & Schmidt, 2007).  This research also suggested that distress intolerance may act 
as a protective factor for cannabis use for individuals less able to tolerate negative physical 
sensations, like some of those produced during cannabis intoxication, resulting in them being less 
likely to use cannabis (Buckner, Keough, & Schmidt, 2007).  These results provide an interesting 
contribution to the vast literature of depression and cannabis.  It appears that depression and 
cannabis have a bidirectional relationship, and it is likely that there are many confounding factors, 
thus it is difficult to ascertain how strong the association between cannabis and 
depression.  Furthermore, evidence that discomfort intolerance may mediate this relationship 
suggests that those less able to tolerate bodily sensation are less likely to use cannabis, and that the 
role of discomfort in those with greater levels of depression may serve as a protective factor. 
2.2.6 Sensation seeking 
Sensation seeking is a personality trait characterised by the need to seek novel experiences and 
intense sensations, including activities involving danger or risk, and having the willingness to take 
risks to have such experiences.  The relationship between sensation seeking and drug use has been 
reported in various populations.  Research investigating sensation seeking is largely based on the 
work of Zuckerman (see, for example: Zuckerman 1979, 1988, 1994).  This work defines sensation 
seeking as a personality trait in which individuals seek varied, novel, complex, and intense sensations 
and experiences which are sought despite associated physical, social, legal and financial 
risks.  Indicated prevention interventions based on this theoretical conception of sensation seeking 
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have been shown to be effective in delaying onset of substance use among high risk, vulnerable 
youth with elevated trait sensation seeking (Conrod et al., 2006; Conrod et al., 2010).  Sensation 
seeking has been implicated in the development of alcohol misuse behaviours, particularly heavy 
episodic drinking, and targeted interventions delivered to younger adolescents (mean age 14 years-
old ) have proven effective in delaying initiation and reducing harmful use (Conrod et al., 2000; 
Conrod et al., 2006).   
In order to better conceptualise the ways in which sensation seeking may be linked to drug 
use, a study investigated the relationship between several factors, including sensation seeking, and 
motivations for alcohol, tobacco and cannabis use (Comeau et al., 2001).  Based on Cooper’s (1994) 
model of motivations for drinking (conformity, enhancement, coping, and social), the authors 
investigated how different risk and protective factors associated with use contributed to different 
motivations for use.  Previous researchers have utilised Cooper’s model with cannabis use and found 
that coping and enhancement motivations led to increased frequency of use, while conformist 
motivations led to more problematic use outcomes (Simons et al., 1998).  In the sample of over 500 
adolescents, personality factors associated with cannabis use motivations were only significant for 
conformity motivations, and anxiety sensitivity was an independent, significant predictor.  The 
authors suggest that anxiety sensitivity and its link with cannabis use are based on the anxiolytic 
effects of the drug and the anxiety related to social encounters (Comeau et al., 2001).  The authors 
did not find an association between sensation seeking and enhancement motivations for cannabis 
use, despite previous research; however, the authors suggest that although sensation seeking may 
not be associated with enhancement motivations, it is possible that sensation seeking is linked to 
expansion motives, or experiential awareness (Comeau et al., 2001). 
Another study investigating the genetic and environmental risk factors associated with 
cannabis use in twins, specifically looked at risk-taking and sensation seeking 
characteristics.  Opposed to using the commonly used Zuckerman Sensation Seeking Scale, a seven-
item scale, still representative of the Zuckerman scale, addressing risky behaviours(including: birth 
control use, sexual promiscuity, riding a motorcycle, seat belt use) was used.  No associations were 
found between the risk-taking behaviours, suggesting that there was not a unitary concept of risk-
taking. Results suggested that the amount of variance in cannabis use attributed to sensation 
seeking differed greatly by the four traits examined (risk-taking attitude, riding a motorcycle, seat 
belt use, and sexual promiscuity).  Furthermore, results indicated that although genetic factors are 
associated with variation in cannabis use, these genetic factors are not associated with risk-taking 
behaviours (Miles et al., 2001). 
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Despite contradictory evidence linking cannabis and sensation seeking personality 
characteristics, it may be that sensation seeking is in fact mediated by other factors associated with 
cannabis use outcomes.  In a study examining the relationship between early sensation seeking in 
children (during 4th and 5th grade of elementary school) and cannabis use during adolescents (during 
11th and 12th grade), early sensation seeking was found to be linked to adolescent cannabis use 
(Hampson et al., 2008). Furthermore, path analysis showed that early sensation seeking leading to 
adolescent cannabis use was mediated through affiliation with deviant peers.  This suggests that 
sensation seeking influenced cannabis used as a result of sensation seeking leading to motivation to 
associate with deviant peers (Hampson et al., 2008).  In addition to looking at sensation seeking and 
deviant peer associations with cannabis, researchers have also investigated the relationship 
between parental monitoring, sensation seeking and cannabis.  Results from a study of college 
students found that while sensation seeking was associated with alcohol and cannabis dependence, 
parental monitoring (as measured by parental monitoring during last year of high school) was only 
associated with alcohol dependence (Kaynak et al., 2013).  
In addition to the relationship between sensation seeking and cannabis use outcomes, the 
relationship between sensation seeking, cannabis, and substance use prevention campaigns has 
been a topic of importance for public health researchers.  Researchers evaluated the effect of the 
National Drug Control Policy’s Marijuana Initiative Campaign (USA) on young people and found that 
high sensation seekers decreased their cannabis use in the past 30 days as a result of the campaign 
(Palmgreen et al., 2007).  Additionally, positive cannabis attitudes and beliefs for high sensation 
seekers were significantly reduced (Palmgreen et al., 2007).  The authors suggest the effectiveness of 
this campaign was due to using ‘dramatic negative consequence’ messages, and although this may 
be useful in preventing use initiation, it is important to consider whether this tool would be useful in 
preventing problematic cannabis use and dependence. 
Sensation seeking has also been evaluated as a moderator of the effects of peer influences, 
consistency with personal aspirations, and perceived harm and cannabis use.  Results indicated that 
peer pressure and perceived peer cannabis use had little effect on low sensation seekers, while 
having a much greater effect on high sensation seekers (Slater, 2003).  Additionally, aspirations 
inconsistent with cannabis use were a protective factor for high sensation seekers.  These results 
provide implications for prevention and provide further evidence that high sensation seekers are at 
an increased risk for cannabis use, and that understanding the mechanisms associated, including the 
influence of peer behaviour, may be useful in designing targeted interventions. 
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2.2.7 Impulsivity 
Impulsivity is a personality trait which can be characterised by the degree to which one has 
behavioural disinhibition.   Impulsivity can manifest in various ways, including performing an act or 
making a choice without considering the potential consequences of the action.  Impulsive 
personality traits are highly prevalent amongst substance-using individuals and have been discussed 
as both a risk factor and a consequence for substance abuse (de Wit, 2009).   There are three major 
hypotheses regarding the relationship between drug use and impulsivity: 1) high levels of impulsivity 
lead to drug use, 2) the use of drugs increases impulsivity, and 3) impulsivity and drug use are 
related to a common factor(s) (Perry & Carroll, 2008). 
Acutely, cannabis use has been associated with the impairment of impulsivity when light 
users received a high dose of THC (McDonald et al., 2003), and on a task of inhibition by intoxicated, 
chronic cannabis users (Ramaekers et al., 2006).  These results suggest that acute cannabis use 
supports impulsive behaviour and influence inhibition of maladaptive responses (Crean, Crane, & 
Mason, 2011).  Long-term effects of cannabis on impulsivity are less certain.  The Stroop Test and 
the Wisconsin Card Sort Test (WCST) have been used to assess the relationship between impulsivity 
and cannabis use, with both demonstrating different results.  The Stroop Test has consistently 
demonstrated no difference between cannabis users and controls (Lyons et al., 2004; Pope et al., 
2001, 2002, 2003; Verdejo-Garcia et al., 2005), while studies using the WCST have largely produced 
significant differences between cannabis users and controls (Bolla et al., 2002; Pope et al., 2001, 
2002, 2003).  It has been suggested that the results are due to differences in the abilities necessary 
to perform the tasks, implicating concept formation, planning, and sequencing as potential facets of 
impulsivity impaired by long-term chronic use of cannabis (Crean, Crane & Mason, 2011).  In 
addition to acute and chronic users of cannabis, recreational cannabis users were found to have 
impulsivity traits, impulsive decision-making, and behavioural disinhibition linked to consumption 
patterns (Moreno et al., 2012).  This research suggests that the progression from recreational drug 
use to chronic drug abuse may be mediated by impulsive traits, and that trait impulsivity, as 
described by the impulsive endophenotype, may be considered as a risk factor (Ersche et al., 2010). 
A review of impulsivity and substance use disorders supports the theory that impulsivity 
precedes the development of substance use disorders (Verdejo-Garcia et al., 2008).  Despite this 
finding, the authors caution that impulsivity is often not a specific predictor of substance use 
disorders, but rather ‘a shared risk factor for multiple clinical manifestations and disorders’ (Verdejo-
Garcia et al., 2008).  Impulsivity is a highly complex behaviour construct, and there appears to be a 
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moderate heritability (Eysenck, 1993).  It is therefore important for future research to identify and 
deconstruct the genetic risk factors associated with impulsivity and their dimensions (Verdejo-Garcia 
et al., 2008).  In understanding how to deliver indicated interventions, it is crucial to understand 
impulsivity and how it relates to other factors associated with the development of cannabis 
problems. 
2.2.8 Risk perception and time perspective 
The perception of risk is closely associated with beliefs about negative consequences of behaviour; 
however, because of the attention given to the concept of risk it merits separate treatment.  Risk 
perception concerns beliefs about the severity of consequences associated with performing a 
specific behaviour, and the probability of those consequences occurring.  The Health Belief Model 
suggests that perceived risk is a key determinant in the decision-making process for health related 
behaviours (Pechmann, 2001).  In a social environment where it often believed that cannabis-related 
behaviour is less stigmatised than other drug behaviour, it is hypothesised that the greater lifetime 
use and heavier, more problematic use result from the lack of perceived risk of cannabis 
use.  Furthermore, evidence suggests that perceived risk and the potential consequences of cannabis 
use act as a protective factor for use initiation, and that for heavy cannabis users the perceived risk 
and potential consequences of use are not congruent to their actual experiences (Kilmer et al., 
2007).    
In a similar vein to risk perception, time perspective is a non-conscious process by which 
social and personal experiences are allocated to temporal categories, or time frames, and work to 
give order, coherence and meaning to those events (Zimbardo and Boyd, 1999).  It is hypothesised 
that the ways in which these experiences are assigned influences the ways in which people make 
judgements and greatly inform the decision-making process.  Time perspective identifies five 
different types of temporal categories:  Past Negative, Present Hedonistic, Future, Past Positive, and 
Present Fatalistic.  Studies using this construct in health research have found, for example, that 
those with a high present orientation, both hedonistic and fatalist, were more sexually active and 
less likely to use alternate methods of reducing HIV exposure than future oriented peers (Rothspan 
& Read, 1996).  When considering cannabis use, a person with a Future-orientated time perspective 
and high perceived risks of cannabis use might be less likely to report use.  Alternatively, a person 
with a present oriented time perspective with lower perceived risk of cannabis use might be more 
likely to be report use. 
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Previous research investigating time perspective has shown Future time perspective as a 
protective factor for cannabis use (Keough, Zimbardo, & Boyd, 1999; Wills, Sandy & Yaeger, 
2001).  In order to better understand the relationship between time perspective and drug use, 
researchers investigated how Future time perspective mediated the role of general drug-oriented 
perception in French adolescents (Apostolidis et al., 2006a).  Results indicated that Future time 
perspective had a negative relationship with reported cannabis use as frequently evidenced in the 
literature, and furthermore that drug-oriented perception may play a mediating role in this 
relationship (Apostolidis et al., 2006a).  This suggests that the relationship between Future time 
perspective and cannabis may be indirect, and that Future time perspective may actually be 
mediated by an individual’s drug perception. 
Another French study investigated the links between cannabis use, risk perception and time 
perspective (Apostolidis et al., 2006b). This study sought to examine the link between cannabis use 
and time perspective, explore the relationship between cannabis use, risk perception, and time 
perspective, and lastly to test whether time perspective moderates the link between cannabis use 
and risk perception (Apostolidis et al., 2006b).  Risk perception was measured by evaluating self-
reported perceived outcomes of cannabis use with two factors: ‘risk relativization’ and ‘risk 
approval’.  ‘Risk relativization’ emphasises the benefits associated with cannabis and rejects the 
risks, while ‘risk approval’ associated with ‘hard drug-taker’ behaviours.  Results showed that higher 
future time perspective scores were associated with lower reported cannabis use, while higher 
scores of Present Hedonistic time perspective were associated with higher reported cannabis use. 
Cannabis users were more likely to emphasise the ‘risk relativization’ dimension than non-users, 
while non-users were more likely to emphasise the ‘risk approval’ dimension than 
users.  Furthermore, regression analysis showed that there was a negative association between the 
level of cannabis consumption and perceived risks.  Time perspective was also shown to moderate 
the relationship between risk perception and cannabis use.  Specifically, the results supported the 
hypothesis that time perspective intervenes between high levels of cannabis use and a risk denial 
view; it is likely that the moderating effect differs by the temporal frame.  Although this provides 
evidence that risk perception and time perspective are linked in their association with cannabis use, 
the cross-sectional design of this study does not allow us to make any causal 
explanations.  Furthermore, it provides evidence that the socio-cognitive factors associated with 
cannabis use are a complex web of mechanisms and research that seeks to unravel how these 
factors work and interact is necessary to understanding how to design prevention measures. 
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To further understand these mechanisms, researchers sought to understand the relationship 
between time perspective and substance use, and how desire for control moderated that 
relationship (Fieulain & Martinez, 2010).  This provided support for a relationship between Future 
time perspective and Present Hedonistic time perspective and substance use outcomes.  However, 
this research also provides further evidence that while Present Hedonistic time perspective is a risk 
factor and future time perspective is a protective factor for substance use, this is dependent on 
whether there is also strong desire for control.  Thus, the desire for control component can be 
associated as a risk factor (Present Hedonistic time perspective) or a protective factor (Future time 
perspective).  Although this research focused on composite measures of substance use, it illustrated 
that the relationship between the mechanisms associated with cannabis use can provide a greater 
understanding of use behaviour and how prevention should aim to prevent problematic and 
dependent use. 
2.2.10 Cannabis effect expectancies 
Cannabis effect expectancies are a construct used to measure the anticipated outcomes of use 
associated with cannabis.  Predominantly, the Marijuana Effect Expectancies Questionnaire (MEEQ) 
(Aarons et al., 2001) has been used to evaluate six lower order scales: Cognitive and Behavioural 
Impairment, Relaxation and Tension Reduction, Social and Sexual Facilitation, Perceptual and 
Cognitive Enhancement, Global Negative Effects, and Craving and Physical Effects, along with two 
high order scales: Positive and Negative expectancies.  Cannabis effect expectancies may provide a 
better understanding to the mechanisms that underpin use behaviour, as evidence suggests that 
those with higher positive expectancies engage in more frequent use, while those with more 
negative expectancies behave conversely (Simons & Arens, 2007).  Research indicates that changes 
in cannabis expectancies are associated with cannabis intentions, which in turn may lead to a greater 
likelihood of initiating or intensifying use behaviours (Skenderian et al., 2008). 
Research investigating the relationship between anxiety and cannabis problems has looked 
at the potential link with cannabis expectancies.  In a sample of undergraduate students, there was 
an association between high negative expectancies surrounding cannabis use and problematic 
outcomes (Buckner & Schmidt, 2008).  Due to the cross-sectional nature of this study, it is not 
possible to derive causality whereby having negative beliefs leads to negative outcomes, or those 
who have negative outcomes begin to expect them.  Additionally, when looking specifically at social 
anxiety associated with cannabis use and expectancies, those with higher social anxiety and greater 
impairment expectancies were more likely to use cannabis.  This may suggest that those with social 
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anxiety intend to use cannabis to alleviate uncomfortableness with social situations.  A further study 
was conducted, looking specifically at individuals determined to meet the clinical diagnosis for Social 
Anxiety Disorder (Buckner & Schmidt, 2009).  Results indicated that Social Anxiety Disorder was the 
only depressive or anxiety disorder related to cannabis problems, and that negative expectancies of 
use (Cognitive and Behavioural Impairment, and Global Negative Effects expectancies) were related 
(Buckner & Schmidt, 2009).  These results suggest that while negative affect may be a risk for 
problematic cannabis use outcomes, it is important to understand the mechanisms that underlie this 
risk and that it may in fact be that specific types of negative affect are associated with cannabis 
problems, as this evidence suggests Social Anxiety Disorder may be one of them (Buckner & Schmidt, 
2009). 
In addition to Social Anxiety Disorder, cannabis expectancies have been hypothesised to 
mediate the relationship between cannabis use outcomes and other risk factors.   A study 
investigated the role of cannabis expectancies and how they mediated the relationship between 
impulsive personality style and cannabis based on the ‘acquired preparedness model’ (Vangsness et 
al., 2005).  Results indicated having negative cannabis expectancies partially mediated the 
relationship between impulsivity and cannabis use; participants with higher levels of impulsivity had 
lower negative expectancies, and in turn, used cannabis more frequently (Vangsness et al., 2005). 
2.3 Methodology 
The first phase of this research programme was developed to determine what factors were associated 
with cannabis use, and more specifically, cannabis dependence and related problems in young people 
aged 18-25 years-old.  The results of this study are intended to inform indicated prevention efforts for 
those young people with increased propensity for developing cannabis dependency and related 
problems.   
2.3.1 Method 
An online questionnaire was used to assess the association between cannabis use and related 
personality, mental health and drug-related factors.  The online survey was made available by Bristol 
Online Surveys and was completed anonymously.  The sample consisted of undergraduate students 
recruited through psychology courses, with additional participants recruited from online forums, 
including Blue Light and Drugs-Forum.  Participants had to be between the ages of 18-25 years-old, 
have no current clinical diagnosis of an affective disorder, or be in receipt of drug treatment to take 
part.  Participants completed a battery of self-report measures via an online questionnaire, inluding: 
the Severity of Dependence (SDS) scale (Martin et al., 2006); AUDIT (Saunders et al., 1993); Marijuana 
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Effect Expectancy Questionnaire (MEEQ) (Aarons et al., 2001); Fagerström test of Nicotine 
Dependence (Heatherton et al., 1991); Brief Sensation Seeking Scale (Zuckerman, Eysenck & Eysenck, 
1978; Hoyle et al., 2002); Impulsivity (Sensitivity to Reward) (Torrubia et al., 2001); Depressive 
Symptamology (Radloff, 1991);  Impulsivity (Consideration of Future Consequences) (Strathman et al., 
1994); Anxiety Sensitivity Index (Taylor et al., 2007); Agression Quesitonnaire (Buss & Perry, 1992); 
Time Perspective (Zimbardo & Boyd, 1999); Marijuana Problems (Stephens, Roffman & Curtin, 2000; 
Simons & Carey, 2002).  The overall questionnaire took approximately 30 minutes to complete. 
2.3.2 Ethical consideration 
Participants were asked to report their substance use history and other sensitive information to the 
researchers through the online questionnaire.  On the participants information sheet, which was 
included on the online system, it explicitly stated that confidentiality would be maintained.  
Participants provided their consent electronically, which followed the presentation of the study 
information sheet.  All research documents included information regarding local services and 
helplines/websites that provide help and information on substance use issues.  All study procedures 
were approved by the Liverpool John Moores University Ethics Board.  No adverse effects were 
reported. 
2.3.3 Statistical analysis 
Demographic, personality, mental health, and drug-related scores were calculated from 
questionnaires using SPSS (v. 18.0+).  Firstly, to assess the main hypotheses, multiple regression 
analyses were performed to analyse the relationship between the aformentioned constructs and 
cannabis outcome measures.  Multiple regression analyses were chosen because of its predictive 
validity for analysing  the relationship between independent variables with multiple dependent 
variables.  Dependent variables were chosen based on previous research, and because all were 
previously found to be associated with drug use behavious, and so a backwards approach was 
employed.  This approach allowed for an understanding of  how risk factors related to cannabis use 
were related to assessments of cannabis use behaviour.  Secondly, Latent Profile Analysis (LPA) was 
conducted using the software package Latent Gold Version 4.5 (Vermunt & Magidson, 2005). Latent 
Profile Analysis is a statistical technique that identifies similar groups based on observations and/or 
responses to questionnaires and other instruments.  Using this approach, distinct classes of 
individuals were identified which were expected to be similar to one another with respect to the 
relationship between the variables of interest, but different from individuals in other classes. For this 
analysis, measures of aggression, anxiety and depressive symptomology were used as indicators of 
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latent classes. The number of classes was determined using several indices. The statistical measure 
of fit used was the Bayesian Information Criterion Index (BIC); lower BIC numbers indicate a better 
fitting model. However, the number of classes was ultimately determined by a combination of 
factors in addition to the BIC, including the average classification probabilities, research questions, 
parsimony, theoretical justification, and substantive interpretability (Bauer & Curran, 2003). Latent 
Gold allows formulation of a model in which the class distribution (class size) is allowed to differ 
between groups by using a random-effects approach rather than by estimating a separate set of 
class sizes for each group, as is done in a traditional multiple-group analysis. Class membership is 
automatically determined by Latent Gold using model based posterior membership probabilities 
estimated by maximum likelihood (ML) methods. Latent Gold uses the EM (Expectation 
Maximization) algorithm for dealing with ML estimation with missing data (McLachlan & Krishnan, 
2008). Classes were then characterised on covariates in SPSS (v. 18.0) using ANOVA (Tukey’s post 
hoc) and multinomial logistic regression analyses, assessing the likelihood of membership to one 
class compared to another.  ANOVA analysis was used to compare mean scores between groups, 
while multiple logistic regressions analyses were used the predictive validity of dependent variables 
to group membership.  Statistical significance was set at p < 0.05 for all analyses. 
2.3.4 Participants 
The sample consisted of 414 (41.8% female) participants, the majority of whom were students (91.2%) 
and from the United Kingdom (57.2%).  Psychology students (≈22.2%) studying at Liverpool John 
Moores University received course credit for their participation, while all other participants received 
nothing.  The mean age was 20.30 years-old (range = 18-25, SD = 2.69).  The racial and ethnic 
composition of the sample comprised 90.3% White, 3.6% Mixed Race, 1.7% Asian British, 1.9% Asian, 
1.0% Black, and 1.4% other.  The Alcohol Use Disorders Identification Test (AUDIT) was used as a brief 
screening instrument to identify harmful and hazardous drinking.  Using a diagnostic cut-off of 11, 157 
(37.9%) of those who had used alcohol were considered to be at risk for  for hazardous and harmful 
drinking (Fleming, Barry & Macdonald, 1991).   Mean AUDIT score were slightly lower to those of other 
studies on UK univeristy students due to the inclusion of non-University students (Atwell, Duka & 
Abraham, 2011; Moreira, Oskrochi, & Foxcroft, 2012).  Recruited participants were given the web 
address for an online questionnaire to complete in their own time. 
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Table 1.  Drug statistics (alcohol, tobacco and cannabis). (N = 414) 
 M (SD)* 
Alcohol  
Age of initiation (Years) (N = 398) 14.54 (1.99) 
AUDIT score (N = 376) 9.97 (5.76) 
Above diagnostic cut-off (%) 157 (37.9) 
Tobacco  
Age of initiation (Years) (N = 317) 14.86 (2.36) 
Fagerström nicotine dependence 
(N = 140) 
1.61 (2.13) 
Cannabis  
Age of initiation (Years) (N = 297) 15.78 (3.48) 
Lifetime cannabis use (%) Never Lifetime Past year Past month 
 103 (24.9) 311 (75.1) 261 (63.0) 199 (48.1) 
Cannabis use frequency (%) Never Less than 
monthly 
Monthly Weekly Daily 
 127 (30.7) 90 (21.7) 33 (8.0) 80 (19.3) 84 (20.3) 
SDS (N = 239) 2.02 (2.53) 
Above diagnostic cut-off (%) 52 (21.8) 
  
Cannabis problems index (N = 311) 1.82 (2.77) 
*M(SD) unit of measurement unless otherwise noted 
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Table 2. Use of drugs other than cannabis. (N = 414) 
 Never Lifetime Past year Past Month 
Ecstasy (%) 246 (59.4) 168 (50.6) 112 (27) 49 (11.8) 
Heroin (%) 382 (92.3) 32 (7.6) 16 (3.8) 8 (1.9) 
Cocaine (%) 282 (68.1) 132 (31.8) 80 (19.3) 31 (7.5) 
Hallucinogens (%) 248 (59.9) 166 (40.0) 139 (33.5) 71 (17.1) 
Ketamine (%) 346 (83.6) 68 (16.4) 48 (11.6) 16 (3.9) 
Legal Highs (%) 286 (69.1) 128 (30.9) 81 (19.5) 42 (10.1) 
Salvia Divinorum (%) 301 (72.7) 113 (27.3) 51 (12.3) 10 (2.4) 
Amphetamines (%) 289 (69.8) 125 (30.2) 88 (21.3) 50 (12.1) 
Anabolic Steroids (%) 403 (97.3) 11 (2.6) 3 (0.7) 1 (0.2) 
 
2.3.5 Measures 
Multiple questionnaires were evaluated for inclusion in the final research instrument.  Use within 
the wider research, suitability for the sample population, theoretical underpinnings, length and 
statistical measures, such as reliability were considered.  When available and appropriate, shorter 
versions of questionnaires were chosen. 
2.3.5.1 Anxiety Sensitivity-III (ASI-3)) 
The ASI-3 is an adaption of the Anxiety Sensitivity Index, which applies multidimensionality to 
previously used indexes, adding subscales of cognitive, social, and physical anxiety sensitivity to the 
construct (Anxiety Sensitivity Index; Reiss et al., 1986; Taylor et al., 2007). It is an 18-item scale that 
assesses three different components of anxiety sensitivity: Cognitive, Physical and Social. The scale 
shows good reliability and validity in non-clinical populations and shows improved psychometric 
properties compared to the original Anxiety Sensitivity Index (Taylor et al., 2007).  The scale has good 
reliability in the current sample (α = .89). 
2.3.5.2 Buss and Perry Aggression Questionnaire (BPAQ) 
The BPAQ is a 29-item questionnaire that assesses four factors of aggression: verbal, physical, anger 
and hostility (Buss and Perry, 1992).   For the purposes of this investigation, only the verbal, physical 
and anger factors of the scale questionnaire were assessed., Hostility is less considered in studies of 
aggression and more associated with indirect forms of aggression (Archer & Webb, 2006). 
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2.3.5.3 Center for Epidemiological Study of Depression Scale (CES-D) 
The CES-D is a 20-item self-report scale designed to measure depressive symptomatology in non-
clinical populations (Radloff, 1991).  The scale has been previously shown to have good reliability in 
young people (Radloff, 1991). The scale showed good reliability in the current sample (α = .92). 
2.3.5.4 Consideration of Future Consequences (CFC) 
The CFC scale measures the extent to which individuals consider the future implications of their 
immediate behaviours and the degree to which they are influenced by these potential outcomes 
(Strathman et al., 1994). The scale consists of 12 statements in which participants indicate on a 5-point 
Likert scale the extent to which the item is characteristic of them.  The Cronbach’s alpha for the current 
sample was poor (α = .37).  
2.3.5.5 Sensitivity to Reward Scale (SRS) 
The SRS was extracted from the longer Sensitivity to Punishment and Sensitivity to Reward 
Questionnaire and measures the dimension of impulsive personality based on Gray’s Behavioural 
Approach System (Torrubia et al., 2001).  The scale showed good reliability in the current sample (α 
= .77).  The 24-item scale describes situations in which people would adopt approach behaviours to 
obtain a reward. 
2.3.5.6 Zimbardo Time Perspective Inventory (ZTPI) 
Time perspective is an inventory of the dimension of time construction, specifically the cognitive 
processes that organise human experience into past, present, and future temporal frames (Zimbardo 
& Boyd, 1999).  The 56-item questionnaire examines 5 dimensions of time perspective: Past Negative 
(α = .83), Present Hedonistic (α = .82), Future (α = .69), Past Positive (α = .62), Present Fatalistic (α 
= .71).  The test has acceptable internal consistency and test-retest reliability.  The scale showed good 
reliability in the current sample (α = .76). 
2.3.5.7 Zuckerman’s Brief Sensation Seeking Scale 
The Brief Sensation Seeking Scale is an 8-item scale adapted from the 40-item Sensation Seeking Scale-
V (Zuckerman, Eysenck, & Eysenck, 1978; Hoyle et al., 2002).  The brief measure of sensation seeking 
maintains suitable internal consistency in young people and is a strong predictor of intention to try 
cannabis in young people (Hoyle et al., 2002) The scale showed good reliability in the current sample 
(α = .81). 
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2.3.5.8 Marijuana Effect Expectancies Questionnaire (MEEQ) 
The Marijuana Effect Expectancy Questionnaire (MEEQ) is a 48-item list of expectations regarding the 
effects of cannabis use (Aarons et al., 2001). The questionnaire was developed to be used by those 
with and without cannabis use histories. The scale is comprised of six lower order scales: Cognitive 
and Behavioural Impairment (α = .81), Relaxation and Tension Reduction (α = .82), Social and Sexual 
Facilitation (α = .61), Perceptual and Cognitive Enhancement (α = .70), Global Negative Effects (α = .89), 
and Craving and Physical Effects (α = .75).  
 
2.3.5.9 Cannabis-related problems 
Cannabis-related problems were measured using a cannabis problems index, a list of 17 items derived 
from the 19-item Marijuana Problems Scale (MPS) (Stephens, Roffman & Curtin, 2000).  Participants 
were first asked whether or not they experienced a problem in the past 90 days (e.g. legal problems; 
difficulty sleeping), and then were asked if this problem was caused or worsened due to cannabis use.  
Two items from the original scale (“feel bad about your use”; “withdrawal symptoms”) were 
eliminated due to their reference to specific drug use.  The removal of specific references to drugs was 
to ensure that it would be a suitable questionnaire for both users and nonusers of cannabis; 
additionally, we sought to measure how cannabis influences general problems. The scale in the 
current sample had good reliability (α = .86). 
2.3.5.10 Cannabis and other substance use 
Cannabis frequency was assessed by asking, “How often do you think you use cannabis?” on a 9-point 
Likert scale (‘never’, ‘1-2 times a year’, ‘6 times a year’, ‘once per month’, ‘twice per month’, ‘once per 
week’, ‘3 times per week’, ‘5 times per week’, ‘everyday’).  Results were adapted to a 5-point scale of 
‘never’, ‘less than monthly’, ‘monthly’, ‘weekly’, and ‘daily’ use of cannabis as to be comparable UK 
prevalence data (Burton et al., 2014). Use of other substances was determined by use of a bespoke 
measure which has been used in previous studies (for example: Sumnall et al., 2004). 
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Table 3. Cannabis risk factors. (N = 414) 
Personality factors  M (SD) 
Sensation seeking  2.21 (0.75) 
Impulsivity (SRS)  0.49 (0.18) 
Impulsivity (CFC) (N= 413)  3.04 (0.38) 
ZPTI Past Negative 3.13; (0.76) 
 Past Positive 3.38 (0.57) 
 Present Hedonistic 3.53 (0.55) 
 Present Fatalistic 2.69 (0.65) 
 Future 3.18 (0.50) 
Drug-related factors   
MEEQ Cognitive Behavioural 
Impairment 
31.69 (7.34) 
 Relaxation and Tension 
Reduction 
27.94 (6.08) 
 Social and Sexual Facilitation 27.21 (5.49) 
 Perceptual and Cognitive 
Enhancement 
25.43 (5.31) 
 Global Negative Effects 19.95 (7.73) 
 Craving and Physical Effects 22.08 (4.30) 
Mental health factors   
ASI-3 Cognitive 3.19 (4.56) 
 Physical  3.50 (4.00) 
 Social 7.05 (5.10) 
 Total 13.74 (11.10) 
BPAQ (N = 399) Anger 16.17 (5.97) 
 Physical 21.36 (7.70) 
 Verbal 15.34 (4.37) 
 Total 53.05 (14.48) 
CES-D  17.15 (11.09) 
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2.4 Results 
2.4.1 Regression analyses 
2.4.1.1 Cannabis use 
In the present sample, 311 (75.1%) reported lifetime cannabis use, 261 (63.0%) reported last year 
cannabis use, and 199 (48.1%) reported last month use, while the remaining sample (103; 24.9%) 
reported lifetime abstainment from cannabis. 
2.4.1.2 Relationship between lifetime cannabis use and personality, drug-related and mental health 
factors 
Multiple regression analysis was performed to examine the relationshp between lifetime cannabis 
use and personality, drug-related and mental health factors.  In this analysis, the dependent 
outcome variable was whether cannabis had ever been used in their lifetime.  Using a stepwise 
approach (backwards method), the predictor variables and sex were entered into the model.  The 
final model accounted for 46.2% of the variance in lifetime cannabis use and was a significant fit of 
the data (F (5, 392) = 67.41, p < .001).  The adjusted R2 (.455) showed little shrinkage, indicating that 
the model would generalise well.  Drug-related cognitions, specifically two subscales from the 
Marijuana Effect Expectancies Questionnaire (MEEQ) were found to be highly correlated with 
lifetime cannabis use; MEEQ (Global and Negative Effects) were negatively correlated with lifetime 
use (β = -0.627, p < .001), and MEEQ (Craving and Physical Effects) (β = 0.277, p < .001) were 
positively associated with lifetime use of cannabis.  Additionally, aggression was significantly 
associated with lifetime cannabis use (β = 0.119, p < .001).  Anxiety sensitivity and MEEQ (Sexual and 
Social Facilitation) were also included in the model, but were only marginally significant. 
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2.4.1.3 Cannabis use frequency 
Cannabis Use Frequency was initially measured on a 9-point Likert Scale (never; 1-2 times per year; 6 
times per year; once per month; twice per month; 3 times per week; 5 times per week; everyday)  .  
The initial responses were found to be too few per response category and the measure was 
recalculated on a 5-point Likert Scale in accordance with pravelance data measurement: Never, Less 
Than Monthly, Monthly, Weekly, or Daily.  In the present samlpe, 127 (30.7%) reported never using 
cannabis, 127 (21.7%) reported less than montly use, 33 (8.0%) reported montly use, 80 (19.3%) 
reportedly weekly use, and 84 (20.3%) reported daily use. 
2.4.1.4 Relationship between cannabis use frequency and personality, drug-related and mental 
health factors 
Multiple regression analysis was performed to examine the relationshp between frequency of 
cannabis use and personality, drug-related and mental health factors.  The analysis was performed 
only on participants that indicated that they had used cannabis in their lifetime.  Using a stepwise 
approach (backwards method), the predictor variables and sex were entered into the model.  The 
final model accounted for 53.3% of the variance in cannabis use frequency and is a significant fit of 
the data (F (5, 293) = 66.861, p < .001).  The adjusted R2 (.525) showed little shrinkage, indicating 
that the model woud generalise well.  Two subscales of drug-related cognitions significantly 
predicted frequency of cannabis use.  MEEQ (Perceptual and Cognitive Enhancement) was positively 
correlated with frequency (β = 0.232, p < .001), while MEEQ (Global and Negative Effects) was 
Table 4.   Model summary for regression of lifetime cannabis use. (N = 414) 
 B SE b β 
Final model    
Constant 0.758 0.127  
Aggression 0.004 0.001 0.119** 
Anxiety sensitivity 0.003 0.002 0.066# 
MEEQ (Craving and 
Physical Effects) 
0.028 0.004 0.277*** 
MEEQ (Global and 
Negative Effects) 
-0.035 0.002 -0.627*** 
MEEQ (Sexual and 
Social Facilitation) 
-0.005 0.003 -0.066# 
Note. R2 = .462. #p < .10, *p < .05, **p < .01, ***p < .001.  
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negatively correlated (β= -0.434, p < .001).  Sensation seeking was negatively correlated with with 
cannabis use frequency (β = -0.114, p < .01).  Anxiety sensitivity (ASI-3) was positively associated 
with cannabis use frequency (β = .089, p < .05). 
Table 5.  Model summary for regression of cannabis frequency. (N=299) 
 b SE b β 
Final model    
Constant 2.249 0.420  
Sex 0.852 0.118 0.311*** 
Anxiety sensitivity 0.011 0.005 0.089* 
MEEQ (Global and 
Negative Effects) 
-0.097 0.100 -0.434*** 
MEEQ (Perceptual and 
Cognitive 
Enhancement) 
0.064 0.011 0.232*** 
Sensation seeking -0.223 0.082 -0.114** 
Note. R2 = 0.533. #p < .10 *p < .05, **p < .01, ***p < .001.  
2.4.1.5 Cannbis use problems index 
The Cannabis use problems index is a 17-item scale adapted from the Marijuana Problems Index 
(Stephens et al., 2000) to assess problems associated with the use of cannabis.  Paricipants were first 
asked whether or not they had experienced the problem within the last six months, and then were 
asked if the problem was caused or worsened by the use of cannabis.  Of those participants who 
reported lifetime use of cannabis, 49.8% reported no associated problems from their cannabis use 
(M = 1.82; SD = 2.77). 
2.4.1.6 Relationship between cannabis problems and personality, drug-related and mental health 
factors 
A multiple regression analysis was used to explore the relationhip between problems associated 
with cannabis use and personality, drug-related and mental health factors.  The analysis was 
performed only on participants that indicated that they had used cannabis in their lifetime.  Using a 
stepwise approach (backwards method), the predictor variables,  cannabis use frequency and sex 
were entered into the model.  The final model accounted for 34.3% of the variance in cannabis use 
frequency and is a significant fit of the data (F (6, 292) = 15.813, p < .001).  The adjusted R2 (.343) 
show a small amount of shrinkage, indicating that the model would generalise reasonably well.  
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Frequency of cannabis use was a significant predictor of cannabis-related problems (β = 0.446, p 
< .001).  The Cognitive Behavioural Impairment (β = 0.158, p < .01) and the Global Negative Effects (β 
= 0.173, p < .05) subscales of the MEEQ were positively correlated with use problems.  Of the mental 
health factors, ASI-3 (β = 0.180, p < .001) was found to be positively correlated with self-report 
cannabis problems.  The Impulsivity (Sensitivity to Reward) (β = 0.128, p < .05) was positively 
associated with cannabis use related problems, while ZPTI (Future time perspective) (β = -0.113, p 
< .05) was negatively associated 
Table 6.  Model summary for regression of cannabis problems. (N = 299) 
 b SE b β 
Final model    
Constant -3.519 1.241  
Sex 0.815 0.304 0.151** 
Anxiety sensitivity 0.043 0.012 0.180*** 
ZPTI (Future) -0.612 0.262 -0.113* 
Impulsivity (SRS) 1.971 0.776 0.128* 
MEEQ (Global and 
Negative Effects) 
0.076 0.030 0.173* 
MEEQ (Cognitive 
Behavioural 
Impairment) 
0.061 0.023 0.158** 
Cannabis frequency 0.0876 0.129 0.446*** 
Note. R2 = .343. #p < .10, *p < .05, **p < .01, ***p < .001. 
2.4.1.7 Severity of dependence  
The Severity of Dependence Scale (SDS) is a brief 5-item scale used to assess the psychological 
aspects of dependence experienced by users of illicit drugs (Gossip et al., 1995).  In a sample of 
adolescent cannabis users in Australia, the diagnostic cut-off point for cannabis dependence was 
determined to be a score of 4 (Martin et al., 2006).  The severity of dependence scale was only 
completed by participants who reported using cannabis in past 3 months.  The severity of 
dependence scale (M=2.02; SD = 2.53) included 52 respondents (21.8% of those who responded) 
who had used cannabis and were above the threshold for cannabis dependence.   
2.4.1.8 Relationship between severity of dependence and personality, drug-related and mental health 
factors 
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A multiple regression analysis was used to explore the relationship between problems associated 
with severity of  dependence and personality, drug-related and mental health factors.  The analysis 
was performed only in those participants that indicated that they had used cannabis in their lifetime.  
Using a stepwise approach (backwards method), the predictor variables and sex were entered into 
the model.  The final model accounted for 26.6% of the variance in cannabis use frequency and was 
a significant fit of the data (F (8, 220) = 9.957, p < .001).  The adjusted R2 (.239) showed a small 
amount of shrinkage, indicating that the model would generalise reasonably well.  Sex was a 
significant predictor of severity of dependence (β = 0.234, p < .001).  The Perceptual and Cognitive 
Enhancement (β = 0.153, p < .05) and the Cognitive Behavioural Impairment (β = 0.332, p < .001) 
subscales of the MEEQ were positively correlated with use severity of dependence, while the Social 
and Sexual Facilitation subscale (β = -0.242, p < .001)  was negatively correlated.  Of the mental 
health factors, anxiety (β = 0.187, p < .001) was positively correlated with dependence, while 
depression (β = -0.167, p < .05) was negatively correlated.  Time perspective (Past Negative) was 
retained in the model, but was not a significant predictor of severity of dependence. 
Table 7.  Model summary for regression of severity of dependence. (N = 116) 
 b SE b Β 
Final Model    
Constant -3.712 1.237  
Sex 1.220 0.311 0.234*** 
Anxiety 0.044 0.016 0.187** 
ZPTI (Past Negative) 0.438 0.244 0.137# 
MEEQ (Global and 
Negative Effects) 
1.905 0.930 0.129* 
MEEQ (Perceptual and 
Cognitive 
Enhancement) 
0.076 0.033 0.153* 
MEEQ (Cognitive 
Behavioural 
Impairment) 
0.177 0.037 0.332*** 
MEEQ (Social and 
Sexual Facilitation) 
-0.110 0.031 -0.242*** 
Depression 0.040 0.018 -0.167* 
Note. R2 = 0.266 for Final Model. #p < .10, *p < .05, **p < .01, ***p < .001. ^p = 0.13. 
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2.4.2 Latent Profile Analysis 
A three class model was identified as the best solution (BIC = 9104.44; R2 = 0.58; entropy R2 = 
0.60), representing a moderate model of the classifications. Class demographics are shown in Table 8. 
Class 1 (Moderate Psychopathology) represented the largest proportion of the sample (37.7%). This 
group had a moderate level of psychopathology compared to the other clusters. Class 2 (High 
Psychopathology) (32.1%) included individuals with the highest levels of psychopathology.  Class 3 
(Low Psychopathology) (28.8%) represented the smallest group and the lowest level of 
psychopathology. 
 
 
 
 
 
 
 
 
 
 
Table 8.  Demographics and psychopathology by cluster. (N=399) 
Variable Moderate Cluster 
(n = 156) 
High Cluster 
(n = 128) 
Low Cluster 
(n = 115) 
Age (M, SD) 20.23 (2.84) 20.43 (2.72) 20.33 (2.29) 
Female (%) 42.3 43.0 42.6 
White (%) 91.3 85.2 94.2 
Student (%) 84.0 82.8 81.7 
Aggression (M, SD) 55.41 (12.93) 58.92 (15.95) 43.30 (8.88) 
Anxiety sensitivity (M, SD) 12.49 (23.52) 23.52 (12.58) 4.73 (2.89) 
Depressive symptomology (M, SD) 14.63 (4.88) 29.00 (10.83) 7.82 (3.52) 
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2.4.3 ANOVA 
Using ANOVA, all of the identified clusters significantly differed on two of the corresponding 
determinants of psychopathology group, anxiety sensitivity and depressive symptomatology; 
however, there were no significant difference in level of aggression between the medium and high 
psychopathology groups.  In identifying differences in cannabis use outcomes, clusters differed with 
respect to cannabis problems (F(2, 388) = 7.60, p < .001), but not cannabis use frequency (F (2, 398) 
= 0.20, p = ns).  As shown in Table 11, classes differed on measures of impulsivity, Sensitivity to 
Reward and Consideration of Future Consequences scales, MEEQ Cognitive and Behavioural 
Impairment and Present Fatalistic, Present Hedonistic, Past Negative, and Past Positive dimensions 
of time perspective were all found to be significantly related to psychopathology.  Tukey’s post hoc 
showed that the low psychopathology group reported significantly lower scores on the MEEQ 
(Cognitive and Behavioural Impairment) subscale of cannabis expectancies and dimensions of 
impulsivity (Sensitivity to Reward and Consideration of Future Consequences) compared to the 
moderate and high psychopathology group.  There were significant differences amongst all three 
clusters on Past Negative and Present Fatalistic time perspective, with higher psychopathology 
indicating higher scores.  
 
Table 9.  Fit statistics and entropy for latent profile analysis.  
Classes LL Parameters BIC Wald P-Value Entropy 
1 -4683.0559 6 9402.0455 NA NA NA 
2 -4524.9839 13 9127.8242 2.0339 p = .15 .7098 
3 -4492.3286 20 9104.4364 2.5119 p = .28 .6205 
4 -4479.4672 27 9120.6364 5.6218 p =.13 .6421 
5 -4470.9212 34 9145.4671 65.6603 p ≤ .001 .6835 
6 -4459.9542 41 9165.4558 56.2694 P ≤ .001 .6697 
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Table 10. Multivariate ANOVA results between psychopathology and cannabis frequency and 
related problems, cannabis expectancies and time perspective. 
 Moderate 
M (SD) 
High 
M (SD) 
Low 
M (SD) 
F 
Cannabis frequency 1.71 (1.56)a 1.80 (1.56)a 1.81 (1.54)a 0.20 
Cannabis problems 1.35 (2.52) a 1.96 (2.89) 0.74 (1.55) a 7.60*** 
MEEQ (Cognitive and 
Behavioural Impairment) 
32.43 (7.22)a 32.85 (6.42)a 29.84 (7.95) 6.21** 
MEEQ (Relaxation and 
Social Tension) 
28.30 (6.19)a 27.95 (6.29)a 27.71 (6.08)a 0.32 
MEEQ (Social and Sexual 
Facilitation) 
27.29 (5.82)a 27.27 (5.38)a 27.28 (5.12)a 0.00 
MEEQ (Perceptual and 
Cognitive Enhancement) 
25.77 (5.36)a 25.73 (5.23)a 24.77 (5.25)a 1.40 
MEEQ (Global Negative 
Effects) 
20.26 (7.84)a 20.73 (6.88)a 18.50 (8.33)a 2.83 
MEEQ (Craving and Physical 
Effects) 
21.78 (4.46)a 22.44 (4.23)a 22.03 (4.27)a 0.80 
ZPTI (Past Negative) 3.15 (0.64) 3.68 (0.64) 2.57 (0.58) 96.00*** 
ZPTI (Present Hedonistic) 3.58 (0.53)a 3.59 (0.53)a 3.42 (0.59)a 3.68* 
ZPTI (Future) 3.18 (0.48)a 3.10 (0.53)a 3.18 (0.50)a 3.01 
ZPTI (Past Positive) 3.40 (0.58)a 3.28 (0.62)a 3.46 (0.57)a 3.34* 
ZPTI (Present Fatalistic) 2.67 (0.60) 2.95 (0.64) 2.45 (0.64) 19.25*** 
Impulsivity (SRS) 0.51 (0.17)a 0.56 (0.20)a 0.40 (0.14) 28.47*** 
Impulsivity (CFC) 3.09 (0.38)a 3.09 (0.36)a 2.92 (0.38) 8.78*** 
Sensation seeking 2.19 (0.74)a 2.14 (0.76)a 2.34 (0.73)a 2.46 
Aggression 55.41 (12.93)a 58.92 (15.95)a 43.30 (8.88) 47.80*** 
Anxiety sensitivity 12.49 (23.52) 23.52 (12.58) 4.73 (2.89) 159.80*** 
Depressive 
symptomology 
14.63 (4.88) 29.00 (10.83) 7.82 (3.52) 286.89*** 
*p ≤ .05, **p ≤ .01, ***p ≤ .001 
a Means not significantly different from one another (p≤.01). 
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2.4.4 Multinomial Logistic Regression 
Multinomial logistic regression was used to predict class membership on the basis of cannabis 
expectancies, frequency and problems, and personality and time perspective factors.  These results 
are shown in Tables 12, 13, and 14.  Compared to members of the low psychopathology group 
(cluster 3), membership of Class 2 (moderate psychopathology) was significantly predicted by 
greater cannabis expectancies Cognitive and Behavioural Impairment (OR = 1.07; 95%CI: 1.02-1.12), 
cannabis expectancies Craving and Physical Effects (OR = 0.88; 95%CI: 0.82-0.95); impulsivity 
(Sensitivity to Reward) (OR = 134.35; 95%CI: 21.06-860.82); and Past Negative time perspective (OR 
= 4.05; 95%CI: 2.58-6.37).  
Compared with the low psychopathology class, membership of the high psychopathology was 
significantly predicted by higher levels of time perspective Past Negative (OR = 14.66; 95%CI: 8.34-
25.69), Present Fatalistic (OR = 1.96; 95%CI: 1.16-3.32), and lower levels of Past Positive (OR = 0.40; 
95%CI: 0.22-0.71);  and higher levels of impulsivity (Sensitivity to Reward) (OR = 368.57; 95%CI: 45.34-
2996.46) and cannabis-related problems (OR = 1.30; 95%CI: 1.07-1.59).   
The assessed variables also differentiated between membership of the moderate and high 
psychopathology groups; the latter group was predicted by higher scores of Past Negative (OR = 3.62; 
95%CI: 2.41-5.45), Past Positive (OR =0.58; 95%CI: 0.38-0.89), and Present Fatalistic (OR = 1.58; 95%CI: 
1.05-2.38) time perspective. 
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Table 11.  Multiple Logistic Regression for clusters of psychopathology. Moderate vs. Low. 
 B S.E. Wald OR Lower CI Upper CI 
Moderate Cluster       
Intercept -4.68 1.12 12.61***    
ZPTI (Past Negative) 1.40 0.23 36.70*** 4.05 2.58 6.37 
ZPTI (Past Positive) -0.39 0.26 2.28 0.68 0.41 1.12 
ZPTI (Present 
Fatalistic) 
0.21 0.22 0.92 1.24 0.80 1.91 
Impulsivity (SRS) 4.90 0.95 26.83*** 134.35 21.06 860.82 
MEEQ (Cognitive and 
Behavioural 
impairment) 
0.07 0.02 8.45** 1.07 1.02 1.12 
MEEQ (Craving and 
Physical Effects) 
-0.13 0.04 10.53*** 0.88 0.82 0.95 
Cannabis problems 0.17 0.10 3.18 1.19 0.98 1.43 
Cannabis frequency 0.02 0.11 0.04 1.02 0.82 1.28 
*p ≤ .05, **p ≤ .01, ***p ≤ .001   
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Table 12.  Multiple Logistic Regression for clusters of psychopathology. High vs. Low. 
 B S.E. Wald OR Lower CI Upper CI 
High Cluster       
Intercept -9.43 1.60 34.89***    
ZPTI (Past Negative) 2.69 0.28 88.14*** 14.66 8.34 25.69 
ZPTI (Past Positive) -0.93 0.30 9.72** 0.40 0.22 0.71 
ZPTI (Present 
Fatalistic) 
0.67 0.30 6.30* 1.96 1.16 3.32 
Impulsivity (SRS) 5.91 1.07 30.55*** 368.57 45.34 2996.46 
MEEQ (Cognitive and 
Behavioural 
impairment) 
0.05 0.03 3.19 1.05 0.10 1.11 
MEEQ (Craving and 
Physical Effects) 
-0.09 0.05 3.81 0.92 0.84 1.00 
Cannabis problems 0.26 0.10 6.71** 1.30 1.07 1.59 
Cannabis frequency -0.12 0.14 0.78 0.89 0.68 1.16 
*p ≤ .05, **p ≤ .01, ***p ≤ .001 
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Table 13.  Multiple Logistic Regression for clusters of psychopathology. Moderate vs. High.  
 B S.E. Wald OR Lower CI Upper CI 
Moderate Cluster       
Intercept -4.76 1.20 15.70    
ZPTI (Past Negative) 1.29 0.21 38.14*** 3.62 2.41 5.45 
ZPTI (Past Positive) -0.54 0.22 6.16* 0.58 0.38 0.89 
ZPTI (Present 
Fatalistic) 
0.46 0.21 4.87* 1.58 1.05 2.38 
Impulsivity (SRS) 1.00 0.70 2.08 2.737 0.70 10.76 
MEEQ (Cognitive and 
Behavioural 
impairment) 
-0.02 0.02 0.71 0.98 0.94 1.02 
MEEQ (Craving and 
Physical Effects) 
0.04 0.03 1.23 1.04 0.97 1.11 
Cannabis problems 0.09 0.05 2.96 1.10 0.99 1.22 
Cannabis frequency -0.14 0.10 1.90 0.87 0.71 1.06 
*p ≤ .05, **p ≤ .01, ***p ≤ .001  
 
2.5 Discussion 
2.5.1 Risk factors and cannabis use outcomes 
The aim of this study was to examine the relationship between risk factors and indicators of 
cannabis use and dependence.  By using different indicators of cannabis use, we sought to gain a 
better understanding of how risk factors associated with cannabis use differed by outcome measure. 
By looking at different cannabis use outcome measures, we aimed to address factors that may be 
associated with different stages of use, including: liftime use (initiation), frequency of use, problems 
associated with use, and dependence.  The results indicated that there was wide variation in the risk 
factors associated with cannabis use by outcome; anxiety sensitivity was the only risk factor that was 
a contributing predictor for all cannabis-related outcome variables.   
Consistent with the study hypothesis, factors associated with cannabis use differed by 
outcome measure; the risk factors that were most significant predictors of lifetime cannabis use 
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were, for the most part, different than those for cannabis use frequency, dependence, and related 
problems.  This is most likely because the different cannabis use outcomes describe different facets 
that inform the collective cannabis behaviour construct (Temple, Brown & Hine, 2010).  Factors 
associated with lifetime cannabis use may correspond with the reasons why someone may be most 
likely to initiate or experiment with cannabis use; cannabis frequency may correspond to why 
someone frequently uses cananbis; cannabis-related problems correspond with the degree to which 
someone may use cannabis excessively or in more risky situations/environments; while cannabis 
dependence suggests the factors associated with developing dependency.   
The lifetime cannabis use measure indicates whether or not a young person has ever used 
cannabis in their lifetime, and corresponds to whether a young person has or has not initiated 
cannabis use.  The results of the multiple regression of lifetime cannabis use and personality, mental 
health and cannabis expectancy factors indicate which factors differ between young people who 
have used cannabis and those who have not initiated cannabis use. Cannabis expectancy constructs 
of Craving and Physical Effects, and Global Negative Effects were most related to lifetime cannabis 
use.  Due to the the cross-sectional design of this study, casuality cannot be determined.  However, 
it would be expected that individuals who initiate cannabis use have different attitudes towards 
cannabis use generally than those who abstain.  The negative correlation between Global Negative 
Effects suggests that those who abstain from cannabis are more likely to expect negative 
consquences from their use than those who have initiated use.  Additionally, it is likely that those 
who have used cannabis will have different expectations regarding use outcomes than those who 
have never used cannabis, especially regarding how use will affect their body.  The postive 
correlation between the Craving and Phsycial Effects and lifetime cannabis use supports this claim.   
In addition to cannabis expectancies, aggression was positively correlated with lifetime 
cananbis use.  Higher reported levels of aggression were associated with a greater likelihood of 
reported lifetime cannabis use.  There are several possible reasons why aggression is related to the 
initiation of cannabis use.  The self-medication hypothesis would argue that young people may use 
cannabis to help them relax and calm down from aggressive feelings (Khantzian, 1985).  Longitudinal 
evidence suggest that externalising behaviours, like aggression, precede cannabis use intiation 
(Fergusson, Horwood & Ridder, 2007; Hayatbakhsh et al., 2008).    However, it is possible that use of 
cannabis can exacerbate or contribute to aggressive behaviour.  In a clinical population of dependent 
cannabis users, participants who reported difficulty controlling violent behaviour reported using 
cannabis to decrease aggression, but often reacted aggressively while intoxicated (Arendt et al., 
2007).  Furthermore, impulsive aggression corresponds to serotonin and dopamine systems within 
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the brain, and THC, a psychoactive component of cannabis, causes increased levels of dopamine.  
Lowered levels of serotonin exist prior to impulsive aggression outburts, while dopamine levels are 
acutely increased following use (Seo, Patrick & Kennealy, 2008; Bossong et al., 2009).  This is in 
alignment with theories that cannabis use precedes externalising behaviours and mental health 
outcomes (Brook, Cohen & Brook, 1998).  Most research, however, posits shared causes of 
externalsing behaviours, like aggression, and cannabis use as a result of shared genetic and 
environmental factors predicting both outcomes (Fergusson, Horwood & Swain-Campbell, 2002; 
Shelton et al., 2007).  Another potential explanation for this relationship is due to the link between 
aggressiveness and deviant, anti-social behaviour, and more representative of that relationship, and 
not specifically related to cannabis use (Jones, Miller & Lynam, 2011; Moore et al., 2014). 
In investigating the relationship between cannabis frequency and personality, mental health, 
and cannabis expectancy factors, only respondents who used cannabis in their lifetime were 
included.  Similar to the analysis of lifetime cananbis use, several cannabis expectancy constructs 
were related to cannabis use frequency.  Global Negative Effect expectancies were negatively 
correlated with cannabis use frequency, indicating that more positive outcome expectancies from 
using cannabis are associated with more frequent use of cananbis use.  Additionally, Perceptual and 
Cognitive Enhancement expectancies were positively correlated with cannabis use frequency, 
indicating that greater expectancies of Perceptual and Cognitive Enhancement were associated with 
greater cannabis use frequency.  Thus, expectancies of euphoria and and increased perceptual 
senses were associated with  more frequent use of cannabis.  These results are consistent with 
previous work that positive expectancies regarding cannabis are associated with more frequent use 
(Simons & Arens, 2007). 
As well as cannabis expectancies, sex was a significant predictor of cannabis frequency, with 
women more likely to report frequent cannabis use than men.  The majority of previous research 
has suggested that men are more likely to be users of cannabis and to use more frequently (Schepis 
et al., 2011).  There are several possible explanations for this unusual result.  It is possible that due 
to the sampling of the population, in which psychology students were recruited in addition to 
members of an online drugs forum, a greater proportion of women cannabis users were reported 
than usual (Bennett and Holloway, 2015).  It is also possible that because the results are self-
reported, women who tend to be more stigmitised for drug use, were more likely to report frequent 
cannabis because of the perceived annonymity of the online questionnaire (Simpson & McNulty, 
2008; Gnambs & Kaspar, 2015).  
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Lastly, sensation seeking and anxiety sensitivity were significant factors associated with 
cannabis use frequency.  Sensation seeking was negatively correlated with cannabis use frequency, 
indicating that higher self-reported sensation seeking scores were associated with less frequent 
cannabis use.  Previous research has frequently found that sensation seeking is related to cannabis 
use (Crawford et al., 2003; Franken & Muris, 2006; Martins et al., 2008).  This research elucidates 
that although sensation seekers may be more likely to use cannabis generally, they may be less likely 
to use frequently compared to others who have used cannabis in their lifetime.  This sugggests that 
when designing prevention services aimed at preventing young people from developing problematic 
use, sensation seeking may not be an appropriate screening tool for identifying at-risk individuals.  
Conversely, higher scores of anxiety sensitivity were related to greater cannbis use frequency.  Thus, 
in addition to being related to lifetime cannabis use, anxiety sensitivity is also a factor associated 
with greater cannabis use frequency; however, it is unknown whether or not more anxious 
individuals self-medicate with cannabis, if cannabis causes anxiety symptomology, or if cannabis and 
anxiety are operating in a dual pathway model in which anxiety exacerbates cannabis use and 
cannabis use also exacerbates anxiety (Kedzior & Laeber, 2014).  Regardless of the pathway, there is 
a relationship between cannabis use and anxiety that requires further investigation.  
The cannabis outcome measure for cannabis dependence implicated several additional risk 
factors that had not been associated with the previously discussed outcome variables of lifetime 
cannabis use and cannabis use frequency.  As with cannabis frequency, sex (being female) and 
anxiety sensitivity were postively correlated with severity of dependence, indicating that women and 
anxious individuals were more likely to have higher score on the dependence scale.  Sex differences 
in reported cannabis depenence was, once again, an unusual result as males were more likely than 
females to develop dependence (Wagner and Anthony, 2007).  The association between cannabis 
dependence and anxiety sensitivity further illustrates a strong relationship between all aspects of 
cannabis use.  Cannabis expectancies of Perceptual and Cognitive Enhancement, Cognitive 
Behavioural Impairment, and Social and Sexual Facilitation were implicated.  Both Perceptual and 
Cognitive Enhancement and Cognitive Behvaioural Impairment were positively correlated with 
cananbis dependence, while Social and Sexual Facilitation was negatively correlated.  Results 
indicate that for those with higher dependence scores on the SDS, expectancies of diminished 
cognitive abilities (Cognitive Behavioural Impairment) and poorer ability to facilitate social and 
sexual interaction (Social and Sexual Facilitation ) were greater.  Unlike cannabis frequency, the 
results of this analysis show that those with higher levels of dependence expect more negative 
consequences of their use, including impaired thinking and difficulty facilitating social and sexual 
facilitation.  In congruence with the drug instrumentalization theory, the cannabis expectancies 
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associated with dependent use, diminished cognitive abilities and lack of facilitation of social and 
sexual interations, suggest that those with dependent use may be ‘overinstrumentalizing’ cannabis, 
and it is no longer being used purposefully to achieve a goal (Müller & Schumann, 2011). 
Although cannabis use iniation, frequency, and dependence are the most common 
indicators for cannabis use, the study sought to investigate different ways in which non-dependent 
cannabis users may experience problematic outcomes.  Based on emerging research that has 
highlighted the difficulties in measuring cannabis-related problems, this study analysed the 
relationship between use and those cannabis-related problems that resulted directly because of use 
behaviour (i.e. missing work, not having enough money, problems with friends) (Asbridge et al.,  
2014).  Cannabis frequency and anxiety sensitivity were the strongest predictors of cannabis-related 
problems.  Higher levels of reported cannabis-related problems due to cannabis frequency is an 
expected outcome, as those who are more frequent users of cannabis are more likely to be 
dependent/problematic users (Coffey et al., 2003; Walden & Earleywine, 2008).  Although anxiety 
was a significant predictor for several other outcome variables, its relationship with cannabis-related 
problems was strongest.  Several other risk factors were associated with cannabis problems, 
including: time perspective (Future orientation), cannabis expectancies (Global Negative Effects and 
Cognitive Behavioural Impairment), and impulsivity (Sensitivity to Reward).  Lower levels of Future 
time perspective were associated with more cannabis-related problems.  Lower Future time 
perspective scores suggest less consideration for the future, and, specifically, future consequences.  
Thus, it would be expected that one might experience more problematic use outcomes if they are 
not as cognisant of the potential future consequences of their use.  Greater cannabis expectancies of 
Global Negative Effects was also associated with greater associated cannabis problems, indicating 
that having greater expectations of negative outcomes from cannabis use is associated with 
experiencing more cannabis-related problems.  Furthermore, expectancies of greater Cognitive and 
Behavioural Impairment was associated with more reported cannabis-related problems; 
expectations of greater impairment when using cannabis were associated with cannabis-related 
problems.  Higher levels of impulsivity (Sensitivity to Reward) were also associated with cannabis-
related problems, which highlights that more impulsive behaviour may lead to more problematic 
outcomes (Simons & Carey, 2002). 
2.5.2 Cannabis use and psychopathology groups 
In addition to developing a better understanding of risk factors associated with cannabis use 
outcomes, this study also sought to inform future applications of indicated prevention research 
efforts by developing a greater understanding of the risk factors related to problematic cannabis 
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use.  Firstly, the study sought to identify groups based on psychopathology amongst a non-clinical 
sample of young people.  Secondly, this work looked to explore the relationship between 
psychopathology and cannabis use behaviour, and cannabis use risk factors.   Previous research has 
established that risk factors, including sensation seeking, impulsivity, marijuana expectancies, time 
perspective, and psychopathology, including aggression, anxiety sensitivity, and depressive 
symptomology, have been associated with or implicated in the initiation of use, or the development 
of cannabis use behaviour (Silins et al., 2013). While there has been work that has looked at 
different facets of psychopathology (for example: depression and anxiety (Arseneault et al, 2004; 
Cheung et al., 2010, Hayatbakhsh et al., 2007, Patton et al., 2002; and van Laar et al., 2007) and it’s 
relationship between cannabis use behaviour and cannabis use risk factors, there has been little 
work exploring the relationship between cannabis use behaviour and cannabis risk factors and 
different classes of psychopathology.  Thirdly, this work sought to explore how membership to 
classes of psychopathology was associated with cannabis use behaviour and cannabis use risk factors 
and its potential as a targeting mechanism for indicated prevention efforts. 
2.5.3 Psychopathology groups  
In addition to investigating how related risk factors associated with cannabis use outcomes, this 
research examined how different groups of users may be identified, which in turn may inform how 
prevention may be used to target those most at-risk for problematic use outcomes.  Latent Profile 
Analysis identified three distinct groups based on self-reported aggression, anxiety sensitivity and 
depressive symptomology.  General psychopathology levels were the defining characteristic of each 
group.  The emergence of general psychopathology instead of specific anxious, depressive, or 
aggressive groups suggests that in this sample at least, the specific form of psychopathology may not 
be as important of a feature as the collective degree to which psychopathology is reported.  Some 
research has suggested general psychopathology be viewed as an index that operates on a spectrum 
(Caspi et al., 2013; Eaton et al., 2015).   
The identification of general psychopathology groups at a sub-clinical level provides an 
alternative approach for the investigation of mental health and its relationship with substance use.  
Due to the non-clinical nature of the sample, it may prove that because self-reported aggressive, 
anxious, or depressive symptoms are operating at a sub-clinical level, that the corresponding 
aggression, anxiety, and depression outcomes are not as pronounced or as important as the general 
level of psychopathology experienced. Identifying specific risk factors of aggression, anxiety 
sensitivity, or depressive symptomology and their relationship to substance use outcomes may place 
too much significance on the corresponding subclinical level of aggression, anxiety or depression.  
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The relationship between aggression, anxiety or depression may not be as important as the 
combined level of general psychopathology experienced. As such, it may be a more effective 
strategy to amalgamate different facets of psychopathology and create a general psychopathology 
construct.  Some research has suggested measuring general psychopathology may be a useful tool 
and may be more useful than looking at specific psychopathological constructs (Caspi et al., 2013; 
Eaton et al., 2015).   
2.5.4 Psychopathology group analysis 
Three groups were identified using LPA, a low, moderate and high psychopathology groups.  Using 
ANOVA analyses, the three identified groups were compared across cannabis use outcomes and risk 
factors associated with use.  The following section discusses the differences between the cannabis 
use outcomes and associated risk factors and the identified psychopathology groups. 
2.5.5 Cannabis use outcomes 
Cannabis outcome measures of frequency and problematic outcomes related to use were analysed.  
Self-reported cannabis use problems were different between groups, while there were no significant 
differences in reported cannabis use frequency.  Specifically, the low and moderate psychopathology 
groups differed from the high psychopathology group. These finding support the hypothesis that 
higher levels of psychopathology may be related to problematic use outcomes, and that frequency 
of use, in and of itself, is not determinant of problematic use.  The framework describing 
instrumentalized drug use states the ‘overinstrumentalization’ of use is the root to problematic use 
outcomes, and that frequency is not indicative of problematic use (Müller & Schumann, 2011).  This 
is aligned with cross-sectional data that implicates coping-motivated cannabis use as a risk factor for 
dependence (Bonn-Miller & Zvolensky, 2009; Norberg & Copeland, 2012; Fox et al., 2011).  In 
correspondence with these results, this suggests that while individuals in the higher 
psychopathology group may not be more likely to use cannabis frequently, they are more likely to 
experience problematic outcomes from their use.  This would suggest that frequent use, 
instrumentalized to achieve the desired effect, whether social or sexual facilitation or any other 
intended effect, is not necessarily associated with problematic outcomes.  Thus, infrequent, 
experimental or recreational users of cannabis may still experience problematic outcomes from their 
use, which is likely to be dependent on other factors which may include psychopathology.  The 
relationship between cannabis-related problems and psychopathology suggests that experiencing 
cannabis-related problems is not necessarily a result of cannabis use frequency.  This is congruent 
with research that has shown that cannabis exposure is not linked to cannabis dependence among 
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frequent cannabis users, but coping motives and negative, stressful life events are most predictive of 
cannabis dependence (van der Pol et al., 2013a).  However, the measurement of frequency of use 
may be an issue when linking problematic use and frequency when factors like joints per day or 
potency of cannabis aren’t measured.  Differentiating types of frequent cannabis use behaviour may 
demonstrate frequency as a critical component in the development of cannabis-related problems 
among frequent cannabis uses (Temple et al., 2011; Zeisser et al., 2012).    Although the cross-
sectional design of this study does not allow for the assessment of causality, cannabis-related 
problems, not frequency, are associated with membership to a group defined by level of 
psychopathology.  It is generally believed that cannabis use corresponds with a problematic 
outcome, and frequent cannabis users are certainly more at-risk for developing dependency (Noack, 
Höfler & Lueken, 2011); however, it may be that factors associated with the use, including 
personality types, temporal perspective, and psychopathology, are major contributors to the 
experience of problematic use outcomes.   
2.5.6 Cannabis use expectancies 
In addition to differences in cannabis use outcomes, the identified psychopathology groups differed 
on cannabis use expectancies.  Generally, more frequent cannabis users have more positive 
expectancies than less frequent users, while many non-users have negative expectancies (Simons & 
Arens, 2007; Galen & Henderson, 1999). Despite differences in reported cannabis use problems, only 
the Cognitive and Behavioural Impairment dimension of cannabis use expectancies differed amongst 
psychopathology group. Cognitive and Behavioural Impairment expectancies were significantly lower 
in the low psychopathology group than in moderate and high psychopathology groups.  If greater 
impairment was associated with more problematic cannabis use outcomes, it would be reasonable 
to expect that Cognitive and Behavioural Impairment expectancies would be greater for the high 
psychopathology group.  As expectancies of cannabis users are likely to be a reflective of past use 
experiences, greater reported cannabis use problems would be associated with a greater 
expectation that use behaviour would be associated with cognitive and behavioural impairment.  
This suggests that individuals in the higher psychopathology groups are more likely to use to an 
extent in which they experience a greater level of impairment, or perceive their experience or 
expected experience to be more impaired than individuals in the low and moderate 
psychopathology group.  These results are similar to previous research that has shown that those 
with greater social anxiety report more negative cannabis effect expectancies (Buckner et al., 2007).  
In the previous analysis, Cognitive and Behavioural Impairment expectancies were associated with 
cannabis use dependence (severity of dependence), but not for any other cannabis use outcomes 
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(lifetime use, cannabis frequency, or cannabis problems).  It may be that individuals with higher 
levels of psychopathology may be more likely to view their experiences as potentially problematic or 
impaired.  Another potential reasoning for this is that a higher level of psychopathology may make 
one more vulnerable to negative outcomes from cannabis use, which may lead to greater 
‘impairment’ and more problematic outcomes. 
2.5.7 Time perspective 
Time perspective, particularly dimensions of Past Negative and Present Hedonistic perspective, was 
significantly different among identified psychopathology groups, with the higher levels of these 
constructs reported in the high psychopathology group.  These results are similar to other research 
looking at time perspective and mental health (Anagnostopoulos & Griva, 2011; Papastamatelou et 
al., 2015).  Past Negative time perspective represents a generally negative view of the past, while 
Present Hedonistic corresponds to a perception in which impulsivity and risk-taking is applied to 
behaviour and the concept of time.  There was a very strong relationship between psychopathology 
group and Past Negative perception, indicating that membership into the high psychopathology 
group corresponded with a high level of Past Negative time perspective.  It is unclear whether 
individuals with high levels of Past Negative have negative past experiences, or whether these 
experiences are reconstructed negatively.  It may be that individuals with higher levels of 
psychopathology are more likely to view their past experiences as negative, which would correspond 
with the previous assertion that levels of impairment due to cannabis use may be reconstructed to a 
larger extent than by other groups of lower psychopathology.  Additionally, the Present Hedonistic 
time perspective corresponds to present pleasure and is not concerned with future consequences. 
Thus, individuals in the high psychopathology group were more likely to have a negative perception 
of their past events, and more likely to engage in impulsive, risky pleasurable behaviours to meet 
their present needs, without much consideration for the future.  
2.5.8 Impulsivity 
Impulsivity is associated with substance abuse, disruptive behavioural disorders and aggression 
(Barratt et al., 1999; Allen et al., 1998; Dougherty et al., 2003; Verdejo-Garcia, Lawrence & Clark, 
2008).  Impulsivity, both measures of Consideration of Future Consequences and Sensitivity to 
Reward, differed between the low psychopathology group, and the high and moderate 
psychopathology group; there were no significant differences in impulsivity between the high and 
moderate psychopathology groups.  These constructs provide an understanding of the degree to 
which the implications of behaviours are considered as well as the degree to which one would be 
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willing to adopt this behaviour in order to obtain a reward.  This suggests that the low 
psychopathology group would be a less risk-taking and more future-oriented, while the moderate 
and high psychopathology group would engage in more impulsive behaviour, with far less 
consideration for the potential consequences. 
2.5.9 Sensation seeking 
There were no reported differences between psychopathology group and sensation seeking.  
Sensation seeking is a personality construct often attributed to drug seeking behaviour and risk 
taking.  Sensation seeking measures an individual’s interest in seeking new and novel experiences, 
and is unlikely to be related to one’s psychopathology (Zuckerman & Neeb, 1979). 
2.5.10 Psychopathology 
There were statistically significant differences among anxiety and depressive measures among all 
three groups, while aggression differed between the moderate and high psychopathology group and 
the low psychopathology group.  Furthermore, the least degree of difference among the factors that 
determined the groups was between aggression, with no significant difference demonstrated 
between the moderate and high psychopathology groups. 
2.5.11 Differences by psychopathology group 
In addition to looking at the composition of the psychopathology groups, differences between 
clusters were specifically investigated.  
2.5.12 Differences between Low and Moderate psychopathology groups 
There were significant reported differences between the low and moderate psychopathology group 
in time perspective (Past Negative), impulsivity (Sensitivity to Reward), and two elements of 
cannabis expectancies (Cognitive and Behavioural Impairment and Craving and Physical Effects).  
Despite differences in risk factors associated with cannabis use behaviours, there were no significant 
differences when comparing these groups when looking at cannabis use frequency or problems.  
Thus, although the risk factors associated with cannabis use outcomes differ between low and 
moderate groups of psychopathology, they did not influence or affect cannabis use outcomes.  
There were differences between Past Negative time perspective, impulsivity and Sensitivity to 
Reward, and the cannabis expectancy of Cognitive and Behavioural Impairment, in which the 
moderate psychopathology group reported higher levels than the low group.  The low 
psychopathology group reported a higher level of expected Craving and Physical Effects of cannabis 
than the moderate psychopathology group.  Craving and Physical Effects expectancies corresponds 
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largely to the ways in which cannabis effects the body and appetite (Aarons et al., 2001); thus, 
membership to the low psychopathology group greater likelihood of expectancies of Craving and 
Physical Effects of cannabis.  It may be that the moderate psychopathology group may be more 
attuned to Cognitive and Behavioural Impairment effects due to their own greater level of 
psychopathology, while the low psychopathology group may be more attuned to the Physical and 
Craving Effects of cannabis use (Buckner et al., 2007; Buckner & Schmidt, 2008; Buckner & Schmidt, 
2009).  Higher levels of impulsivity and Past Negative time perspective suggest that the moderate 
psychopathology group is more likely to view their past experiences as negative, and more likely to 
engage in impulsive behaviours geared towards reward (Anagnostopoulos & Griva, 2011; 
Papastamatelou et al., 2015).   
2.5.13 Differences between Moderate and High psychopathology groups 
The only differences measured between the moderate and high psychopathology groups were 
dimensions of temporal perspective, including: Past Negative, Past Positive, and Present Fatalistic.  A 
greater Past Negative time perspective was significantly more likely to be a characteristic of the high 
psychopathology group, than the moderate psychopathology group.  This is likely to be a result of 
the higher levels of anxiety sensitivity and depression reported within the psychopathology group, 
which correspond to negative perceptions regarding past experiences.  Additionally, the Present 
Fatalistic time perspective suggests the high psychopathology group is more likely to be present 
focused, with little regard for future consequences of present behaviour (Anagnostopoulos & Griva, 
2011; Papastamatelou et al., 2015).  Conversely, the moderate psychopathology group was likely to 
have higher scores of Past Positive time perspective indicating that they are more likely to have a 
nostalgic and positive view of their past.  Although these results suggest that the high 
psychopathology group is likely to be more negative regarding their experiences as well as focused 
on the present with little regard for future consequences, these increased risk factors associated 
with cannabis use do not translate into statistically significant differences between cannabis use 
frequency or associated problems between groups.  There are several possible explanations for 
these differences.  There are a complex web of factors that are linked between both cannabis and 
other drug use and mental health (Jané-Llopis & Matytsina, 2006).  It is likely that the risk factors 
associated with cannabis use are also linked to psychopathology.  Although there are differences 
between these groups, it is likely they are a reflection in the difference between psychopathology 
and not cannabis use outcomes.  Previous research has found that mental health factors, aside from 
externalising behaviours, are similar among frequent, non-dependent cannabis users and the 
general population, while mental health factors are worse among dependent, frequent cannabis 
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users (van der Pol et al., 2013b).  Alternatively, the level of difference in psychopathology between 
the groups may not be great enough to display differences in use cannabis use outcomes, and a 
greater difference would be necessary for differences in cannabis use outcomes to be discerned. 
2.5.14 Differences between Low and High psychopathology groups 
There were significant differences between the low and high psychopathology group in risk factors 
associated with cannabis use, including temporal perspective (Past Negative, Past Positive, Present 
Fatalistic) and impulsivity (Sensitivity to Reward), as well as reported problems associated with 
cannabis use.  As with the two previous analyses looking at the differences by psychopathology 
group, Past Negative time perspective is a strong predictor of class membership, with greater 
likelihood of membership the high psychopathology group with higher scores of the construct.  
Furthermore, Present Fatalistic time perspective is also associated with membership to the high 
psychopathology group.  Conversely, a positive and nostalgic view of the past (Past Positive) is 
associated with membership to the low psychopathology group.  These results further illustrate that 
temporal perspective is likely to be significantly related to psychopathology, and one’s view of past 
events is likely to be influenced by the degree of anxiety, depression and aggression they report to 
be experiencing (Anagnostopoulos & Griva, 2011; Papastamatelou et al., 2015).  In addition to risk 
factors associated with cannabis use, greater reported cannabis related problems were associated 
with membership to the high psychopathology group.  Although there were no reported differences 
between the low and moderate, or the moderate and high psychopathology groups, significant 
differences were detected between the low and high psychopathology group.   This is consistent 
with evidence linking mental health and cannabis problems (Degenhardt, Hall, & Lynskey, 2001; 
Chabrol et al., 2005; Rey et al., 2002; Monshouwer et al., 2006; Degenhardt et al., 2013).   The high 
psychopathology group either engages in more problematic use due to the factors associated with 
this membership (anxiety, depression and aggression) than peers in the low psychopathology group, 
or they are more likely, due to other factors like temporal perspective and impulsivity, to view their 
experiences with cannabis as problematic (Ansell et al., 2015). 
2.5.15 Conclusions 
These analyses provide important findings for prevention work, particularly around risk factors and 
their relationship with cannabis use outcomes.  There is debate in the cannabis literature about the 
challenges in cannabis prevention and research, particularly regarding cannabis assessment, like 
frequency and potency (Temple, Brown & Hine, 2010; Copeland, 2011; Patton, 2011; Earleywine, 
2011; Hammersley, 2011; Andréasson, 2011).  Results demonstrate that the ways in which we assess 
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cannabis use influences which risk factors are associated.  This work highlights the importance for 
prevention work to focus on the perceived user profile and which risk factors are associated with the 
target population.  For indicated prevention, targeting frequent cannabis users individuals may not 
be appropriate.  Although relationship between the risk of dependence and cannabis frequency is 
well-documented (Hall & Degenhardt, 2009), research has shown that in identifying problematic 
cannabis users, user-related harm may be more suitable (Davis et al., 2009; Thake & Davis, 2011; 
Zeisser et al., 2012; Asbridge et al., 2014).  Some research has suggested cannabis dependence does 
not necessarily indicate problematic cannabis use (Liebregts et al., 2015).  It may be more useful to 
explore different ways to assess cannabis use behaviour in order best target users most susceptible 
to experiencing problematic outcomes (Hughes et al., 2014; van der Pol et al., 2014; van Laar et al., 
2013; van der Pol et al., 2013b).  Indicated prevention efforts could specifically target which users 
have problematic outcomes and work to curb those issues and prevent the graduation to dependent 
use. 
The first analyses investigated the associations of risk factors associated with cannabis use, 
and looked at those associations across different use outcomes variables.  Risk factors associated 
with lifetime cannabis use, which corresponds with whether one has initiated cannabis use, differed 
from the risk factors associated with severity of dependence, problematic outcomes, and frequency.  
These results suggest that the factors that may be associated with initiation of cannabis use are not 
the same factors that lead to the continued use of cannabis.  Thus, universal prevention efforts that 
seek to stop the initiation of cannabis use may look to factors that are associated with lifetime 
cannabis use, while indicated and selective prevention efforts may target different risk factors. 
The second analyses looked specifically at groups of users by psychopathology, and sought to 
determine if this might be a potential tool for indicated prevention.  Research has highlighted the 
relationship between cannabis and mental health (Cheung et al., 2010; Degenhardt et al., 2013; 
Degenhardt, Hall & Lynskey, 2003; Crippa et al., 2009; Stinson et al., 2006).  The results indicated that 
higher levels of psychopathology were associated with more problematic cannabis use outcomes, but 
not frequency.  This suggests that higher psychopathology may not be linked to frequent use of 
cannabis, but rather problematic outcomes when recreational or experimental use occurs.  This is 
consistent with research that has shown the mental health of non-dependent, frequent cannabis users 
is similar to the general population, while the mental health of frequent, dependent cannabis users is 
worse (van der Pol et al., 2013a). This suggests that using psychopathology as a screening instrument 
for targeted, indicated prevention efforts may be suited to target high psychopathology and tailor 
interventions to the specific relationship between psychopathology and problematic use outcomes.  
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Understanding more about the relationship between psychopathology and problematic cannabis use 
would be necessary, but this provides evidence that targeting specific problematic users, opposed to 
frequent users, may be a way to prevent experimental and recreational cannabis users from 
experiencing problematic outcomes or transitioning into problematic, dependent use. 
2.5.17 Limitations 
Several limitations should be considered, including the study population, self-report data, internet-
based survey, cross-sectional design, comorbidity of anxiety, depression and aggression, and 
confounding factors.  This investigation specifically was interested in young people without a previous 
clinical diagnosis of a clinical affective disorder.  Despite this established criteria, it seems highly 
possible that several of the participants in this study may meet the criteria of clinical depression, 
anxiety, and alcohol and drug dependence.  Furthermore, although a significant portion of 
respondents were university students, analyses showed that these participants did not significantly 
differ in their responses to other participants. The cross-sectional design of this study limits our ability 
to comment on the causal relationship between level of psychopathology and the use of alcohol and 
drugs.  It does, however, examine the complexities related to factors associated with assessments of 
cannabis use.  Additionally, a potential limitation of this outcome is the comorbidity of anxiety and 
depression (Lamers et al., 2011). As shown in section 2.2, there are numerous risk and protective 
factors associated with drug use.  In addition to their relationship with drug use outcomes, many of 
the risk factors have been shown to be related. For example, over 60 confounding factors were 
considered to determine whether causal explanations of cannabis use and mental health outcomes 
(psychosis) were overestimated (Moore et al., 2008).  It is likely that factors not included in the models 
for this study, like IQ, sociodemographic markers, and poor educational attainment would contribute 
to the model, and consideration of these non-included factors must be considered when interpreting 
these results. 
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Chapter 3 
Implicit associations and cannabis use behaviour 
in frequent cannabis users 
 
3.1 Introduction 
One of the main challenges in drug and alcohol research is understanding why people engage in 
behaviours despite possessing knowledge that it is detrimental to their health.  In drug and alcohol 
research, explicit measures, such as attitudes, knowledge, and use expectancies, have been primarily 
used to predict behavioural outcomes of use, like in study 1 of this PhD (von Sydow et al., 2002).  
The previous study in this PhD looked at explicit measures and their relationship with cannabis use 
outcomes.  Despite the extensive use of explicit measures in drug and alcohol research, this 
measurement tool has considerable limitations, including participants’ self-presentation efforts for 
their answers to be aligned with social convention, and lack of self-insight and knowledge regarding 
the underlying mechanisms that contribute to their behaviour (Nisbett & Wilson, 1977; Schwarz, 
1999; Schwarz & Oyserman, 2001).  Theories regarding behaviour suggest that a dual-process model 
of “rational” and “impulsive” processes jointly predict behaviour (Strack and Deutsch, 2004), an 
indication that the sole use of explicit measures (rational processes) to predict behavioural 
outcomes is insufficient.  The rational processes is a system in which behavioural decision are made 
based on facts and knowledge (explicit measures), and the impulsive system is a system based on 
associative links and motivational orientations (implicit measures). Implicit cognitions are 
spontaneous evaluative responses to stimuli which have been shown to influence behaviour 
(Perugini, 2005). To provide a more comprehensive understanding of how cognitions affect alcohol 
and drug behaviour, researchers have developed tools to measure the impulsive cognitive processes 
and the implicit evaluations that influence drug and alcohol behaviour in conjunction with explicit 
measures.  
 The Implicit association test (IAT) is a test used to measure implicit cognitions (IAT; 
Greenwald, McGhee & Schwartz, 1998).  The IAT test is administered by presenting the participant 
with stimuli (word, or picture) representing target and attribute dimensions.  The main objective for 
the participant is to categorise the stimuli as quickly and accurately as possible.  The participant 
performs the categorisation task in several different phases for the target dimension (e.g. race:  
Black vs. White) and attribute dimension (e.g. Positive vs. Negative).  In the critical phases of the 
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task, participants perform double-categorisation tasks in which they are instructed to make binary 
decisions for stimuli for two dimensions simultaneously (e.g. press left button for Black and Positive 
Words, and press right button for White and Negative Words), followed by a phase in which the 
target and attribute dimensions are switched (e.g. press left button for Black and Negative Words 
and press right button for White and Positive Words).  In the IAT test, response latency and accuracy 
are the main dependent variables (generally latency is used as the primary variable of interest).  The 
underlying reasoning for using this methodology is that the pattern of response latencies and error 
percentages provide an index to the strength of the target-attribute association in memory.   In the 
aforementioned example, the difference between the average response latency between the two 
combination phases would be calculated to produce the IAT effect.  Therefore, if participants were 
faster at responding when the combination of White and Positive versus Black and Negative than 
when the combination is reversed, the conclusion would be that the participant has a more positive 
association with Whites than Blacks, even though the participant may not admit to this directly 
when asked. 
In addition to the IAT, several variants of the test have been created in order to deal with 
some of the limitations of the original test.  For example, when studying alcohol and drugs, it is 
important to test both negative (e.g. unhealthy) and positive (e.g. fun) associations independently, 
as expectancies are not mutually exclusive.  In order to test both of these associations, the unipolar 
IAT was developed in which the target attribute (e.g. unhealthy) is contrasted with a neutral 
attribute, and then repeated with the other target attribute (e.g. fun) and the same neutral (see, for 
example, Jajodia & Earleywine, 2003).  This technique has been used particularly with measuring 
positive and negative associations with the target of alcohol versus soft drinks (e.g. Wiers et al., 
2003; Houben & Wiers, 2007; Tibboel et al., 2015).  This data can then be used to understand how 
negative and positive implicit associations of alcohol affect behaviour separately and concurrently.  
A limitation of the IAT measure is that when two categories are contrasted by the participant, 
conclusions derived can only be made in reference to how one views a selected category in 
comparison to another (De Houwer, 2001).  To compensate for this limitation, a further variant of 
the IAT test, the single-category IAT (SC-IAT), was developed and eliminates comparison of two 
target categories. 
The SC-IAT requires participants to categorise words as quickly as possible into different sets 
and is presented in four blocks (e.g. Houben &Wiers, 2008; Dekker et al., 2009).  In the first block, 
participants press the left key when the stimulus word that comes up in the middle of the screen is 
an attribute word (e.g. active) and press the right key when the stimulus word is neutral.  In the 
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second block (combination task), participants press the left key when the stimulus word is an 
attribute or a cannabis word and press the right key when the stimulus word is neutral.  In the third 
block (reversed practice phase), participants press the left key when stimulus word is neutral and 
press the right key when the target word is an attribute word.  In the fourth block (reversed 
combination phase), participants press the left key when the stimulus word is neutral or a cannabis 
word and press right when the stimulus word is an attribute word.  The difference between the 
reaction times of the combination and reversed combination phases is the IAT effect and gives an 
indication of the strength of association between the target (e.g. cannabis) and the affective 
category (e.g. active) (Greenwald, McGhee & Schwartz, 1998). 
A key component in addition to measuring implicit associations towards drugs and alcohol is 
measuring the strength of implicit cognitions and their influence on behaviour.  Hedonism is 
conceptualised as the motivation to seek and participate in pleasure-oriented behaviour 
(Veenhoven, 2003).  This seeking of pleasure is thus considered to be related to the indulgence of 
sensory-oriented pleasures such as drug use, often with reward pathways being influenced by 
hedonic effects (Wise & Rompre, 1989; Featherstone, 1991; Szmigin et al., 2008; Nestler, 2005; Koob 
& Moal, 2005; Everitt & Robbins, 2005; Kalivas, 2005).  The paradox of hedonistic behaviour is if the 
participation in a hedonistic lifestyle leads to unhealthy (potentially unpleasant) behaviour a true 
hedonist would reject this behaviour.  This suggests that a hedonist participates in ‘risky, hedonistic’ 
behaviours despite the risk involved, or because the pleasure derived from the experience in the 
short-term has a greater importance to the individual (Sullivan, Hammerstein & Hagen, 2008).  Thus, 
it should be noted the seeking of pleasure-oriented behaviour is not the only component associated 
with the construct, but also hedonic impulsivity.   
In order to measure hedonistic impulsivity implicitly, it is not only the evaluation of pleasure-
oriented stimuli that must be assessed, but also the inability to down-regulate the influence of these 
stimuli over time.  The regulation of these evaluations is called affect regulation (Hoffman, Friese & 
Roefs, 2009).  An adapted version of the Affect Misattribution Procedure is used to measure hedonic 
impulsivity (Payne et al., 2005; Hoffman, Friese & Roefs, 2009).  This task presents participants with 
positive (pleasure) and negative oriented stimuli, followed by neutral stimuli which are rated by the 
participant (Payne et al., 2005; Hoffman, Friese & Roefs, 2009).  A standard task is completed, 
followed by the same task with an extended period of time between the presentation of affective 
stimuli and the evaluation of the neutral stimuli (Payne et al., 2005; Hoffman, Friese & Roefs, 2009).  
Individuals who continue to rate neutral stimuli influenced by the presentation of hedonic affective 
  
74 
 
stimuli have more difficulty down-regulating hedonic impulses and are more likely to participate in 
hedonic behaviour (Payne et al., 2005; Hoffman, Friese & Roefs, 2009). 
The present study had two specific aims. Firstly, it investigated how implicit cognitions 
regarding cannabis expectancies as well as the ability to down regulate impulses (affect regulation), 
influenced cannabis use and related behaviour.  Moreover, this research sought to build upon the 
first study of this PhD, to explore how implicit measures added to models that use explicit measures 
and risk factors associated with cannabis use behaviour.  Secondly, the research looked to 
specifically understand how previously determined factors associated with cannabis use influenced 
cannabis-related behaviour in frequent cannabis users.  It was hypothesised that the inability to 
down-regulate impulses (affect regulation) and greater positive implicit expectancies of cannabis 
would be associated with greater levels of cannabis-related behaviour.  Additionally, it was 
hypothesised that higher levels of psychopathology would be related to greater levels of cannabis-
related behaviour in frequent cannabis users. 
3.2 Methodology 
3.2.1 Participants and procedure 
Participants were recruited through Liverpool John Moore University psychology student population, 
and by snowball sampling.  Participants were included if English was their first language, they were 
between the ages of 18-35 years-old, and reported using cannabis at least weekly; participants were 
excluded if they indicated that they were colour-blind or dyslexic as this would affect performance 
on the experimental test.  Frequent cannabis users were targeted to focus on the relationship 
between the extent of cannabis behavioural involvement and adverse outcomes.  
Participants first completed the SC-IAT and the modified version of the affect-misattribution 
procedure, followed by a battery of questionnaires.  Next, participants were asked to roll a typical 
‘joint’ using a cannabis-like substitute (a cooking herb) and provide information regarding their joint 
using behaviour, in order to obtain more data regarding cannabis user behaviour   Following all 
elements of the data collection procedure, participants were debriefed. 
Ethical approval was obtained from Liverpool John Moores University Research Ethics 
Committee for this research.  Participants were presented with a participant information sheet 
describing the nature of the research.  Participants were fully informed of the nature of the 
interview and provided their written consent on the day of the research following a discussion of the 
participant information sheet with the researcher.  Participants were informed that their 
participation was voluntary and of their right to withdraw from the research at any time without 
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reason.  Furthermore, participants were informed that their anonymity would be protected and no 
references to individuals, place names or organisations would be made in documentations regarding 
this research.  Participants received course credit or a ₤30 Love-2-Shop vouchers in exchange for 
their participation.  The payment of drugs users for their participation in drugs research and the 
corresponding ethics are an important consideration.  A review and practical guide to these 
considerations concluded that payment is ethically justifiable in most cases of drugs research (Fry et 
al., 2015). Payment as undue influence and payment as justifiable incentive for participation was 
considered, and this research aimed to ensure that payment of vouchers to research participants 
was an appropriate reimbursement for their time. The research payment strategies employed by 
comparable research studies were reviewed and evaluation when making decisions regarding the 
amount of incentive offered.  
3.2.2 Materials and measures 
3.2.3 Implicit measures 
The Implicit Association Test and the Affect Misattribution Procedure were programmed and 
controlled using INQUISIT Millisecond software package (INQUISIT 3.0, Millisecond Software, Seattle, 
WA, www.millisecond.com).   
3.2.4 Hedonistic impulsivity (affect regulation) 
The Affect Misattribution Procedure is a task developed to measure the extent to which briefly 
presented positive and negative stimuli influence the pleasantness judgment of neutral stimuli 
presented shortly afterwards (AMP; Payne et al., 2005).  The AMP effect measures the 
positive/negative judgements of the neutral stimuli when preceded by positive/negative primes and 
the difference in evaluation between positive and negative prime trials serves as the indicator of 
affective reactivity towards these stimuli.  An updated version of AMP was developed to measure 
how affect regulation is down-regulated over time (Hoffman, Friese & Roefs, 2009).  In addition to 
the original AMP, a second within-subjects condition in which the time between prime and target 
presentation (stimulus-onset-asynchrony; SOA) is increased from 100ms for the standard AMP trial 
to 1000ms.  Utilising this AMP method, the dependent measure of affect regulation is the difference 
in affective reactivity between the long and short SOA.  The rationale being that rating of the neutral 
stimuli following the presentation of the valenced prime after a longer time between stimuli 
indicates a higher affect regulation (Hoffman, Friese & Roefs, 2009). 
For the prime stimuli, 20 positively and 20 negatively valenced pictures were selected from 
the IAPS (Lang, Bradley, & Cuthbert, 2005).  Prime stimuli were presented for 75ms according to a 
  
76 
 
predetermined, random order that was identical for all participants.  In addition, each prime was 
paired with a new neutral image for evaluation, a Chinese target pictograph taken from Payne et al. 
(2005).  Each pictograph was presented for 200ms followed by a mask. The order in which SOA 
(100ms vs. 1000ms) were presented to the participant was randomly selected. 
In order to ensure that the Chinese target pictographs were neutral, Chinese fluency was 
assessed to make certain that the characters presented were ambiguous.  To assess Chinese 
proficiency, participants were asked, “How well do you speak Chinese?” with response options 
ranging from 1 (not at all) to 4 (fluently).  No participants reported being fluent in Chinese. 
3.2.5 IAT test 
The IAT test was used to measure participants perceived evaluations of cannabis-related words 
(Greenwald et al., 1998; Field, Mogg & Bradley, 2004).  The IAT has previously been used to evaluate 
the valence of drug-related words in samples of cannabis users (Field, Mogg & Bradley, 2004, Dekker 
et al., 2009; Ames et al., 2007; Ames et al., 2013).  Implicit affective associations towards cannabis 
were assessed using three unipolar Single Category Implicit Association Tests (SC-IATs; Karpinski & 
Steinman, 2006), and have previously been used in cannabis research (Dekker et al., 2009).  Each SC-
IAT measured a different affective association towards cannabis.  Three subscales (‘active’ for 
positive arousal; ‘negative’ for negative affect; ‘relaxed’ for positive sedation) have been previously 
used in drugs research (for example: Ames et al. 2007; Wiers et al. 2007; Dekker et al., 2009) 
because they represent the three main types of expectancies associated with cannabis (Goldman & 
Darkes, 2004Wiers, 2008; Dekker et al., 2009).  The words used for the affective, cannabis and 
neutral categories were derived from previous research (Dekker et al., 2009; Table 1). 
In the SC-IAT, participants must categorise words as quickly as possible by pressing the right 
or left button.  Each SC-IAT consisted of four phases and was presented in random order (Dekker et 
al., 2009; Table 2).  During the practise phase (block 1), a target word appeared in the middle of the 
screen.  The participant pressed the left key (‘E’) if the target word that appeared was a valenced 
word (e.g. a word from the list of one of the affective categories: active, relaxed or negative; Table 
1), or pressed the right key (‘I’) when the target word was a neutral word (e.g. from the list of 
neutral words; Table 1).  In the combination task (block 2), participants pressed the left key when 
either the target word was a valenced word or a cannabis word, and pressed the right key when the 
target word presented was a neutral word.  In the reverse practice phase (block 3), participants 
pressed the left key when the target word was a neutral word, and pressed right when the target 
word was a cannabis word.  In the reversed combination task (block 4), participants pressed the left 
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key when the target word was either a neutral word or a cannabis word, and pressed the right key 
when the target word was a valenced word.  During the combination task (block 2) and the reverse 
combination task (block 4), cannabis is paired with either one of the affective categories or the 
neutral category.  The difference in reaction times measured between these two blocks is the IAT 
effect, which indicated the strength of the association between cannabis and the affective category 
(for example: active, relaxed, or negative) (Greenwald et al., 1998; Dekker et al., 2009).  Participants 
with a strong association between cannabis and an affective category, finding it easier on the task 
with the cannabis word and the affective word on the same side, would consequently complete the 
task faster compared to the reverse task, when the cannabis words and the relaxed word are on 
opposite sides (Dekker et al., 2009).  
Table 1. Word stimuli for IAT (Dekker et al., 2009). 
Active stimuli Creative; Energetic; Cheerful; Motivated; Talkative 
Neutral stimuli Indefinite; General; Usual; Standard; Impartial 
Relaxed stimuli Relaxed; Calming; Contented; Comforting; Reassuring 
Neutral Stimuli Accompanying; Preceding; Supplementary; Frequent; Additional 
Negative stimuli Miserable; Suspicious; Listless; Anxious; Confused 
Neutral stimuli Central; Daily; Middle; Common; Customary 
Cannabis stimuli Weed; Hash; Cannabis; Stoned; Blow 
 
Table 2.  Schematic overview of the block sequence for active, relaxed and negative single-
category implicit association tests (SC-IATs) (Dekker et al., 2009). 
 Block 1 
Practice Phase 
Block 2 
Combination 
Phase 
Block 3 
Reversed 
Practice Phase 
Block 4 
Reversed 
Combination 
Phase 
Active SC-IAT  Active       Neutral Active       Neutral 
Cannabis 
Neutral   Active Neutral   Active 
Cannabis 
Relaxed SC-IAT Relaxed    Neutral Relaxed    Neutral 
Cannabis 
Neutral   Relaxed Neutral   Relaxed 
Cannabis 
Negative SCIAT Negative  Neutral Negative  Neutral 
Cannabis 
Neutral  Negative Neutral  Negative 
Cannabis 
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3.2.6 Explicit measures 
3.2.7 Explicit cannabis expectancies 
The explicit cannabis expectancy measure is a questionnaire with 18 unipolar items consisting of 
statements related to using cannabis and an affective outcome, the same as those that were used in 
the implicit measure (positive arousal, positive sedation, and negative) (Dekker et al., 2009; 
Eastwood et al., 2010).  Participants indicated the extent to which they agreed or disagreed with 
each statement on an unmarked visual analogue scale (VAS).  Lower values indicated a higher level 
of expectancy.  Moderate levels of consistency were measured in the scales: positive-arousal (α 
= .666), positive-sedation (α = .691), and negative (α = .787).  This questionnaire was chosen to 
ensure consistency between the implicit and explicit expectancy measures. 
3.2.8 Impulsivity and sensation seeking 
Impulsivity was measured using the Consideration of Future Consequences (CFC) instrument 
(Strathman et al., 1994), and the Sensitivity to Reward questionnaire (Torrubia et al., 2001).  The CFC 
measures the extent to which individuals consider the potential distant outcomes of their current 
behaviours, and the extent to which they are influenced by these potential outcomes.  This measure 
showed good reliability (α = .888).  The Sensitivity to Reward Questionnaire is based on Gray’s 
Behavioural Approach System (BAS; Gray, 1981) and measures impulsive dimensions of personality 
(α = .825). 
The Sensation Seeking Scale (SSS) measures the sensation seeking trait, defined by 
Zuckerman (1979) as “the need for varied, novel, and complex sensations and experiences and the 
willingness to take physical and social risks for the sake of such experiences (p.10)”.  The Brief 
Sensation Seeking Scale (BSSS; Hoyle et al., 2002) is an 8-item, shortened version of the original scale 
and considered to be a valid and reliable measure (α = .738). 
3.2.9 Trait self-control 
The short version of the trait self-control scale will be used to measure individual differences of self-
control on a wide variety of behaviours (Tangney, Baumeister & Boone, 2004).  An index of self-
control was used combining the scores of the 13 items with a possible range between 0 (low trait 
self-control) and 5 (high trait self-control; α = .549). 
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3.2.10 Aggression 
The Buss and Perry Aggression Questionnaire (BPAQ) is a 29-item questionnaire that assesses the 
dimensionality of aggression and how it is manifested, looking specifically at four factors: verbal 
aggression (α = .844), physical aggression (α = .883), anger (α = .887), and hostility (α = .870) (Buss and 
Perry, 1992).    
3.2.11 Anxiety sensitivity 
The ASI-3 is an 18-item adaption of the Anxiety Sensitivity Index (ASI) that provides three subscales of 
anxiety sensitivity: cognitive (α = .916), social (α = .543), and physical (α = .846) anxiety sensitivity 
(Anxiety Sensitivity Index; Reiss et al., 1986; Taylor et al., 2007).  The scale shows good reliability and 
validity in non-clinical populations and shows improved psychometric properties compared to the 
original Anxiety Sensitivity Index (Taylor et al., 2007).   
3.2.12 Depression 
The Center for Epidemiological Study of Depression Scale (CES-D) is a 20-item self-report scale 
designed to measure depressive symptomatology in a non-clinical population (Radloff, 1991).  The 
scale showed good reliability in the current sample (α = .883). 
3.2.13 Time perspective 
Time perspective assesses the cognitive processes that organise human experience into past, present, 
and future temporal frames (Zimbardo, 1999).  The 56-item time perspective questionnaire (ZPTI) 
examines five dimensions of time perspective: Past Negative (α = .797), Present Hedonistic (α = .801), 
Future (α = .790), Past Positive (α = .743), Present Fatalistic (α = .627).  The test has acceptable internal 
consistency and test-retest reliability.   
3.2.14 Dependent variables 
3.2.15 Cannabis frequency and joint consumption 
To assess participants’ cannabis consumption during the past week, they were asked write down 
how many occasions they smoked cannabis and how many joints they smoked on each occasion in 
accordance with the ‘timeline followback’ methodology.  This approach has excellent test-retest 
reliability and convergent and discriminate validity for the assessment of cannabis and other illicit 
drug use (Fals-Stewart et al., 2000).  To compute the dependent measure, participants were to roll a 
joint to assess the amount of cannabis used per joint.  Once participants completed the self-report 
section of the study, participants were presented with rolling papers, tobacco, and a legal herbal 
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cannabis substitute (similar in appearance and smell to cannabis), and were asked to roll a ‘typical’ 
joint  to estimate the quantity of cannabis and tobacco used per joint (Mariani et al., 2011).  This 
method was used to obtain a more accurate measure of cannabis use as there is great variation in 
the amount of cannabis used per joint.  The provided supply of cannabis and tobacco was weighed 
before and after the experiment procedure, and the difference determined the quantity of cannabis 
and tobacco used in the joint.  Participants were informed that the substance was a legal cannabis 
substitute prior to the task and that they would not be breaking the law.  
In addition to reporting on cannabis consumption, participants answered questions about 
other aspects of their cannabis use, including the variation in quantity of cannabis and tobacco used, 
and the frequency in which the participant rolls the joints they smoke.  Most (87.5%) used tobacco 
with their joint.  A considerable number of participants (25%) never rolled the joints they smoked 
and only 20% indicated that they always rolled their own joints.  In the joint rolling task portion of 
the experiment, participants who never rolled their own joints were asked to proceed as best they 
could.  This did, however, have implications for the reliability of cannabis estimates used in this 
study.  Participants were also asked the reasons for which they might alter the quantity of cannabis 
and tobacco in their joints.  The people they were smoking with, the quantity they had, time of day, 
work/life responsibilities and intended high were all given as reasons. 
3.2.16 Severity of dependence  
Cannabis dependence was assessed using the cannabis version of the Severity of Dependence Scale 
(C-SDS), which provides an overall score ranging from 0 to 15, with higher scores indicating more 
severe dependence.  This scale shows good reliability (α = .705) (Martin et al., 2006).   
3.2.17 Cannabis-related problems 
Cannabis-related problems index was measured using a list of 17 items derived from the 19-item 
Marijuana Problems Scale (MPS) (Stephens et al., 2000).  Participants were first asked whether or 
not they experienced a problem in the past 90 days (e.g. legal problems; difficulty sleeping), and 
then were asked if this problem was caused or worsened due to cannabis use.  Two items from the 
original scale (“feel bad about your use”; “withdrawal symptoms”) were eliminated due to their 
reference to specific drug use.  The removal of specific references to drugs was to focus specifically 
on problems associated due to use, and not dependency problems.  The scale in the current sample 
had good reliability (α = .740). 
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3.2.18 Cannabis composite score 
In order to obtain a normally distributed dependent variable with minimal Type I error, a composite 
cannabis score was calculated (e.g. Thush et al., 2007).  Z scores of cannabis frequency, cannabis 
quantity per joint, number of joints per week, cannabis-related problems, and severity of 
dependence scale were calculated.  Next, a mean of the five Z scores was used to create the 
cannabis composite score.  This score provided a composite that includes different dimensions of 
cannabis use, including frequency of use, number of joints and the amount of cannabis used per 
joint, as well as problems and dimensions of dependency experienced due to cannabis use. 
3.2.19 Drugs use index 
Drugs use index was a bespoke composite measure that included the number of drugs a participant 
had used in their lifetime. Participants were asked about their lifetime use of ecstasy, heroin, 
cannabis, cocaine, anabolic steroids, legal highs, hallucinogens, amphetamines, and ketamine.  The 
mean score for the drugs index was 4.06, indicating the average participant had used or 
experimented with at least 4 different drugs. 
3.2.20 Craving for cannabis 
The 12-item brief version of the Marijuana Craving Questionnaire (MCQ-SF; Heishman, Singleton & 
Liguori, 2001 and Heishman et al., 2009) was used to assess subjective cannabis craving.  The MCQ-
SF items are based on a four-factor scale structure of the MCQ: compulsivity, emotionality, 
expectancy and purposefulness.  The MCQ-SF is a valid and reliable measure of marijuana craving, 
measuring the same multidimensional aspects of the MCQ in marijuana users not seeking treatment 
(Heishman et al., 2009).  The craving questionnaire was presented at the beginning of the 
experiment and again at the end to investigate whether the experimental procedure affected 
cannabis craving. 
3.2.21 Alcohol use 
The Alcohol Use Disorders Identification Test (AUDIT) was used as a brief screening instrument to 
identify harmful and hazardous drinking.  Using a diagnostic cut-off of 11, 25 (62.5%) of those who 
had used alcohol were considered to be at risk for  for hazardous and harmful drinking (Fleming, 
Barry & Macdonald, 1991).  In addition to the AUDIT, participants were asked about frequency of 
drunkenness; participants were asked, ‘How many times have you been drunk in the past month?’    
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3.2.21 Missing values computation 
Multiple imputation was used to account for missing data (SPSS).  Multiple imputation is an 
approach used to deal with the problem of missing data by creating several different probable 
imputed data sets and pooling the results obtained from them.  Multiple copies of the dataset are 
created and missing values are replaced with imputed values, derived from the predictive 
distribution of the data, based on the Bayesian approach (Rubin, 1996).  Each of the imputed 
datasets is used to fit the intended model, using an average of the imputed datasets to give overall 
estimations.  In SPSS, only the unstandardized betas are given, so standardized betas, r values, and f 
values are calculated by hand by taking the mean values of the imputed datasets (SPSS, 2009).  In 
the following sample five measures had missing data and were used to create multiple imputations: 
aggression (Physical), AUDIT score, depression, drugs index, drunkenness frequency, and self-
control. 
3.2.22 Statistical analyses 
A multiple regression analysis was employed with cannabis composite score as the dependent 
variable.  Multiple regression analysis was chosen for its predictive validity when using an 
independent variable and multiple continuous, dependent variables.  Gender and Age were entered 
using a forced entry first into the first step of the model because of their strong association with 
cannabis outcomes in the extant literature.  For other steps, a step-wise approach was used.  The 
second step included drug-related factors of audit score, frequency of drunkenness and drugs use 
index.  The third step was explicit cannabis expectancies.  The fourth step included measures of 
mental health: aggression, anxiety sensitivity and depression.  The fifth step of the model included 
personality measures of impulsivity (Sensitivity to Reward and Consideration of Future 
Consequences), sensation seeking, time perspective and self-control.  The final step of the model 
included implicit cognition measures of affective associations towards cannabis and hedonic 
impulsivity. 
3.3 Results 
3.3.1 Sample characteristics 
The sample consisted of 40 (60% male) participants, the majority of which were students (85%).  
Psychology students at Liverpool John Moores University received course credit for their 
participation, while all other participants received  a ₤30 Love-2-Shop vouchers.  The mean age was 
22.8 (range = 18-35, SD =  4.1).  The racial and ethnic composition of the sample was predominately 
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White (90%).  Table 3 gives the demographics of the sample population, while Table 4 provides 
general drug use data.   
Table 3.  Demographics. (N = 40) 
 
Sex (%) Female = 0.40; Male =  0.60 
 
Age (in years) M = 22.8; SD = 4.1 
  
Ethnicity (%) White British = 0.90 
 Mixed Race = 0.05 
 Black British  = .025 
 Other = .025 
 
Student (%) 0.85 
 
Relationship  Single = 0.525 
 In a relationship =  0.475 
 
 
Table 4. Alcohol, tobacco and cannabis use. (N = 40) 
 M (SD)* 
Alcohol  
Age of initiation (Years) 13.95 (1.43) 
AUDIT (N = 39) 14.28 (5.85) 
Above diagnostic cut-off (%) 25 (0.625) 
Drunk frequency (N = 36) 4.72 (3.75) 
Tobacco  
Age of initiation (Years)  (N= 39) 14.82 (2.01) 
Fagerström nicotine dependence (N  = 23) 0.348 (0.573) 
Cannabis  
Age of initiation (Years) 15.95 (1.66) 
Cannabis use frequency 2.98 (0.62) 
Severity of dependence  2.63 (2.38) 
Above diagnostic cut-off (SDS ≥ 4) 13 (32.5 %) 
Cannabis-related problems 2.41 (2.38) 
Joint quantity 0.20 (0.15) 
Days per week 3.15 (2.15) 
Joints per week 7.33 (8.67) 
*M(SD) measurement unless otherwise noted 
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Table 5. Use of drugs other than cannabis. (N = 40) 
 Never Lifetime Past year Past Month 
Ecstasy (%) (N = 39) 30.8 12.8 28.2 28.2 
Heroin (%) (N = 37) 97.3 2.7 0 0 
Cocaine (%)(N = 39) 30.8 15.4 28.2 25.6 
Hallucinogens (%)(N = 39) 38.5 17.9 30.8 12.8 
Ketamine (%) (N = 37) 51.4 18.9 18.9 10.8 
Legal Highs (%) (N = 37) 54.1 21.6 16.2 8.1 
Amphetamines (%) (N = 38) 36.8 10.5 28.9 23.7 
Anabolic Steroids (%) (N = 38) 94.4 5.6 0 0 
 
 
 
Table 6. Cannabis joint descriptives. (N = 40) 
Tobacco in joints (%) Yes No 
 87.5 12.0 
Joint quantity variation 
(%) 
None A little Some A lot 
 10.0 52.5 22.5 15.0 
Frequency of time joint 
rolling (%) 
None Little  Some A lot All 
 24.4 14.6 12.2 26.8 21.8 
Variation between 
tobacco and cannabis 
ratio (%) (N = 36) 
None  A little Some Quite a bit 
 8.3 41.7 25.0 25.0 
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Table 7. Measures. 
 N Valid Missing  Mean  SD 
Cannabis composite score     
Severity of dependence 40 0 2.62 2.38 
Cannabis joint quantity (in grams) 38 2 0.2 0.14 
Cannabis frequency 40 0 6.77 1.6 
Cannabis problems 39 1 2.41 2.38 
     
Other substance use variables     
AUDIT 39 1 14.28 5.84 
Drug use index 36 4 4.02 1.91 
Drunk frequency 36 4 4.72 3.75 
     
Mental Health     
Aggression (Anger) 40 0 16.28 7.83 
Aggression (Hostility) 40 0 19.5 7.8 
Aggression (Physical) 39 1 24 8.58 
Aggression (Verbal) 40 0 15.48 4.94 
     
Anxiety (Cognitive) 40 0 3.95 5.22 
Anxiety (Physical) 40 0 0.51 0.42 
Anxiety (Social) 40 0 0.74 0.27 
     
Depression 38 0 14.18 8.88 
     
Cannabis expectancies     
MEEQ (Arousal) 40 0 52.96 14.58 
MEEQ (Relaxation) 40 0 32.2 15.28 
MEEQ (Negative) 40 0 64.01 18.23 
IAT (Arousal) 40 0 0.001575 0.304515 
IAT (Relaxation) 40 0 0.191325 0.248648 
IAT (Negative) 40 0 0.019875 0.266776 
AMP 40 0 0.0402 0.06812 
     
Personality     
Self-control  38 2 36.18 9.14 
Sensation Seeking 40 0 4.21 0.56 
ZPTI (Future) 40 0 3.26 0.62 
ZPTI (Past Negative) 40 0 2.99 0.77 
ZPTI (Past Positive) 40 0 3.47 0.52 
ZPTI (Present Fatalistic) 40 0 2.57 0.54 
ZPTI (Present Hedonistic) 40 0 3.68 0.51 
Impulsivity (SRS) 40 0 0.55 0.2 
Impulsivity (CFC) 40 0 3.2 0.83 
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3.3.2 Original dataset 
Multiple regression analysis was undertaken to examine the relationshp between cannabis use and 
drug-related, cannabis expectancy, mental health, personality, and implicit cognition factors.  In this 
analysis, the dependent outcome variable was the composite score of cannabis use frequency (days 
used), joints used per session, quantity of cannabis per joint, cannabis-related problems experienced 
and severity of dependence.  Using a stepwise approach (backwards method), gender and age were 
entered into the first step.  The final model accounted for 49.3% of the variance in composite 
cannabis score and was a significant fit of the data (F (4, 30) = 6.33, p = .001).  The adjusted R2 (.415) 
shows little shrinkage, indicating that the model would generalise well.  Gender (β = -0.252, p < .10 ) 
and age (β = 0.598, p < .01) were entered into the variable, and gender was non-significantly 
negatively correlated (being male was more associated with greater cannabis composite score) while 
age was positively correlated (being older was associated with a greater cannabis score).  Drug-
related cognitions, specifically the explicit cannabis expectancy ‘sedation’, was found to be highly 
correlated with cannabis composite score (β = -0.749, p < .001), with higher scores of sedation-
related expectancies correlated with a lower cannabis composite score.  Additionally, impulsivity 
Consideration of Future Consequences was significantly associated with composite cannabis use (β = 
0.346, p<.01), indicating that greater consideration of future consequences was associated with a 
higher cannabis composite score. 
Table 8. Model summary for regression of cannabis composite score on original data.  
(N =31) 
 b SE b β 
Final Model    
Constant -1.705 0.61  
Gender -0.327 0.187 -0.252# 
Age 0.087 0.025 0.598** 
MEEQ (Sedation) -0.029 0.007 -0.749*** 
Impulsivity (CFC) 0.247 0.103 0.346* 
Note. R2 = .493. #p < .10, *p < .05, **p < .01, ***p < .001. 
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3.3.3 Imputed data (Pooled estimate) 
Multiple regression analysis was performed to examine the relationship between cannabis use and 
drug-related, cannabis expectancy, mental health, personality, and implicit cognition factors as done 
in the original analysis above.  The same backwards approach was used as with the original data.  
Please note that SPSS does not compute traditional p values for pooled estimates.  Compared to the 
analysis of the original dataset, the imputed data had more factors included in the model, with the 
inclusion of anxiety sensitivity (physical) and aggression (physical).  The standardized beta values for 
explicit cannabis expenctancy ‘sedation’ and impulsivity (Consideration of Future Consequences) 
were similar to analysis of the original dataset, while standardized beta values for age and gender 
were much smaller.  The final model accounted for 63.28% of the variance in composite cannabis 
score, while the adjusted R2 (.5524) shows little shrinkage, indicating that the model is generalisable.  
Gender (β = -0.011) and age (β = 0.052) were entered into the variable, and gender was negatively 
correlated (being male was more associated with greater cannabis composite score) while age was 
positively correlated (being older was associated with a greater cannabis score).  Drug-related 
cognitions, including the explicit cannabis expectancy sedation (β = -0.725) and negative (β = -0.588), 
were found to be correlated with cannabis composite.  Both were negatively correlated with 
cannabis composite score, indicating the greater expectancies of sedation and negative outcomes 
associated with cannabis use is related to a lower cannabis composite score.  Additionally, 
impulsivity Consideration of Future Consequences was significantly associated with composite 
cannabis use (β = 0.328), indicating that greater consideration of future consequences is associated 
with a higher cannabis composite score.  Anxiety (physical) (β = -0.378),  and aggression (physical) (β 
= 0.268),  were both correlated with cannabis composite score; anxiety sensitivity to physical 
responses was associated with lower levels of cannabis composite score, while higher scores of 
physically manifested aggression was associated with a higher cannabis composite score. 
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Table 9.  Model summary for regression of cannabis composite score on imputed data.  
(N =40) 
 b SE b β 
Final Model    
Constant -0.541 0.636 
 
Gender 0.013 0.137 0.0112 
Age 0.075 0.019 0.0517 
MEEQ (Sedation) -0.028 0.005 -0.7254 
Impulsivity (CFC) 0.236 0.08 
0.3288 
MEEQ (Negative) -0.019 0.005 -0.588 
Anxiety Sensitivity (Physical) -0.044 0.015 -0.3788 
Aggression (Physical) 0.018 0.008 0.2688 
Note. R2 = .632. #p < .10, *p < .05, **p < .01, ***p < .001. 
 
3.4 Discussion 
3.4.1 Implicit cognitions and cannabis outcomes 
The first aim of this study was to investigate the relationship between implicit cognitions and their 
relationship with cannabis use outcomes.  Positive (both aspects of arousal and sedation) 
expectancies of cannabis use were hypothesised to be associated with higher reported levels of 
cannabis use outcomes, while negative expectancies were hypothesised to be associated with lower 
levels.  Results indicated, however, that the association between the composite cannabis score and 
expectancies was only evident for explicit (negative and sedation subscales), and not implicit 
measures.   
There are several possible explanations for why implicit cannabis expectancies were not 
found to be associated with the composite cannabis use outcomes measure.   First, implicit cannabis 
expectancies may not be significantly different within frequent (weekly) users of cannabis.  In other 
research looking at implicit cannabis expectancies, differences between users and non-users of 
cannabis implicit cognitions were indicated by comparing the two groups (Field et al., 2004; Field et 
al., 2006).  The results highlighted the differences in implicit cognitions between users and non-users 
of cannabis suggesting that non-users had a negative attitude to cues of cannabis that was not 
present in users of cannabis.  This difference is likely because of the cultural perception and societal 
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representations of cannabis, as well as the drugs legality; non-users of cannabis are likely to have 
negative associations of cannabis from education, both culturally and formally through schools, that 
it is an unhealthy, illegal, and dangerous drug (Swanson, Swanson & Greenwald, 2001; Field et al., 
2004). In other studies looking at implicit cannabis associations among heavy cannabis users and 
controls, significant differences were found in implicit negative cannabis associations (Dekker et al., 
2010; Beraha et al., 2013).  In the present study, there was no relationship between frequency of use 
of cannabis and negative implicit cannabis expectancies, despite differences in negative 
expectancies of cannabis use when using explicit measures.  These results reveal that among 
frequent users of cannabis, there were no differences in their response to cannabis cues and how 
quickly they are able to categorise them as ‘negative’, while there are differences in explicit cannabis 
expectancies.  Although negative implicit associations with cannabis do not differ among frequent 
users of cannabis, explicit negative expectancies of cannabis do differ among frequent users of 
cannabis.  This suggests that frequent users, although they do not differ in implicit, unconscious 
negative associations, differ on their conscious ruminations of negative cannabis expectancies based 
on their cannabis use outcomes.  This could be because a sample of heavier, more problematic 
cannabis users was needed to identify differences in cannabis experiences among frequent users, or 
that the implicit association test does not adequately measure implicitness (see, for example: 
Fiedler, Messner & Bluemke, 2006). 
The results of the present study indicate that lower cannabis composite score were 
associated with lower negative and positive (sedation) explicit expectancies of cannabis.  This would 
suggest that in frequent users of cannabis, those with lower negative or positive (arousal) 
expectancies are likely to have lower cannabis use outcome scores.  These results are similar to 
other research which has shown greater cannabis-related problems were related to greater explicit 
negative expectancies (Beraha et al., 2013).   Explicit and implicit measures of cannabis expectancies 
measure user associations with cannabis, and despite measuring the same concept, these measures 
are based on different dimensions of the construct.  Implicit expectancy measures reflect 
unconscious associations between affective states related to cannabis use (Greenwald et al., 1998), 
while explicit expectancy measures reflect ruminations of past cannabis behaviour and experiences 
which lead to a expectations of future use outcomes, or a representation of how cannabis behaves 
when used (Aarons et al., 2001).  The implicit expectancy score measures the speed of 
categorisation, limiting the degree of self-awareness for ruminations and conscious thought 
regarding the expectations of use behaviour and focusing specifically on the strength of unconscious 
associations between affective states associated with cannabis (De Houwer et al., 2009).  
Conversely, explicit measures of expectancies allow for reflection of a multitude of cannabis 
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knowledge, including cultural and societal perceptions and personal experiences, resulting in a 
thought-based evaluation of cannabis use and expected outcomes of use (Jones, Corbin & Fromme, 
2001).  These results suggest that among weekly users of cannabis, expectations of cannabis that are 
a result of reflective consideration, opposed to implicit associations, are more indicative of varying 
cannabis use behaviour.  Thus, it would appear that although previous research has identified 
differences in implicit associations between cannabis users and non-users, this study suggests that 
among frequent users of cannabis there are no marked differences in the implicit associations of 
cannabis that differentiates between frequency, intensity and problematic outcomes of use. 
In addition to implicit cannabis use expectancies, another element of implicit cognitions 
measured in the present study was hedonic impulsivity (affect regulation) as measured through the 
affect misattribution procedure (AMP).  This measure was used to estimate the ability to down-
regulate impulses, like cannabis cues that were used in previously discussed measures of implicit 
cannabis expectancies (Field et al., 2004; Ames et al., 2007; Dekker et al., 2010; Beraha et al., 2013).  
The measure specifically looked at how valenced stimuli influenced the evaluation of neutral stimuli 
and how this response changes based on the duration of time between the presentation of the 
valenced stimuli and the neutral stimuli.  Previous research investigating the role of eating habits, 
implicit expectancies and the affect misattribution procedure found a relationship with affect 
regulation (Hofmann, Friese, & Roefs, 2009).  The results indicated that affect regulation mediated 
the relationship between expectancies and food consumption (Hofmann, Friese, & Roefs, 2009).  It 
was hypothesised, based on these results, that individuals with greater affect regulation, having a 
greater difficulty down regulating impulses, would be more influenced by implicit associations and as 
a result be more likely to engage in more risky, intensive cannabis use leading to a greater cannabis 
composite score. 
The results of the study indicated that the measure of hedonic impulsivity (affect regulation) 
did not influence cannabis consumption among frequent cannabis users.   Similar to effect 
expectancies, an explicit measure of impulsivity, specifically the Consideration of Future 
Consequences scale, was found to be associated with the composite cannabis score.  These two 
measures, however, measure very different dimensions of impulsivity.  While affect regulation looks 
at the degree to which one is influenced by stimuli (Hoffman, Friese & Roefs, 2009),  the 
Consideration of Future Consequences measures the degree to which one considers the future when 
making decisions (Strathman et al., 1994).  Although it was hypothesized that affect regulation 
would be highly associated with cannabis use outcomes, there are several reasons why this may not 
be the case.  Epidemiological evidence suggests that most users of cannabis will use will never 
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graduate to dependent use (Lopez-Quintero et al., 2011).  It is possible that in this sample of 
frequent cannabis users, there was no marked difference among responses to cannabis stimuli and 
affect regulation.  It might be necessary to compare this group to more frequent, heavier cannabis 
users, or to non-using controls.  Furthermore, hedonic impulsivity (affect regulation) may be an apt 
measure for discerning how users of legal drugs, such as tobacco and alcohol, are influenced by 
implicit associations.  Although it would seem likely that cannabis users would be presented with 
cannabis stimuli in their lives, it is unlikely they would be exposed to stimuli as frequently as alcohol 
and tobacco, which are more accessible due to their legality, and consequently may have less of an 
effect on behaviour. 
3.4.2 Implicit cognitions and prevention 
In addition to understanding how implicit cognition may provide a better understanding of the 
factors that influence cannabis use behaviour, this research sought specifically to look at the 
potential of implicit cognitions measures to be used as a future tool for indicated prevention.  This 
study looked specifically at frequent, young cannabis users and the associations between risk factors 
associated with use, and a composite cannabis measure reflective of factors most associated with 
developing dependence, including frequency of use, intensity of use and problems related to use.  If 
greater likelihood of cannabis dependence had an association with implicit measures, it suggests 
that traditional prevention efforts may be ineffective at preventing the escalation of use by not 
addressing unconscious cognitions related to behavioural outcomes.  Thus, implicit cognitions would 
be a potentially strong tool for identifying individuals at risk for developing dependence and an 
opportunity to develop an innovative way for designing interventions.  These results, however, 
suggest that in this sample there was not an association between implicit associations of cannabis, 
or hedonic impulsivity, and related cannabis consumption.  Previous research has suggested that 
there are differences among users and non-users of cannabis and negative implicit associations of 
cannabis, yet there does not appear to be differences among users of cannabis that reflect the 
degree of their use related behaviour.  It is likely that lesser negative associations experienced by 
users of cannabis, but are present to a greater degree in non-users of cannabis, are based personal 
experiences with cannabis and that many frequent users of cannabis continue to use because they 
have more positive expectancies with use.  Based on the results in this study, it is unlikely that 
implicit cognition tests of cannabis expectancies would be a useful tool for other types of 
interventions, particularly universal prevention; the implicit association with cannabis in a 
population of cannabis users is likely to be an appropriate target for preventing the initiation of use.  
Emerging research on bias training and modification has shown promise, with one web-based study 
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showing effectiveness in reducing drinking behaviour (Schoenmakers et al., 2010; Boffo et al., 2015; 
Wiers et al., 2015a; Wiers et al., 2015b).  Further research around implicit cannabis associations and 
cannabis use in young people is needed to assess whether bias modification training is a suitable 
prevention strategy for cannabis use. 
3.4.3 Relationship between cannabis and risk factors 
3.4.4 Age 
The results of the analysis showed that age was associated with related cannabis consumption, with 
older participants reporting higher scores on the cannabis composite score.  Recent epidemiological 
data from the UK details that as age increases reporting last year use of cannabis decreases (Home 
Office, 2015).  However, in this sample, an inverse relationship exists.  The current sample consists 
largely of students and it is likely that although they are all frequent users (weekly) of cannabis, the 
ways in which they use may be different and effect the outcomes of use (Shrier et al., 2013).  It may 
be that although ‘frequent users’ were classed similarly, there are in fact, quite different subsets of 
users within this population (Miller and Plant, 2002; Hammersley & Leon, 2006).  It may be that 
some frequent users of cannabis in the sample are recreational/experimental, polydrug users who 
are seeking drug use experiences, not specifically seeking out cannabis use (Schelle et al., 2015).  
Thus, it may be that older cannabis users in this sample may be more interested specifically in 
cannabis use and have more intensive use behaviours than younger, frequent users.  Further 
research investigating the types of cannabis user profiles in young people and how use develops as 
they age is necessary.   
3.4.5 Cannabis effect expectancies (Negative) 
Self-reported cannabis effect expectancies (negative) had a negative association with cannabis 
composite score; lower negative effect expectancies of cannabis were associated with a lower 
cannabis consumption score.  This indicated that those participants who expect negative outcomes 
from their use of cannabis were more likely to have lower cannabis consumption scores, which is 
similar to other research (Buckner, 2013).  Other studies, however, have shown that higher levels of 
negative expectancies are related to intensity of cannabis use (Hayaki et al., 2010; Connor et al., 
2011).  As cannabis consumption is an amalgamation of measures of frequency, intensity and 
related-problems, this suggests that in this study having negative expectancies is associated less 
frequent, less intensive use sessions and less problematic use outcomes.  Further research, however, 
is needed to understand drug user profiles and behaviour, specifically why users continue to use, 
and how use experiences influence expectancies.  
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3.4.6 Cannabis effect expectancies (Positive sedation) 
Higher scores of effect expectancies (positive sedation) were associated with lower cannabis 
consumption scores, indicating that lesser expectancies of sedative experiences with cannabis were 
associated with lower composite scores of cannabis consumption.  In frequent cannabis users, 
expectancies of relaxation are associated with less frequent intensive, problematic use.  Previous 
research has identified that positive effect expectancies are related to more frequent use, but not 
related to cannabis dependence (Connor et al., 2011).  Furthermore, research on cannabis 
expectancies has found that low levels of positive expectancies in addition to high levels of negative 
expectancies were related to abstinence (Galen & Henderson, 1999).  Effect expectancies (positive 
sedation) refer to cannabis making one feel comforted, relaxed, or calm. This suggests that users in 
this sample who expect experiences with cannabis that were positively calming and comforting, 
were less likely to have greater cannabis consumptions scores.  This finding suggests that 
expectancies of relaxing cannabis experiences, potentially based on previous experience, may result 
in less intensive, problematic, and frequent use.  This suggests that research focusing on the role of 
cannabis use expectancies, intentions and outcomes may provide a better understand of how use 
behaviour in frequent cannabis users differs. Research has demonstrated that cannabis effect 
expectancies are related to other factors, like impulsivity and anxiety, and cannabis use behaviour 
(Vangsness, Bry, & LaBouvie, 2005; Buckner & Schmidt, 2008; Buckner & Schmidt, 2009).  
Furthermore, this suggests that cannabis use outcomes may influence future use outcomes and 
behaviours; cannabis users with relaxing use experiences may use differently than cannabis users 
with arousal, or negative experiences.  This highlights the importance of identifying cannabis user 
profiles and the ways in which they use cannabis, the degree of variability between drug use 
intentions and outcomes, and how to specifically target user profiles that have the greatest 
propensity for transitioning to problematic, dependent use and what factors protect users from 
these outcomes. 
3.4.7 Impulsivity (Consideration of Future Consequences) 
Results indicated that lower scores of impulsivity (greater Consideration of Future Consequences) 
were associated with higher scores on the cannabis composite measure.  Although this may initially 
seem like a counterintuitive association, the Consideration of Future Consequences measure of 
impulsivity looks specifically at how one considers the future when making decisions (Stratham et 
al., 1994).  One study looking at delay discounting and cannabis found no differences among 
impulsivity (Consideration of Future Consequences) and cannabis dependent, formerly cannabis 
dependent, and control groups (Johnson et al., 2010).  Cannabis, however, is popularly believed to 
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have fewer negative health outcomes than tobacco, alcohol, and many other drugs, and this may 
lead to a dependent-cannabis use population that is high in delay discounting, dissimilar to other 
drug-using populations (Johnson et al., 2010).  In the present study, greater Consideration of Future 
Consequences was associated with a greater cannabis composite score, as in a more frequent, 
intensive and problematic use.  This suggests that in the current sample, greater Consideration of 
Future Consequences may be more indicative of frequent, intensive and problematic cannabis use 
outcomes.  This suggests that among frequent cannabis users, more research is needed to 
understand the different types of drug users and the factors associated with different use pathways 
and outcomes, and how knowledge about health outcomes associated with cannabis may affect the 
perceived risks associated with use. 
3.4.8 Aggression (Physical) 
Aggression, specifically physical manifestations of aggression, was associated with higher levels of 
composite cannabis scores; thus, among frequent users of cannabis, higher self-reported scores of 
physical aggression were associated with higher cannabis consumption scores, reflecting the 
frequency, intensity and related problems of cannabis use.  In chronic cannabis uses, withdrawal 
from use has been associated with more displays of aggressive behaviour (Kouri et al., 1999).  There 
are many possible pathways to explain the relationship between physical aggression and cannabis 
composite scores. For example, cannabis use is associated with the ability to produce a calming, 
relaxing effect on users (Hall & Solowij, 1998), which may be used as a means of self-medication for 
alleviating pre-existing feelings of aggression (Arendt et al., 2007).  Additionally, physically aggressive 
behaviour, especially if it results in an altercation of a physical nature, is representative of an 
impulsive, deviant behaviour, and the use of cannabis may be associated with general deviant 
behaviour (Herrero, Estévez, and Musitu, 2006).  These pathways are not mutually exclusive and it is 
likely that some users may use cannabis to curb feelings of aggression, while the relationship 
between physically aggressive behaviour and cannabis use outcomes may be the association 
between deviant behaviour.  Further research is needed to investigate profiles of cannabis users, 
and which individuals may be self-medicating and which individual’s use may be reflective of general 
deviance, and how to design interventions to prevent these groups from transitioning to 
problematic, dependent use. 
3.4.9 Anxiety (Physical)  
Results of the present study indicate that physical anxiety, when physical changes in the body 
(tightening of the chest, an upset stomach) manifest into anxious ruminations, was associated with 
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lower cannabis consumption scores (Taylor et al., 2007).   The use of cannabis generally causes 
physical, bodily responses and as a result it would seem likely that a cannabis user that finds 
physical, bodily changes to be anxiety-inducing would be less likely to participate in heavier, more 
intensive use behaviour.  It is important, however, to note that the present sample was 
compromised of frequent cannabis users.  Thus, it would inform further research investigating the 
degree to which physical anxiety would prevent use of cannabis, and the degree to which it 
influences the decision-making process for cannabis users.  Evidence from one earlier study found a 
relationship between anxiety sensitivity and coping motives for cannabis use (Bonn-Miller, 
Zvolenksy, Bernstein, 2007).  Although the majority of research linking anxiety and cannabis focuses 
on aspects of social anxiety (Buckner et al., 2006; Buckner & Schmidt, 2008; Buckner & Schmidt, 
2009), physical anxiety and sensitivity to bodily responses, may be a factor that deters young people 
from frequent, intensive and problematic use, and should be further investigated to understand how 
this relationship mitigates use among young people. 
3.4.10 Conclusions 
This study provided evidence that suggests implicit cognitions do not add to current models of use 
behaviour for frequent cannabis users in a sample of young people.  Although implicit associations 
and cognitions may influence behaviour, it is unlikely that they do so to a degree that makes them 
suitable for targeting in indicated prevention efforts.  This research, however, does highlight that 
among frequent users of cannabis, previously determined risk factors of mental health 
factors/psychopathology, personality factors and explicit cannabis expectancies are associated with 
more frequent and problematic use outcomes.  There results highlight the need for further research 
investigating types of drug user profiles.  The results of this study demonstrate that specific risk 
factors are associated with more frequent, intensive and problematic cannabis use behaviours.  
Furthermore, it is imperative to develop a better understanding of how groups of cannabis users 
behave, and the characteristics of these groups, so that prevention efforts can be designed to target 
groups of users most likely to graduate from recreational/experimental use to 
problematic/dependent use.   
3.4.11 Limitations 
The experimental design of this study limits the generalisability of data and the results derived.  Due 
to the small and predominately student population sample, these results should be considered with 
caution.  Additionally, tasks used to evaluate implicit associations towards drugs are a part of an 
evolving area of research, and future developed implicit measure tasks and may serve as a more 
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appropriate and valid instrument.  Despite these limitations, these results are the first of their kind 
to look at multiple risk factors associated with cannabis use, including implicit cognitions, and the 
factors which are most associated with problematic and frequent use in young people.  Further 
research examining the relationship between factors associated with problematic use in young, 
frequent users of cannabis is needed to understand which users are most susceptible for developing 
problematic use outcomes, and why other users maintain unproblematic use, or discontinue use. 
  
  
97 
 
Chapter 4 
Cannabis use behaviour and problems among 
young people in support services 
4.1 Introduction 
4.1.1 Cannabis use and dependence 
Cannabis is the most widely used illicit drug globally (United Nations Office on Drugs and Crime, 
2015), however the majority of users will never develop dependency, and of those who try cannabis 
some 9% will develop dependence (Budney et al., 2007; Lopez-Quintero et al., 2010).  Frequent 
cannabis is often associated with an increased risk of developing dependency (Coffey et al., 2003, 
Grant and Pickering, 1998; Noack, Höfler, & Lueken, 2011), however even in daily users, only an 
estimated 20-50% develop dependence (Coffey et al., 2002; EMCDDA, 2009).  The underlying 
mechanisms which explain why certain individuals develop dependency and others do not are not 
yet understood.  More knowledge regarding the development of dependency in high frequency 
users, including the predictors associated with problematic use development, is needed to inform 
prevention and treatment for young people most at-risk for developing cannabis dependence and 
associated problems. 
In assessing cannabis use in young people, it is important to define the distinction between 
non-dependent and dependent users.  Dependent users will experience significant problems from 
their use that reduce their ability to control their use, while non-dependent frequent users will not 
experience these drug-related problems (Budney & Moore, 2002, Looby & Earleywine, 2007; 
Temple, Brown & Hine, 2011).  Although cannabis is known to be related to many adverse effects 
(Hall & Solowij, 1998; Hall & Degenhardt, 2009), addressing this distinction is important because 
some evidence suggests that cannabis use, to a certain extent, is relatively harmless for much of the 
population (Nutt et al., 2010; Van Amsterdam et al., 2010).  Additionally, when comparing 
dependent and non-dependent users, evidence shows that the risk of comorbid disorders is much 
lower in non-dependent frequent cannabis users, highlighting the difference between dependent 
and non-dependent users (Swift, Hall, & Teesson, 2001; van der Pol et al., 2013b). 
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4.1.2 Cannabis dependence and services for young people in the United Kingdom 
Despite evidence that cannabis use is declining (Home Office, 2015), the increasing number of young 
people entering treatment for cannabis is cause for concern (Public Health England, 2015). There are 
a multitude of potential reasons for increased incidence of young people entering treatment for 
cannabis as well as the poor treatment outcomes.  Recent evidence suggests that there is an 
association between cannabis potency and severity of dependence (Freeman & Winstock, 2015).  
Thus, while less people may be using cannabis, the proposed increased levels of THC in street 
cannabis may be responsible for the increased number of people presenting at treatment for 
problematic, and/or dependent use (Hamilton et al., 2014). In addition to developing dependent 
use, high-potency cannabis is associated with onset of psychosis (Di Forti et al., 2013; Di Forti et al., 
2014; Di Fort et al., 2015).  Although the link between high-potency cannabis and psychosis has been 
debated, with the self-medication hypothesis and residual confounding presented as alternative 
explanations (Macleod et al., 2004; Gage, Zammit & Hickman, 2013; Hall & Degenhardt, 2015).   
Until the early 2000s, the majority of cannabis available in the UK market was cannabis 
resin, which accounted to roughly 70% of the ‘street’ market, with traditional imported herbal 
cannabis, followed by sinsemilla (known generically as ‘skunk’) providing the remainder (Hardwick & 
King, 2008). Both cannabis resin and herbal cannabis have 2–4% Δ 9-THC, however resin has a similar 
proportion of cannabidiol (CBD) (which counters the psychotic effects of Δ 9-THC) to Δ 9-THC, while, 
in a study of cannabis seized in the UK, herbal cannabis had less than 0.% CBD (Hardwick & King, 
2008; Potter, Clark & Brown, 2008).  Evidence, however, shows that sinsemilla has increasingly taken 
over the UK market, representing high potency cannabis, with a THC concentration that has been 
consistently rising.  In a report of seizures of cannabis in England in 2008 by police showed, analysis 
showed that sinsemilla had a market share of more than 70%, and concentration of Δ9-THC was 12–
18% with little cannabidiol present (Hardwick & King, 2008; Potter, Clark & Brown, 2008).  There is, 
however, no causal evidence linking high-potency cannabis and psychosis, and there are arguments 
that suggest that those experiencing psychosis combat symptoms with cannabis, and that increased 
rates of psychosis and cannabis might be more reflective of other social factors, and increased 
access to mental health services (Macleod & Hickman, 2010).  In addition to increased treatment 
due to availability of high potency cannabis, it is likely that the increase in young people entering 
treatment for cannabis is due to improved access to treatment services, which may mean that more 
people needing treatment are accessing services than before (Hamilton et al., 2014), and that people 
with low levels of use are entering treatment to improve social function without necessarily having 
to achieve abstinence, resulting in poorer treatment outcomes (Monaghan et al., 2015).  Also, the 
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effects of funding changes in services for young people with alcohol and drug issues may also lead 
people who were previously utilising low threshold services (which are no longer as available), now 
using more serious, treatment services (Public Health England, 2013; Hamilton et al., 2014).  
4.1.3 Instrumentalized drug use 
Evidence detailing cannabis use behaviour and patterns, among both dependent and non-dependent 
users, provides a better understanding of underlying mechanisms leading to the development of 
problematic, dependent use.  In addition to the frequency of use, a multitude of other factors 
influence use outcomes, including: mode of use (water bong, joint, vaporized, pipe), type of cannabis 
(skunk, resin, herbal, oil, edibles), and factors like when, where, with whom, and cannabis use 
expectancies (Hughes et al., 2014; Buckner, 2013, van der Pol et al., 2014).  In an environment in 
which most users of cannabis, even frequent, daily users of cannabis, never develop problematic or 
dependent outcomes (Budney et al., 2007; Lopez-Quintero et al., 2010), understanding how non-
addictive use behaviours differ from problematic use behaviour may provide a useful pathway in 
understanding the underlying mechanisms for problematic use.  The drug as instruments framework 
postulates that drugs can be instrumentalized, a behavioural process in which psychoactive drugs 
are consumed to change the present mental state into a previous mental state allowing ‘better 
performance of other, previously established behaviours and better goal achievement’ (Müller & 
Schumann, 2011).  The instances, called proximal mechanisms, in which psychoactive drugs are used 
to reach instrumentalized goals include: improved social interaction, facilitated sexual behaviour, 
improved cognitive performance and counteracting fatigue, facilitated recovery from and coping 
with psychological stress, self-medication for mental problems, sensory curiosity, euphoria/hedonia, 
and improved physical appearance and attractiveness (Müller & Schumann, 2011).  This framework 
is similar to theory and evidence linking motivations for cannabis use and cannabis use outcomes 
(Bonn-Miller & Zvolensky, 2009; Bonn-Miller, Zvolensky & Bernstein, 2007; Bonn-Miller et al., 2008; 
Buckner et al., 2007; Bujarski, Norberg & Copeland, 2012; Charbol et al., 2005; Fox et al., 2011; 
Johnson et al., 2010; Mitchell et al., 2007; Simons, Correia & Carey, 2000; Zvolensky et al., 2007).  
Furthermore, among frequent cannabis users, coping motivations for cannabis use are associated 
with dependence (Benschop et al., 2015).  The drugs as instruments framework suggests that non-
addictive psychoactive drug users are knowledgeable and purposefully instrumentalize their use to 
achieve intended outcomes (Müller & Schumann, 2011). Conversely, drug addiction or problematic 
drug outcomes, are the result of the escalation of drug use to the point in which drug use becomes 
compulsive and controlled, goal-directed instrumentalization is no longer the outcome (Müller & 
Schumann, 2011).   
  
100 
 
Taking into account the drugs as instrument framework, it is important to acknowledge 
cannabis user knowledge, patterns and decision making and how they inform outcomes of use.  
There is limited qualitative work exploring cannabis use motivations and expectancies (Hammersley 
et al., 2001; Miller & Plant, 2002; Hammersley & Leon, 2006; Osborne & Fogel, 2008; Järvinen & 
Ravn, 2011; Liebgrets et al., 2015). In addition to focusing on factors that contribute to the 
development of problematic use behaviours and patterns, it is important to understand the 
subjective experiences of the majority of cannabis users who never develop problems or 
dependency.  A more in-depth understanding of motivations for use and the positive experiences 
associated with cannabis use may help provide suitable alternatives for those wishing to limit or 
cease use, and provide prevention workers with a better understanding of who might be most at-
risk for developing problematic cannabis use patterns. 
4.1.4 Cannabis normalization in the United Kingdom 
The concept of ‘drug normalization’ has been proposed to describe the increase in prevalence of 
drug use by young people in the UK beginning in the 1990s (Measham, Newcombe & Parker, 1994; 
Parker, Aldridge & Measham, 1998; Aldridge, Parker & Measham, 1999; Parker, Aldridge, Egginton, 
2001; Parker, Williams & Aldridge, 2002; Parker & Egginton, 2002; Parker & Williams, 2003; Parker, 
2005; Aldridge, Measham & Williams, 2013).  Although recent prevelance data suggests drug use by 
young people has decreased, it remains high compared to other European and international 
countries (for example, see Hibbell et al., 2011).  Normalization is not a rigid theoretical paradigm, 
but a malleable framework that evaluates attitudes and behaviours associated with illicit drug use 
and their development over time (Parker, 2005).  This framework operates through dual pathways 
and may explain how cultural shifts provide an environment for increased use (illicit drugs), and how 
increased stigmitisation and public health campaigns can alter the perceived normalitity of other 
social behaviours (tobacco) (Parker, 2005).  Critics of normalization argue that normalization fails to 
acknowledge cannabis subcultures, particularly the importance of opposition and cultural 
differences in cannabis user subculture (Sandberg, 2012).  Furthermore, it has been argued that 
normalization oversimplifies young people’s cannabis choices and their meaning (Shiner & Newburn, 
1997).   
It should be noted that the theory of drug normalization is based on non-dependent drug 
use.  Although the sample investigated in this study would not be considered non-dependent users, 
consideration of this theory is appropriate and relevant when considering the evolution of their use 
behaviour, particularly when combined with perspectives of over-instrumentaliation.  This work 
seeks to understand the development of cannabis use, and how it might become problematic within 
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an environment of normalization.  Consdieration of an environment in which recreational use is 
normalized provides a lens for which to view the development of problematic use, and whether use 
is inherently problematic, or transitions and dips in and out of recreational, non-problematic use 
behaviour.   
The concept of drug normalization has been operationalised into six dimensions in order to 
better understand the evolution of attitudes and behaviours towards ‘recreational’ drug use (Parker, 
2005).  The proposed dimensions of drug normalization that describe this phenomenon are: 
availability and accessibility of illicit drugs; increased prevalence of drug experimentation; 
increasingly tolerant attitudes of illicit drug by both users and non-users of drugs; social 
accomodation of ‘sensible’ recreational drug use by abstainers, the ‘cultural accomodation’ of drug 
cultures in the media, and more liberal policy shifts (Parker, 2005; Aldridge, Measham & Parker, 
2011).  Although this framwork is used to look at drug use generally and the evolution of illicit drug 
use perception by the public, the normalization process has advanced to the degree to which 
recreational cannabis use is regarded by some as a normalized behaviour (Parker et al., 2002).  A 
consideration of the dimensions of normalization allows for cannabis use to be viewed in the social 
and cultural environment, and how use is negotiated, expressed and interpreted under these 
conditions.  This consideration allows for openness in interpreting the development of cannabis use 
behaviour in young people, how social and cultural environments for problematic users may be 
experienced differently. 
Cannabis use normalization is based on the idea that stigmatisation or deviance associated 
with recreational use no longer exists or is low.  In some countries, however, such as Sweden, low 
prevalence rates, public attitudes, and strong prohibitionist drug policies means that illegal drug use 
is not normalized (Snitzman, 2008).  The most well-known and influential work regarding cannabis 
use motivation is that of Becker, and his study of recreational cannabis users, the majority of which 
were jazz musicians (1953; 1955). This work highlighted two key points regarding deviant 
behaviours: 1) people who deviate from the norms of conventional society and culture are not 
anomalies, but average people who derive pleasure from activity considered ‘illicit by moral 
entrepreneurs’; 2) the use of cannabis, or other drugs, does not necessarily lead to problematic, 
dependent use, but can be, and often is a controlled activity (Järvinen & Ravn, 2014; Osborne & 
Fogel, 2008).  This work has contributed to the development of drug research describing cannabis 
use as either ‘calculated hedonism’ (Featherstone, 1991) or ‘controlled loss of control’ (Measham, 
2004), in which drug users are rational risk managers, with use that is a compatible and functional 
aspect of their lives (Askew, 2016; Järvinen & Ravn, 2014; Hutton, 2006; Malbon, 1999; Measham, 
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Aldridge, & Parker, 2001; Measham, Newcombe, & Parker, 1994; Parker, Aldridge, & Measham, 
1998; Sanders, 2005; Williams & Parker, 2001).  This suggests that dual process models, which 
include implicit bias and associations, a reliable predictor of substance use, complicate the 
normalization theory and the concept of rational decision making (Rooke, Hine & Thornsteinsson, 
2008).  The consensus from this research is that recreational drug use is largely a normalized 
behaviour (Measham et al., 1994; Parker et al., 1998), with ‘sensible’, unproblematic use considered 
to be a behaviour that is socially and culturally facilitated (Järvinen & Ravn, 2014). Although there 
are critics of the ‘normalization’ hypothesis (Aldridge, Measham, & Williams, 2011; Measham & 
Shiner, 2009; Shildrick, 2008), the research focuses primarily on recreational, controlled cannabis 
use with little work focusing on why and how individuals transition into problematic, dependent use 
patterns (Järvinen & Raven, 2014). 
There has been limited work exploring cannabis use problems and young people in the UK 
(Hammersley et al. 2001; Miller & Plant 2002; Hammersley & Leon, 2006; Hathaway et al. 2008).  
Hammersley et al. (2001) outlined self-identity and cannabis use in young people, particularly 
highlighting the importance of understanding how this influence use behaviour and outcomes.  .  An 
investigation of young, heavy cannabis highlighted that among frequent users, there were different 
motivations and contexts within which use occurred (Miller and Plant, 2002).  Furthermore, despite 
evidence suggesting that cannabis users were not a homogenous group, it was also suggested that 
many cannabis users did not use other illicit drugs, emphasising the importance of investigating 
cannabis users as a specific group, and not as general polydrug users. A reconsideration of the 
construct of cannabis abuse and dependence was subsequently proposed, demonstrating evidence 
that chronic, frequent cannabis use was not, necessarily problematic in itself and that an emphasis 
on treatment and prevention of use associated with health and psychosocial harms was important 
(Hathaway et al., 2008).  
Furthermore, exploratory qualitative research has investigated the motivations and the 
social context for use, and supports the view that the majority of cannabis users’ exhibit controlled 
use.  For example, in interviews with middle-class, Canadian adult cannabis users there was little 
evidence to support the idea that there was a ‘typical’ cannabis user, and that different users tend to 
have different experiences of their cannabis use (Osbourne & Fogel, 2008).  This research supported 
previous findings that users often make rational, not compulsive, decisions about their use, which is 
often used to enhance leisure time/activities (Osbourne & Fogel, 2008), and is in contrast with 
research that implicates sensation seeking and hedonic impulsivity (Donohew et al., 2000; 
Dougherty et al., 2012).  Furthermore, this research supports the drug normalization thesis in that 
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cannabis use was integrated into the day-to-day life of users and did not lead to negative 
consequences (Osbourne & Fogel, 2008).  This research, however, is limited to the use of cannabis 
by ‘middle-class’ individuals, and does not extend to the wider population; in particular, vulnerable 
population groups, such as racial/ethnic/sexual minorities, individuals with low socioeconomic 
status, and young people with little social capital, who may be more susceptible to or are already 
experiencing problems.  Evidence from marginalised drug users in Dublin found that normalisation 
was differentially experienced, despite similar cost-benefit consumption choices, due to social 
exclusion and inclusion in the informal drugs economy (O’Gorman, 2016).  More research on the 
experience of marginalised groups and their experience of normalisation is needed. 
An important aspect in the assessment of cannabis use, when considering normalization, is 
how use is influenced by perceived risks and harms.  Cannabis normalization theory suggests societal 
and cultural perceptions of risk mediate the relationship between adult cannabis use behaviour 
patterns.  In a study of Canadian adult cannabis users and the relationship between normalization, 
cannabis use, and perceptions of risk and harm was explored (Duff & Erickson, 2014), specifically 
addressing attitudes towards health risks associated with cannabis and the risk profile of cannabis in 
Canada and its evolution (Duff & Erickson, 2014).  The risk profile of cannabis in Canada was viewed 
by participants as an environment in which conservative views towards drug use were less common 
due to increased prevalence and emerging public awareness of evidence of therapeutic benefits of 
cannabis use (Duff & Erickson, 2014).  Furthermore, participants mostly agreed that the health 
harms associated with cannabis were ‘modest and manageable and less significant than those 
related to alcohol and tobacco use’ (Duff & Erickson, 2014).  Despite this, cannabis was not 
considered to be without potential harms, with concerns regarding use and its relationship with 
health risks (predominately cancer and respiratory problems), emotional problems (mental health 
issues such as anxiety and depression, bad trips, and memory issues), parenting/pregnancy 
concerns, and the risk of developing dependence, although most felt that these potential harms 
could be managed (Duff & Erickson, 2014).  Participants expressed how their ‘state of mind’ and 
social norms regarding appropriate use (particularly around timing, frequency and quantity of use) 
mediated their cannabis use decision making and helped them avert potential harms (Duff & 
Erickson, 2014).  Of particular interest was the expression of participants that harms experienced by 
themselves or by their peer group to be more integral to shaping attitudes towards use than 
knowledge of general health risks (Duff & Erickson, 2014).  The authors note that the diminished risk 
profile of cannabis in Canada in addition to the lack of perceived health or social consequences from 
controlled, moderate use has compounded into the culture of normalization in which cannabis has 
few perceived risk (Duff & Erickson, 2014).  This work highlights the need for consideration of how 
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problematic outcomes of use are perceived and responsibilities and consequences of use are 
negotiated by problematic cannabis users. 
It is important to consider how risk perception, and the influence of cultural and societal 
norms and perceptions, influence and contribute to cannabis use behavioural patterns.  In both the 
UK and internationally, cannabis use is the most frequently used illicit drug by young people (United 
National Office of Drugs and Crime, 2015).  Despite prevalence rates suggesting a degree of 
‘normalization’, the ways in which risks are perceived by individuals and how they are presented by 
societal and cultural bodies’ influence the degree to which use is perceived.  A study of Canadian 
newspaper reports on cannabis found ‘privileged normalization’, in which use was acceptable for 
some, and found deviant by those without power (Haines-Saah et al., 2012).   The risk profile in the 
UK is likely to be much different among specific population groups, and different than countries with 
more liberal laws, like Canada, United States (some states) and the Netherlands.  The lack of 
consensus regarding cannabis drug policy, particularly in the UK, make cannabis prevention difficult 
(Monaghan, 2014; Shiner, 2015).  Some countries have either implemented, or are in the process of 
adopting new policies towards cannabis, with many also implementing ‘medicalised’ availability 
(Cerdá et al., 2012; Spapens, Müller, and van de Bunt, 2014; Fisher, Kuganesan, & Room, 2015; 
Snitzman & Zolotov, 2015).  Varied international cannabis laws and varied print media depicting 
cannabis produce a very confusing public perception of cannabis (Coomber, Morris & Dunn, 2000).  
In the United Kingdom the severity of penalty for cannabis use and possession has shifted, with its 
classification raised from a Class C to a Class B drug in 2009 after being temporarily downgraded 
(Monaghan, 2014; Shiner, 2015).  Although factors like high levels prevalence, availability for an illicit 
drug, accommodating attitudes from non-cannabis using peers (although nuances of this have been 
demonstrated) support the normalization thesis, the illegal status of cannabis and its associated 
stigma complicates it (Chatwin & Potter, 2014; United Nations Office of Drugs and Crime, 2015; 
Hathaway et al., 2015).  In a qualitative study investigating the stigma and normalization in cannabis 
users in Canada, results emphasised that cannabis users do not fit the myths and stereotypes 
perpetuated in the media, and although the illegal status of cannabis did not affect their use 
behaviour, it altered their perception of their own use (Hathaway et al., 2011).  In the UK, where 
cannabis use has returned to greater severity of potential criminal justice harm after temporarily 
being suspended (Monaghan, 2014; Shiner, 2015), the stigma associated with use and normalization 
must be investigated.  Specifically, how vulnerable groups who are more susceptible to stigma, are 
affected by perceptions of cannabis users in an environment of ‘normalization’. 
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Evidence suggests that cannabis users make calculated decisions based on risk (Parker, 
Aldridge, Measham, 1998; Duff & Erickson, 2014), although these decisions are affected by 
automatic behaviour and unconscious biases (Rooke, Hine, & Thorsteinsson, 2008).  It is important 
that we understand how risk is assessed and interpreted in response to use behaviour.  
Furthermore, it is important to contextualise this both from users’ own experience and that of their 
peers, and from media and cultural influences, and how it is disseminated.  Specifically, in an 
environment of ‘normalization’, how young people who use cannabis, initiate use, and then 
(sometimes) transition into problematic, or dependent use, and how they negotiate this use in their 
lives, and how their perceptions and others’ perceptions of their use influence their use behaviour 
and outcomes.  Furthermore, how they envisage their own use and its effect on their life, and the 
potential ways in which use could cease or be adapted. 
Under the tenets of the normalization thesis cannabis use is considered a rational choice, yet 
only as it applies to recreational use (Aldridge et al., 2011).  In contrast, problematic and dependent 
use is considered non-recreational as it interferes with daily functioning (cf.Kronbæk & Frank, 2013).  
As a result, whilst recreational use by frequent, non-dependent users would be bound by a 
considered, cost–benefit analysis, different considerations would be factored by frequent 
dependent, non-recreational users. However, cannabis dependence is not a homogeneous 
condition, and understanding the continuum of experience for dependent users is critical (McBride, 
Teesson, Slade, & Baillie, 2010).  Thus, it is important to examine whether and how frequent 
dependent users differ in leisure from frequent, non-dependent users and trajectories. Furthermore, 
understanding the relationship between leisure and cannabis dependence trajectories may help 
target prevention and treatment; specifically by focusing on frequent users at high risk of 
dependence, as most frequent users of cannabis have use patterns that are bound by their leisure 
time (Liebregts et al., 2015).  Additionally, the concept of ‘ageing out’ of drug use must be 
considered, as research on young amphetamine-stimulant users in Australia found that although 
health, wellbeing and responsibilities contributed to a change in use pattern, including quitting and 
less frequent use, negotiation of non-stigmatised and ‘normal’ identities influenced changes more 
strongly (Green, 2016). 
Cannabis use trajectories and the role of delinquency and leisure were explored in an 
investigation of young cannabis users in the Netherlands (Liebregts et al., 2015).  The Netherlands is 
a particularly useful place to explore cannabis use within the context of normalization because of the 
legal framework for cannabis, in which use is tolerated (Spapens, Müller, & van de Bunt, 2014); 
these results, however, have limitations in their generalisability because cannabis use is not legal or 
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tolerated in many Western countries, including the UK.   Utilising a longitudinal approach, qualitative 
interviews, with 1.5-year and 3-year follow-up interviews, were conducted.  Results supported 
normalization theory, with evidence suggesting that frequent, non-dependent cannabis users led 
‘conventional lives’ and that cannabis use was mediated by work/study responsibilities and was 
generally used in leisure time (Liebregts et al., 2015).  Furthermore, results indicated that definitions 
of problematic use and dependency need development to address the more nuanced behaviour, as 
many participants use trajectory shifted between dependent and non-dependent use, and 
dependent use was not evidenced by ‘homogenous, stable’ use (Liebregts et al., 2015).  The 
definition of dependent use in the DSM-V did capture dependency within this study population and 
suggests that the way in which dependency is operationalised in the DSM-V is oversimplified 
(Liebregts et al., 2015).   
4.1.5 Cannabis normalization discourse 
Although global prevalence rates indicate that cannabis is increasingly a ‘normal’ behaviour, one in 
which a large minority of the population engages at some point in their life, there are critics of the 
assertion that this is a normalized behaviour (Blackman, 2004; Ramsay & Partridge, 1999; Shildrick, 
2002; Shiner & Newburn, 1997, 1999).  In particular, the idea of normalization suggests that the 
behaviour is without stigma, a point of contention with some researchers (Hathaway, Comeau, & 
Erickson, 2011; Sandberg, 2012; Hathaway et al., 2015).  In a Norwegian population of 100 cannabis 
users, cannabis discourse was explored, particularly around normalization, subculture, and 
neutralisation/risk denial and justifications discourses (Sandberg, 2012).  This research investigated 
how users of cannabis negotiated their use in relation to cultural and societal perceptions of use.  
With normalization discourse emphasising the normalization thesis, and that use is normal, and that 
those who use are not ‘others’.  Subculture and neutralisation/risk denial discourses provide 
different theoretical narratives to cannabis use.  Subculture theory posits that special groups exist 
with particular values and lifestyles, that may deviate from the general, normal population, and that 
these groups often embrace these differences, while being labelled by others.  In relation to 
discourse, this perspective emphasises the celebration of use, and the benefits of use and the 
enlightenment of those who use.  Neutralisation/risk denial discourse focuses on the denial of harms 
related to cannabis, and the focus is placed on misinformation as well as the harms related to other 
substances like alcohol and tobacco.  Sandberg argues that normalization as a thesis for researching 
cannabis use is insufficient, particularly in a Norwegian context (2012).  Sandberg argues that both 
normalization and subculture discourses operate concurrently and relegating research to one style 
improperly frames conclusions about the role of cannabis in contemporary culture (2012).   
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Furthermore, the use of neutralisation discourse to justify cannabis use, both in normalization and 
subculture discourse suggests that cannabis use is stigmatised and users are forced to address and 
negotiate it (Sandberg, 2012).    Normalization discourse around cannabis has particularly 
emphasised the comparison between cannabis and alcohol use, with comparisons used largely to 
legitimise cannabis use (Järvinen & Demant, 2011; Sandberg, 2012; Mansson & Ekendahl, 2013).  In a 
content analysis of online discussion of alcohol and cannabis on drug forums in Sweden, important 
nodes of discourse around danger and discrimination were explored (Mansson and Ekendahl, 2013).  
This particularly illuminates how policy discriminates use of cannabis, and the perceived dangers 
around alcohol and cannabis, with constructions of alcohol being harmful and cannabis being 
harmless prevailing (Mansson & Ekendahl, 2013).   
Moreover, research is needed that investigates perceptions of cannabis in the context of 
normalization and its associations with the initiation of use, current use behaviour, and use 
development.  Particularly when designing prevention programs, it is important to address the 
relationship between positive cannabis perceptions and how they are associated with cannabis use 
production and maintenance (Hammersley & Leon, 2006).  In a study of Norwegian young adults 
(aged 16-21 years-old), positive and negative perceptions of cannabis were related to cannabis use, 
perceived normative use, and acceptance of use (Holm et al., 2013).  The positive perceptions of 
cannabis were as useful as perceptions of risk associated with use and the perception of the 
prevalence of their peers use in cannabis use outcomes (Holm et al., 2013).  Prevention work that 
focuses on risk perception and the risks associated with cannabis use may not appropriately address 
the factors young people consider and negotiate when making decisions about their cannabis use.   
This evidence highlights the nuances of normalization, and how cultural environments and 
perceptions contribute to the consideration of the framework across different cultures.  Although 
normalization focuses on recreational, non-problematic use, the use of this framework is useful in 
understanding different types of use behaviour.  Particularly in the UK, the country within which 
normalization theory was developed, acknowledgment of this environment is useful in looking at 
problematic use outcomes, and how they develop in an environment in which recreational use is 
largely normalized.  Of particularly interest is how use develops and use is interpreted and perceived 
by young people who are considered problematic cannabis users. 
4.1.6 Transition to problematic use behaviour 
There has been some work that has explored the transition from recreational to regular use of illegal 
drugs (Jӓrvinen & Ravn, 2011).  This has noted the distinct differences that differentiate recreational 
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and regular use, including: networks (open networks vs. closed networks), partying (all night 
partying vs. whole weekend), intoxication (as a means to another intended goal vs as a goal in itself), 
access to drugs (buying only vs. buying and selling), effects of drugs (fixed vs. diverse), and self-
presentation (in control vs. alternations between control and loss of control) (Jӓrvinen & Ravn, 
2011).  In this sense, regular users are not described in terms of frequency of use, but the factors 
that contextualise use behaviour, thus a recreational user may use frequently.  The interviews with 
young, polydrug users described the transition from recreational to regular use as subtle, gradual 
transition, which they were not conscious of as it was occurring (Jӓrvinen & Ravn, 2011).  Further 
research with young cannabis users in drug treatment in Denmark used the concept of drug 
narratives to identify underlying causal mechanisms for the transition from recreational to regular 
cannabis use (Jӓrvinen & Ravn, 2015).  Four causal narratives were identified childhood 
experiences/trauma, self-medication, peer influence; alternative life approach/perspective (Jӓrvinen 
& Ravn, 2015).  Additional dimensions were considered to further explore the nuances of these 
causal narratives, individual vs. societal explanations for use and agency vs. fatalism in consideration 
of future use (Jӓrvinen & Ravn, 2015).  This construction of causal use narratives provides evidence 
of how users conceptualise their current and future use, including the factors which made them 
vulnerable to problematic use and the underlying mechanisms which influence their future use 
behaviour (Jӓrvinen & Ravn, 2015). 
4.1.7 Purpose and aims of this study 
In the previous studies of this PhD, the aim has largely been to formulate and understand cannabis 
use behaviour, with an emphasis on defining, exploring problematic cannabis use and the factors 
that are associated with problematic cannabis use outcomes.  The first two studies looked 
specifically at general, student populations of cannabis users.  This study focused on young people 
who were in touch with drug services.  Using open-ended interviews, the objective of this study was 
to gain a better understand of young people who are considered to have developed problematic 
cannabis use outcomes.  Specifically, the aim of this study was to explore several areas related to 
cannabis use, including: 
1)  How does cannabis use initiation transition from recreational cannabis use to problematic or 
dependent use behaviour?  This includes the exploration of logistical nature of use, including the 
acquisition of cannabis, the environment in which use occurs, and the patterns of use and how they 
influence and change cannabis use patterns over time. 
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2)  How do cannabis expectancies, intentions, beliefs and perceptions influence behaviour and use 
outcomes?  Cannabis use, and in particular, how it’s meaning and importance is reflected in the 
users experience and outcome of use, and how this is managed in their life. 
3)  What are the perceptions of currents use behaviours and the motivations for use behaviour 
modification or cessation?  Based on the drug treatment services the participants were in touch 
with, there was an assumption that there is a desire for modification of current cannabis use 
behaviour in most participants.  An exploration of how and if participants want cannabis use to be 
modified, the motivations for desire to change current use behaviours, the perception and effects of 
use modification/cessation, and the ramifications of behaviour change will be employed.   
The study looked at four specific factors of use: cannabis use history; cannabis use 
experiences; cannabis behaviour and knowledge; and motivations for cannabis use and 
cessation/modification of use.  The drug instrumentalization framework provided a tool to examine 
cannabis use experiences, behaviour, knowledge and motivations and how users evaluated their use 
behaviours, while normalization theory was used to contextualise these behaviours within the UK 
cannabis environment and how this influences these behaviours.   
4.2 Methodology 
4.2.1 Qualitative analysis approach 
This study was informed by the social constructivist approach, in which knowledge and experience of 
cannabis is constructed through social interaction (Lincoln & Guba, 2000; Charmaz, 2006; Andrews, 
2012).  Adapting this approach allows for the consideration of the language and discussion used by 
social groups, and focuses on the ways in which meaning is created, negotiated, sustained and 
modified.  The emphasis, therefore, was placed on perspectives, both individual and collective, and 
the recognition of a reality that is both subjective and objective, and the construction of knowledge 
and meaning is dependent on context.  This research, as a result, focused on how research 
participants’ knowledge and experience around cannabis was constructed, and the subsequent 
individual and shared meanings expressed.  This approach allowed for exploration regarding how 
identity and experience of cannabis was negotiated through participants’ cannabis use history, and 
the evolution of meaning, identity and knowledge. 
The transcripts were read several times for familiarity, and grouping of the data was 
conducted in order to find similarities and differences between accounts in a pre-determined 
manner. The themes were then related and studied in relation to the theoretical concept of 
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‘normalization’ and ‘instrumentalization’ and how they could be applied to the concept of young 
cannabis use.  When presenting quotations as examples, an effort has been made to ensure that the 
quotations used were representative of young people’s views and experiences.  Any inconsistencies 
and contradictions within the data have also been acknowledged. 
4.2.2 Theoretical position 
This study was informed by the drug normalization thesis and the ‘drugs as instruments’ framework 
(Müller & Schumann, 2011; Measham, Newcombe & Parker, 1994; Parker, Aldridge & Measham, 
1998; Aldridge, Parker & Measham, 1999; Parker, Aldridge, Egginton, 2001; Parker, Williams & 
Aldridge, 2002; Parker & Egginton, 2002; Parker & Williams, 2003; Parker, 2005; Aldridge, Measham 
& Williams, 2013).  The drug normalization thesis contextualises the environment in which cannabis 
use exists in the United Kingdom.  Despite critics of normalization (Blackman, 2004; Ramsay & 
Partridge, 1999; Shildrick, 2002; Shiner & Newburn, 1997, 1999; Aldridge, Measham, & Williams, 
2011; Measham & Shiner, 2009; Shildrick, 2008), evidence supports the idea that the many cannabis 
users do so without stigma, and do not encounter significant problems as a result of their use.  This 
theoretical position contextualises the current cannabis environment in the United Kingdom.  
Furthermore, it allows the researcher to examine use under the assumption that the development of 
problematic or dependent use outcomes is non-normal.   In tandem with this theoretical approach, 
the drugs as instruments framework infuses and explores agency, and how cannabis intentions, 
expectancies and knowledge are used to ‘instrumentalize’ non-addictive, psychoactive drugs and 
how this influences use outcomes.   
The focus of this study was predominantly on individuals who exist on the periphery, and 
how these vulnerable individuals navigate their trajectory of use and negotiate the patterns and 
outcomes of use in an environment of ‘normalization’.  Under this theoretical approach, cannabis 
use is considered a normalized behaviour, one that is done without prejudice and stigmatisation, 
and is done so as a rational choice that takes into account risk, and is motivated by specific 
outcomes, mediated by knowledge and experience, and instrumentalized without problematic 
outcomes.  Furthermore, this theoretical approach allowed use described by the participants to be 
considered normal, until otherwise described.  By adopting this approach, users were able to express 
their own perception of their cannabis use and the ways in which it may or may not be related to 
acute and associated problems.  Furthermore, this research explored agency among users, the 
motivations for use, and how, or if, use is overinstrumentalized in this population, and explored the 
possibility that use in and of itself is not homogenously problematic, and the circumstances in which 
problematic use arises.  This inclusion of the drugs as instruments framework allowed for the 
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consideration of meaning and purpose of use, and how this is negotiated.  This theoretical approach 
allowed for a more nuanced understanding of cannabis and the variability in use patterns and 
outcomes and how users may flux in and out non-problematic, normalized use behaviour. 
4.2.3 Interview guide 
A cannabis interview guide was developed around factors associated with problematic cannabis use 
outcomes and the framework of ‘drug normalization’ (see Appendix 1).  Four aspects of cannabis use 
were used: Cannabis History; Cannabis Experiences; Cannabis Use Behaviour and Knowledge; and 
Cannabis Motivations and Cessation, with emphasis on drug instrumentalization throughout.  
Cannabis Use History included questions about the initiation of cannabis use and the evolution of 
use behaviour from initiation to current or most recent use behaviour.  This included factors 
surrounding the first use session, the environment and people associated with cannabis use and the 
circumstances in the initial use session.  Furthermore, questions were included on the development 
of use behaviour, it’s evolution over time, and the factors that contributed to changes in use 
behaviour.  This section was important for the understanding of how use was constructed over time, 
and how the interpretation of their own use is expressed and negotiated, and how the factors 
associated with use contribute.  Cannabis Experiences sought information regarding the types of 
experiences that result from cannabis use, including both positive and negative feelings and 
attitudes, and how these have evolved throughout their use history.  This was important for 
understanding the meaning associated with cannabis use. Cannabis Use Behaviour and Knowledge 
sought information regarding the relationships associated with purchasing cannabis and how use 
was negotiated through friendships and dealers.  Furthermore, questions regarding user knowledge 
of the cannabis they use, how they make decisions about getting and using cannabis, and how their 
intended outcomes are negotiated through their use behaviours are explored.  This allows for the 
understanding of how use was pragmatically negotiated.  Lastly, Cannabis Motivations and Cessation 
questions surrounded their current intention to either reduce or cease using cannabis, with the 
assumption that many participants will seek to abstain or reduce their use because of their 
association with the drug support services.  Particularly, the reasons for their intention to change 
their cannabis use, tools and strategies they employed, and expected barriers to changing their use 
behaviour.  This allowed the researcher to understand how they view their current and future use 
behaviour, and how they intend to negotiate any possible differences.  The main points of interest 
were: 
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Environment:  Emphasis will be placed on the contextualised environment in which use occurs.  
Specifically, drawing on work by Järvinen and Ravn (2011) exploration of aspects of the use 
environment including: network, access to cannabis, and patterns of use.   
Stigma and perceptions of use:  Perceptions of use, both perceived by others and by themselves, will 
be explored and how these influence use behaviour and the interpretation of one’s identity, and 
construction of current and future use concepts. 
Instrumentalization: Motivations for use were key aspects of understanding how problematic use 
arises.  Cannabis use intoxication intended to achieve specific goals was associated with less 
problematic use than use purely for the purpose of intoxication (Müller & Schumann, 2011).  Focus 
on where the motivations for use within participants were explored, and how specific goals were 
negotiated and achieved.   
Outcomes of use: Although motivations for use were important as were intended outcomes of use, 
outcomes of use were critical in understanding both the underlying mechanisms for use and how 
and why problems arise because of use. 
4.2.4 Population and recruitment 
This study was based on 11 qualitative interviews with cannabis users in contact with drug services 
in Northwest, England.  The interviewees were in touch with either one, or both, of two services: a 
young people’s service for drug support and young homeless people with housing support needs.  
Interviewees were recruited by staff at the services and were informed of the research project.  
Interested participants were then designated appointments for interviews to take place.  Interviews 
were conducted in a private office in the drug support service, and a recreation room in the housing 
support centre.  
Interviews took place between April 2011 and June 2015.  Initially, four interviews took place 
in 2011 through local drug support services; however, no more appropriate participants were 
identified.  After initial analysis of the data, additional interviews took place in 2015 and an 
additional 7 participants were identified to develop emerging themes in more detail.  Participants 
were paid £20 in vouchers, which could be redeemed at several clothing, grocery or electronics 
shops, for their time and contribution to the study.  This method was also approved as being 
appropriate by the gatekeepers for the qualitative interviews (for discussion of ethics of paying drug 
users for research participation see section 3.2.1)  The interviews lasted between 20 minutes and an 
hour, with most taking about 40 minutes.  The interviews were semi-structured and based on four 
themes: Cannabis History; Cannabis Experiences; Cannabis Use Behaviour and Knowledge; and 
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Cannabis Motivations and Cessation.  A semi-structured interview guide was chosen to allow for 
participants to expand and explore critical elements that were important for individual participant, 
but also allowed the investigation to be focused on specific elements of cannabis use development 
overtime to support comparability of analysis.  Furthermore, interviewees were asked to fill out a 
brief questionnaire describing their history of alcohol and drug use.  In line with social science 
research ethical standards, interviewees were given informed consent and allowed to withdraw at 
any time Considerable time was given to delivering informed consent to participants to ensure that 
separation between the support services and the interviewer was understood, and to ensure the 
participants were not coerced by staff to participant; the interviewer read through the participant 
information sheet with each participant and explicitly discussed the consent process, the role of the 
researcher, and the rights of the participant.  Interviews were digitally recorded and transcribed 
verbatim with all identifiable data anonymised. Interviews were coded and analysed by the 
researcher who conducted the interviews.  
4.2.5 Analysis Procedure 
Directed Content analysis is a qualitative methodology used to expand upon existing theory or prior 
research (Hsieh & Shannon, 2005).  It is an approach that provides a structured process of qualitative 
analysis that identifies core concepts and values defined by previous theory as initial coding 
variables (Hickey & Kipping, 1996; Potter & Levine-Donnerstein, 1999).  Using the predetermined 
theory, operational definitions are developed for each category and used accordingly to provide 
guildelines for thematic analysis of content (see Appendix 2).   
The previous chapters in this PhD have sought to gain an understanding of the factors 
related to the motivations for individuals to experiment with cananbis use, and the factors 
associated with the continued use of cannabis for individuals who experiment with cannabis.  This 
work seeks to build on this information by gathering data from interviews conducted with young 
people engaged with community-based drug services.  Such young people typically access services to 
help with the reduction of use or to address associated behaviours, and self-identify as problematic 
or dependent users of cannabis.  Thematic coding schemes were developed prior to the analysis of 
interviews.  The interview guide was developed to provide a time-based linear evaluation of the 
progression of use from initiation to the current use behaviour.  Additionally, key components 
derived from previous findings from this PhD regarding factors associated with problematic use 
outcomes were incorporated into the interview guide.  Interview transcripts were initially read for 
understanding and to surmise each case.  The coding framework was then applied to all interviews. 
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4.2.6 Ethical considerations 
Ethical approval was obtained from Liverpool John Moores University Research Ethics Committee for 
this research.  Participants were fully informed of the nature of the interview and provided their 
written consent on the day of the research.  Participants were informed that their participation was 
voluntary and of their right to withdraw from the research at any time without reason.  
Furthermore, participants were informed that their anonymity would be protected and no 
references to individuals, place names or organisations would be made in documentations regarding 
this research. 
4.3 Results 
4.3.1 Demographics 
Eleven young people (4 female and 7 male) volunteered to participate in the interviews.  All 
participants were between 18-25 years of age at the time of the interview and all were White, and 
born in the UK.  Participants were current cannabis users except for one who had recently ceased 
using cannabis, and all had initiated cannabis use prior to 18 years of age.  Only one participant 
reported not using alcohol, with the other participants reporting early initiation of use (younger than 
15 years of age) and frequent or heavy use of alcohol.  Tobacco use was reported in all interviewees, 
with all initiating use prior to 17 years of age and all reporting smoking 21-30 cigarettes a day.  All 
participants reported using at least one other illicit drug in addition to cannabis in their lifetime, 
while three reported using at least one other illicit drug in the past 12 months.  Additionally, data, 
including drug use statistics, on participants interviewed for this study is presented in tables 1-3. 
 
 
 
 
 
Table 1. Descriptive statistics. (N= 11) 
Sex (% female) 41.8 
Age (Years) (M(SD)) 20.81 (2.08) 
Country (%) England (100) 
Ethnicity (%) White (100) 
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Table 2. Drug statistics (alcohol, tobacco and cannabis). (N = 11) 
Alcohol M (SD)* 
Age of initiation (Years) (N = 10) 13.9 (1.52) 
 Never Less than weekly Weekly 
Alcohol use frequency (%) (N = 10) 3 (30) 5 (50) 2 (20) 
Drinks in typical drinking session 
(%) (N = 9) 
1 or 2 3 or 4 5 or 6 7 to 9 10 or 
more 
 1 (11.1) 1 (11.1) 3 (33.3) 2 (22.2) 2 (22.2) 
Tobacco  
Age of initiation (Years) (N = 11) 14.0 (2.05) 
Tobacco use frequency (%) Never Daily 
 2 (18.2) 9 (81.8) 
Number of cigarettes per day (N = 
10) 
10 or fewer 21-30 
 5 (50.0) 5 (50.0) 
Cannabis  
Age of initiation (Years) (N = 11) 14.54 (1.63) 
 Never Less than weekly Daily 
 1 (9.1) 4 (36.4) 6 (54.5) 
*M(SD) unit of measurement unless otherwise noted 
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Table 3. Use of drugs other than cannabis. (N = 11) 
 Never Lifetime Past year Past Month 
Ecstasy (%)  36.4 18.2 36.4 9.1 
Heroin (%)  90.9 2.7 0 9.1 
Cocaine (%) 27.3 27.3 36.4 9.1 
Hallucinogens (%) 27.3 27.3 36.4 9.1 
Ketamine (%)  63.6 36.4 0 0 
Legal Highs (%)  36.4 27.3 27.3 9.1 
Amphetamines (%)  72.7 18.2 0 9.1 
Anabolic Steroids (%)  100 0 0 0 
 
4.3.2 Cannabis history 
The Cannabis History section was designed to understand the environment in which cannabis use 
was initiated, and the ways in which use developed and evolved.   
4.3.2.1 Cannabis initiation 
The Cannabis use history section of the interview guide asked participants about the initiation of use 
and the circumstances regarding their first experiences of use.   Specifically, this was undertaken to 
better understand how use developed with consideration of theoretical concepts of drug 
normalization and drug instrumentalization.  Nearly all of the interviewees reported that they were 
introduced to cannabis by friends or partner, with the majority of interviewees describing initial use 
sessions occurred either in a park or at a friend’s house.  Only one participant reported being in a 
hostel when introduced to cannabis, and described an experience in which they were ‘pestered’ into 
initiation by older men.  All participants were 17 or younger when they initiated cannabis use, with 
the earliest reporting initiation of use at 12 years old. Any element of ‘peer pressure’ was only 
alluded to by other participants, with language and tone that described gentle offering, or interest in 
trying cannabis, but some references to the ‘wrong crowd’ or ‘wrong people’ and other language 
associated with ‘deviant youth behaviour’  were made.  One participant described a social 
environment in which cannabis was visible and commonplace.  A social environment in which 
cannabis use was accessible and accepted seemed to permeate throughout the interviews.   
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 “Umm, well when I was 12 and I first started secondary school, mixing with the wrong crowds, the 
older lots, we used to smoke cigarettes and that and went behind the bike shed, ya know, and I 
started from there, ya know, they were smoking green behind the bike shed and that…just started 
doing tokes and started then.” (Participant 1; male) 
“…was just like with mi friends and we were all having a spliff, and I was standing with them and 
they asked if I wanted some, like I thought, ‘yeah, I’ll have some….’’ (Participant 3; female) 
“Yeah, I lived on a street where everyone smoked weed, and everyone on the streets around, a mass 
community of weed smokers.” (Participant 8; male) 
The first instance of use of cannabis was associated with tobacco use in every participant 
except one, who reported smoking a blunt (a cannabis joint without tobacco) and then eventually 
adding tobacco into his joints.  A few participants reported drinking alcohol during their first use 
session, but the majority used cannabis and tobacco exclusively, and none reported using any other 
illicit drugs.  Participants’ described casual, intimate use sessions with a small group of people, 
opposed to a communal, party-oriented initial use session.  The social aspect of use however, was 
also a key element associated the initial use session.  When describing their interest in initiating 
cannabis use, one participant noted how their friends and/or peers who were using cannabis 
seemed ‘relaxed’ or ‘chilled out’.  This outcome associated with use appears to be an important 
factor in encouraging the initiation of use.   
“I was about 16 and a couple of weekends….erm, just wanted to try it because they all seemed to be 
dead chilled out, laughing, and having a joke and I always like, more like stressing over exams and 
stuff, and that’s when I first started” (Participant 2; female) 
“Like in a park on a day out with just kids.” (Participant 6, female) 
“Basically, I was in a band and after the band practice we went to (the park)….and he had the bag of 
lemon haze weed and put it into thing and smoked it.  It was the first time I smoked; it was the first 
time I smoked anything.” (Participant 10, male) 
Cannabis initiation was described as a natural progression by most participants, who 
described a casual, initial use session with friends or peers.  One participant described a more 
intensive experience, in which the use of cannabis was integral to gaining a sense of belonging with 
their social group. 
‘What happened was I come out of the army, right? I joined the marching regiment, I smoked ciggies 
in there because I was stressed out because I missed my family and that, but when I came out they 
wouldn’t let me go back and live with them (parents), you know what I mean? So I moved into a 
hostel.  As soon as I moved into the hostel I started hanging out with a couple lads in there who 
smoked weed and people kept pestering me to have a go. I was only 17 and I was in a worker’s hostel 
and they were all 30 plus, so I thought, ‘yeah, I’ll have a go’ and since that day I haven’t stopped.’ 
(Participant 4; male) 
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 “Just out with mi mates at a park, just out for a few bevvies, a few drinks and that, cuz I used to 
drink when I was younger, so we used to go to the park and drink and smoke at a young age, like 
12/13, and then moved to cannabis at 15.”(Participant 9, female) 
The outcomes of the initial use session was recounted as mostly positive by every 
participant, with most emphasising the ‘high’ that was experienced, and that the experience left 
them feeling ‘relaxed’.  In addition to noting the ‘high’ and ‘relaxation’, other participants noted how 
they felt more confident, and laughed, while some noted how they felt paranoid and were fearful.  
Furthermore, several participants discussed how they believed the initial high was one that could 
never be experienced or reached again, and one even described their current use as constantly 
trying to recreate that subjective experience high.  In addition to the feelings experienced relating to 
the effects of the drug, one participant noted how the experience of using cannabis ‘just felt right’. 
 “At first it was quite scary, it was good at first, I don’t know, I got a bit paranoid then, and just going 
into me house I was dead like nervous, whereas if I wouldn’t have had a drug I would have just 
walked in normal but I was nervous because I knew I took drugs and that but when I started the more 
I smoked it the less paranoid I was getting about going in because I wasn’t getting caught, and then I 
was enjoying it I was getting my giggles, I was chilling out, and I wasn’t thinking about the stuff that 
was going on.” (Participant 2, female) 
“It was amazing. Just feel so relaxed, and felt a lot more confident.” (Participant 3, female) 
“Alright, I felt good, it just felt right at the time” (Participant 5, male) 
“I just laughed for like an hour, like it was really, really good.  It was the best high I’ve ever had in my 
life.” (Participant 6, female) 
“I thought it was mad at first to be honest, just sat there and couldn’t move or nothing, just layed 
there, chilled out, stoned out of mi head” (Participant 7, male) 
4.3.2.2 Cannabis development 
The development from initial cannabis use to present cannabis use behaviour was critical, 
particularly in understanding how problematic use developed and evolved.  
4.3.2.3 Cannabis behavioural development 
Although use initiation generally followed typical expectations of drug experimentation (tobacco and 
alcohol, followed by cannabis, followed by ‘harder’ drugs), the development of use following initial 
cannabis use varied among participants.  Some expressed how use quickly escalated to more 
frequent use, while other participants described use trajectories that were either more gradual or 
far more nuanced, describing times which were either more frequent or use was much less.   For 
participants that reported the greatest negative consequences as a result of their cannabis, a rapid 
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escalation of frequent use following initiation was described.  Participants, who described a more 
gradual, or inconsistent use pattern, reported less extensive consequences as a result of their use.   
“It would be day and night, day to night, straight away when I wake up before I even leave my house. 
I’d have three spliffs before I leave and ya know just to make me feel like if I left the house I’d be like 
a bit anxious or ya know a bit paranoid ya know what I mean but if I had 3 joints inside me I’d feel 
great I’d be buzzing.” (Participant 1; male) 
 “It wasn’t frequent from the start because I was too young.  When I came home that first time, my 
mom actually smokes as well, she was like she knew and then I started smoking a bit in the house 
with, and it was like when I got to sixth form I started to smoke every day and it as mainly it was to 
deal with because I’ve got mental health issue…and now it’s just fine, I just do it.” (Participant 6, 
female) 
“We just bought it more often, and we bought more of it more often, and then we started buying 
tobacco and putting it into joints as well, nothing out of the ordinary, just started smoking more 
often really.” (Participant 7; male) 
In addition to the evolution of use frequency, the context and environment of use evolved 
among participants.  All participants reported that cannabis was a social experience, but after the 
initial use session, many participants described using on their own.  Most participants who reported 
using cannabis on their own did so specifically because they instrumentalized cannabis to either 
‘relax’ following work or school, or to help them get to sleep in the evening.  Although the 
participants who described the most severe consequences of use reported using on their own, so did 
participants who reported the least severe consequences of use. It appears that potential over-
instrumetalisation, however, rather than solitary use, is most indicative of more severe 
consequences of use. 
 ‘It would be day and night, day to night. Straight away when I wake up, before I even leave my 
house I’d have three spliffs before I leave, and ya know, just to make me feel like if I left the house I’d 
be all like a bit anxious or ya know a bit paranoid, ya know what I mean, but if I had 3 joints inside 
me I’d feel great…’. (Participant 1; male) 
‘It used to be a like a group of us, and then as you get older, you go different ways, and I just carried 
on smoking it, on my own’. (Participant 2, female) 
“I do smoke my own, I’ve said that many times. If I got a bag of weed I’m sitting on my own, I’d 
rather sit and smoke with someone else, maybe to the end of the bag, I might have a spliff on my 
own.” (Participant 8, male) 
“Yeah, I do smoke on my own, especially at night time, like when I got to bed, I’ll have a spliff on my 
own and go to sleep, that’s the only way I can get to sleep.” (Participant 9, female) 
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4.3.2.4 Change in acute effects of cannabis 
A key point in understanding the change in cannabis use behaviour over time is the consideration of 
the ways in which the effects of acute use changed over time.  Most participants discussed how the 
amount of cannabis needed to attain the level of high they desired increased over time.  Others 
described how the high they desired to achieve was no longer attainable.  Despite many reporting 
that the amount and frequency of cannabis needed to achieve their desired high increased, one 
participant described how experience using cannabis improved their use outcomes and experiences. 
“Yeah, when I first started it was like not even 4 pulls and it’d be knocking me out for hours. And then 
making me feel like that ‘buzz’ but now it’s like you’ve got to smoke one then build another and then 
smoke it and then build another to get the effect because you’ve smoked it that long that it’s not 
doing nothing to ya it’s a waste of money” (Participant 1; male) 
“Yeah, like, at the beginning, I felt like, I’d only have to smoke like a quarter of it, and feel really 
stoned, where now, I have to smoke a whole ten pounds worth to me self or with one other person, 
for me to feel the same way I felt with a couple of pulls a couple of years ago” (Participant 9; female) 
“Definitely, at first I didn’t have a clue what it was going to do to me, just seen people on films, 
people smoking weed, then when I tried it, you do actually get high, it’s mad, and each time you get 
high, it’s just like more experience on it for you, you make your high better for yourself, from knowing 
what you know.” (Participant 10, male) 
4.3.2.5 Changes in feelings about cannabis use 
In addition to the behavioural and acute effect changes associated with cannabis, most participants 
described that the ways in which they viewed their use of cannabis over time.  Participants who 
reported fewer negative consequences of use had a less negative summation of their use compared 
to other participants who experienced more severe consequences of use.  About half of the 
participants indicated that there were times in which their perception of cannabis use became 
negative as a result of their experiences and outcomes.  The catalyst for these changes in feelings 
about cannabis use seemed to be informed by both physical and mental changes from using cannabis, 
as well as factors like financial and social outcomes resulting from use. 
“We used to play a lot of football and I just used to be on the streets and sitting around and I grew up 
down in London and here, just hang in the streets and football and weekends and partying and 
going …I used to go to free raves when I was younger when I started getting into heaving drugs like 
ecstasy, party drugs and just like whatever comes along…’ (Participant 1; male) 
“I felt happy like it was a nice buzz, but after that say about 4 months after that, I started to feel like 
my world was collapsing because all mi money before I started smoking I always had money, and 
then when I started smoking I never had money, I started feeling more tired….” (Participant 4; male) 
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“It was alright at first, it just got worse and worse and worse, you know what I mean, in the end it 
was just boring and depressing.” (Participant 5; male) 
4.3.2.6 Cannabis transitions 
An important consideration in cannabis use development is understanding how users transition in 
and out of problematic use, and the variability of use behaviour.  In order to demonstrate this 
among participants in this sample, this section will look at one participant (Participant 2; female) and 
describe how their use developed over time, with a particular emphasis on how they perceived their 
use as problematic and non-problematic. 
Participant 2 initiated cannabis use with friends and was drawn to use by the perception of 
other users and their experience with cannabis, particularly the perceived relaxed and ‘chilled’ 
demeanour of users.  The participant was interested in use to alleviate their own stress because of 
exams. 
“Errrm, I was about 16 and a couple of weekends….erm, just wanted to try it because they all seemed 
to be dead chilled out, laughing, and having a joke and I always like, more like stressing over exams 
and stuff, and that’s when I first started.” 
When asked about her current use of cannabis, she described substantial variability, with 
one week smoking daily and the next possibly abstaining.  
“It depends. I’m up and down at the moment with my cannabis use.  One week I could be smoking 
every day, and then I could two weeks without it, and then I could go a month on it, It’s up and down 
really.” 
 Part of the variation of cannabis use is due to the management of responsibilities.  In 
addition to responsibilities, emotional triggers also seem to influence the amount and frequency of 
cannabis use.  The participant described different school responsibilities as a reason to reduce their 
use of cannabis, and stress from familial relationships as a cause for an increase in use behaviour.  
Furthermore, the participant noted that when things were going well, it was easy to manage 
cannabis use, but when life was ‘difficult’ it impeded on their ability to manage their use. 
“Yeah, cuz, say with 6 weeks holidays if I’m off from school I’ll smoke it then, now I’m in Uni, when 
I’ve got exams and things, I just try and stay completely off it, all together.” 
“It’s when I get stressed out, and what’s the point of arguing mi mum anyways, mine as well have a 
spliff and chill out, and then you have one and then you have another and then it leads to another 20 
bag.” 
“Erm, it’s difficult to stop all together, but it’s not difficult not to stop when life’s going ok, if you 
understand….” 
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 The participant also noted that they did not smoke cannabis for several years because of 
their partner, and as a result, used other drugs, including alcohol and cocaine.  This highlighted how 
environmental opportunity and relationships influenced drug decisions, include type and frequency. 
“Yeah, when I was like 16 and using and then I was back on it when I was 21, so from when I was 21 
until I was now it’s been the worst.” 
“I got into a relationship, and he didn’t smoke weed, so, like, I gradually stopped myself, and it was 
more the scenery of alcohol and cocaine and that…” 
 By looking at participant 2 exclusively for cannabis transitions, it becomes apparent that use 
for the individual is difficult to ascertain at a glance.  Use variability and experiences are bound by 
their current situation, and changes in responsibilities, relationships and environment contribute to 
changes in use behaviour.  The influence of factors associated with use is critical in understanding 
use behaviour and transitions from non-problematic to problematic use.  Although participants 
might not currently be expressing problematic use behaviour, the propensity for problematic use 
behaviours is an important consideration.  Specifically, it is important to understand the mechanisms 
that contribute to the experience of problematic outcomes and how users negotiate the factors that 
influence behavioural outcomes. 
4.3.3 Cannabis experiences 
This section looks specifically at cannabis use experiences, particularly the consideration of use 
intentions and outcomes.  With consideration of drug instrumentalization theory, which argues that 
non-addictive psychoactive drug use is purposeful and deliberate, the outcomes of use, both positive 
and negative, were reported as well as intentions and expectancies of use.  
4.3.3.1 Cannabis use purposeful outcomes 
Informed with the drugs as instruments framework, participants were explored the purposeful 
reasons for their cannabis use.  Participants were not specifically asked about any of the 
instrumentalized factors of non-addictive psychoactive use, but generally about their use 
experiences.  There are eight factors identified within the framework, however, in this study 
participants only discussed five of those factors: high/hedonia, improved cognitive performance, 
self-medication for mental illness, improved social interaction, coping with psychological stress and 
sensory curiosity/expansion.  Factors associated with purposeful use, including facilitation of sexual 
behaviour and improved physical appearance and attractiveness were not reported by participants.   
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4.3.3.2 High/hedonia 
High/Hedonia represents the instrumentalized drug use with the intention of achieving euphoria or 
intense well-being, happiness.  Although this is an outcome frequently associated with psychoactive 
drug use, the dosage required and potential for tolerance requiring higher doses posits hedonia as a 
pathway that may easily lead to over-instrumentalization (Müller & Schumann, 2011).  High/Hedonia 
was mentioned by several participants, although not necessarily as their main intended outcome of 
use, but an enjoyable by-product of use. 
‘When I first started I enjoyed the ‘buzz’ off it, ya know, like the way that makes you feel like ‘WAY’ 
you lose your mind a bit that kind of stuff, but it makes you feel like stoned for 10 minutes, and that 
buzz is like a hypo one where you just sit there you’re laughing but then it just like goes so it’s just a 
waste of time really.’ (Participant 4; male) 
4.3.3.3 Improved cognitive performance 
Improved Cognitive Performance describes instrumentalization with the goal of increasing cognitive 
performance, sometimes to counter mild impairments as a result of fatigue, exhaustion or mood 
swings (Müller & Schumann, 2011).  Only one participant indicated use cannabis for the intention of 
improved cognitive performance, although other participants noted use cannabis for improvement 
in cognitive performance in artistic endeavours, which for this analysis we chose to classify as 
creativity and thought expansion (see 4.3.3.7). 
“it’s just relax and play games and stuff like that, and concentrate more on things more, do mi 
coursework and stuff, like I actually work better.” (Participant 3; female) 
4.3.3.4 Self-medication 
Self-medication is the instrumentalization of psychoactive drugs with the intention of curbing or 
altering aversive mental states, typically with the aim of assuaging anxious or depressed mood 
states.  Self-medication is consistently discussed as a potential mechanism for drug use, particularly 
cannabis for the alleviation of symptoms of mental health disorders, like anxiety and depression, as 
well as schizoaffective disorders (Lazereck et al., 2012).  Results indicated that self-medication was 
instumentalized in particular with feelings of anxiety and depression.  Although instrumentalization 
by self-medication was described as a way to alleviate anxious and depressive symptoms, 
participants described a pathway in which this mechanism was often over-instrumentalized 
exacerbating those symptoms as well. 
“I was a lot more anxious before I started smoking weed than I am now.” (Participant 3; female) 
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“I’ve got bad anxiety problems and depression anyways which doesn’t help me smoking weed, but I 
feel like it helps me in a way, when I have a spliff, I can relax, I don’t think, I don’t worry, because I 
worry about the littlest things, the stupidest things, and soon as I have a spliff I forget all about my 
worries and then just be me then, that’s the only time.” (Participant 9, female) 
4.3.3.5 Improved social interaction 
The instrumentalization of cannabis for improved social interaction is used for the facilitation of 
social behaviour.  In addition to enhancing the social interaction, the social environment is enhanced 
by the use of psychoactive drugs (Müller & Schumann, 2011).  Participants described their cannabis 
use as a means for social interaction, mostly described as a casual means for ‘hanging out’ and 
socialising with friends and partners.  Participants, however, also described that cannabis use was 
ingrained into their social life, to the point where it may be more of an outcome of being in a social 
group that predominately uses cannabis, rather than a way to instrumentalize use.  As a results, 
although most participants referred to the use of cannabis for this reason, this did not seem to be 
their primary reason for use.  Rather, participants described this as a secondary or tertiary reason for 
their use. 
“Yeah, that would be affected quite a lot to be honest cuz near enough everyone I know smokes 
weed, like everyone, and if they’re smoking weed and I’m not, I wouldn’t want to be chilling with 
them, so I’d see less of my friends to be honest, definitely affect the social group 100%.” (Participant 
9; female) 
“Just hanging, chilling, a social thing.” (Participant 8, male) 
4.3.3.6 Coping with stress 
Goal-oriented cannabis use to cope with stress was used to transition an affective state of 
tiredness/stress to one of relaxation/fresh.  The psychoactive drug instrumentalization is used with 
the intention to speed up this process (Müller & Schumann, 2011).  For many of the participants, 
stressful lives were described, and cannabis was depicted as a both a cause for stress and a tool to 
alleviate stress.  As participants were in contact with housing and drug support services, the sample 
in this study would likely experience more stressful living situations than those in the general 
population, which may account for why their cannabis use would be discussed in relation to 
problematic, or stress-inducing outcomes.  Furthermore, the use of cannabis to alleviate these 
stressful situations and experiences seemed to indicate a cycle in which cannabis became both a 
contributing factor and a perceived tool to alleviate stress.  The use of cannabis to instrumentalize 
the alleviation of stress was often described as ‘chilling me out’, or some type of escapism from 
reality and the factors causing stress. 
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“I had it rough, ya know, my Dad was an alcoholic and, ya know, had rough environments and 
situations and that just made me….helped me to forget about home and that just ummmm chilled 
me out....” (Participant 1; male) 
“Just the way it makes you feel like, like, I have lots going on in mi head, and worry, and I have guilty 
feelings, and I think about mi nan a lot, mi two nans that passed away, when I have a spliff, it’s not 
like, like you don’t have to, it’s not that I forget about them, it just doesn’t hurt inside as much, it’s 
not as vivid.” (Participant 2; female)  
“For me, I don’t even enjoy it anymore, but I know I just, it relieves stress, it’s not me being stoned, 
like that’s a plus, if that makes sense, for me it’s smoking it, and letting it  hit the back of your throat 
when, it feels like, I can’t explain, I just woke up, I can’t even explain, it hits the back of your throat 
and it’s like, ‘fair enough’, it’s one of them.” (Participant 11; male) 
4.3.3.7 Sensory curiosity/expansion 
The instrumentalization of drug use for sensory curiosity is with the intention of expanded 
perception horizon.  Novelty and expanded perception of stimuli and environment permit the 
restructuring of information to gain new perspective (Müller & Schumann, 2011).  
Instrumentalization for sensory curiosity/expansion was described by less than half of the 
participants.  The use of was often described by participants who used cannabis for creative and 
artistic expression.  The use of sensory curiosity/expansion was described by participants who 
described less problematic outcomes for their use.  It may be that particular instrumentalized goals 
result in less problematic outcomes than others. 
“it’s just you think about different things when you’re high, it’s just entirely different things, and 
nothing that’s related to what you’re doing or anything that bothers you, like even if there’s nothing 
bothering you, the thing that you think about normally and the things you think about when you’re 
high are completely different.” (Participant 10; male) 
“It makes me think about other stuff, the other life out there, we can’t be the only ones here, that’s 
what it makes me think and believe, and then, I’ve sat there for ages puzzling me head.” (Participant 
11; male) 
4.3.3.8 Consequences of cannabis use 
Although the use of cannabis to achieve specific outcomes is within the framework of non-addictive 
psychoactive drug use, it is important to consider how use can be overinstrumentalized.  If use to 
achieve these outcomes becomes uncontrolled, it is likely to be problematic for the user. 
Furthermore, it is important to consider how outcomes of use could become problematic due to 
consequences related to both acute and long-term use.  Nearly all of the participants reported 
consequences that they attribute to their use of cannabis, with varying degrees of severity and 
frequency.  Consequences as a result of cannabis use are likely to occur for both problematic and 
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non-problematic users of cannabis, but excessive and recurring problems due to use is cause for 
concern.  Consequences were coded into four categories: social, financial, mental health and 
criminal justice.  Consequences of use were similar by gender, except for criminal justice effects, 
with only male participants reporting involvement in gang activity or being arrested for possession of 
cannabis. 
4.3.3.9 Criminal justice consequences 
Criminal justice consequences of cannabis use were described by nearly half of the male 
participants, while none were described by female participants.  In general, participants who 
descried criminal justice consequences of use did not indicate any greater levels of problematic use 
in other areas.  However, criminal justice consequences were often described by participants who 
were more engaged with a cannabis lifestyle that included low-level dealing and gang activity.  
Additionally, participants who experienced criminal justice consequences descried lives more on the 
periphery of the ‘normal population’ than others, and lesser belief in their desire or belief that their 
cannabis use could change. 
“Loads, being nicked with bags of weed on me, so I’ve been like cautioned and fined, like 80 pounds 
spot fine for having a ten bag, how stupid that was, and ya regret even getting the ten bag, to be 
honest with ya a ten bag isn’t worth an 80 pound fine is it, but that’s it, I get judged by police, ya 
know how police know you’re face when they’ve nicked ya for weed, they’ll always, police will see 
you they’ll always follow you and search you.” (Participant 4; male) 
“No, got arrested with a few bags of weed that was a few years ago.” (Participant 5; male) 
 
4.3.3.10 Financial consequences 
Every participant described financial consequences that resulted from their cannabis use.  In most 
instances, money problems seemed to be one of the main issues at the forefront of their negative 
perception of their use.  These financial consequences were described as an impediment to the 
evolution to a life out of support services.  Furthermore, in describing a desire to change their use, 
financial issued was often described to be one of the primary motivations of cannabis behaviour 
change. 
“Yeah, if I didn’t get into it I wouldn’t be spending money it on useless crap.” (Participant 3, female) 
 
“Just money problems.  For last year, I went through a stage, because of stuff that was going on, just 
smoking it all the time, more to just to block out the world than actually wanting to do it, you know 
what I mean, I spent so much, I must have spent 80 pound a week, every week, but apart from that, 
I’ve never been paranoid and stuff off it.” (Participant 6; female) 
4.3.3.11 Mental health consequences 
In addition to financial consequences, mental health consequences were described by all 
participants.  In addition to anxiety and depression, deficiencies in memory and other mental 
capacities were described, although to a much lesser extent than anxiety and depression.  In 
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addition to cyclical issues with instrumentalized stress, mental health consequences were described 
as a bidirectional relationship; although issues with mental health were believed to be a result of 
cannabis use, cannabis use was also instumentalized to alleviate these consequences.  The 
relationship between mental health self-medication and consequences of use seems to be a very 
complex relationship, one that was described by the majority of participants in this sample. 
 “I was border and border and felt depressed and depressed, and now I’m suffering from anxiety and 
depression, I think, that’s the effects of what it does to ya, you know what I mean.” (Participant 5; 
male) 
“I’d say my memory, it’s rubbish, like  especially short term more than long term, if someone said to 
me what have you been doing an hour ago or where was you an hour ago, I’d say I don’t know.” 
(Participant 9; female) 
4.3.3.12 Social consequences  
Like financial and mental health consequences of use, social consequences were described by a 
majority of the participants.  Unlike financial and mental health consequences, however, there was 
much greater variability in the severity of those consequences.  The most severe of consequences 
were those that resulted from family relationship issues, which led to estrangement from members 
of their family.  In most instances, however, participants described breakdowns in relationships with 
friends and partners.  In addition to relationships, many participants described social consequences 
of use that resulted in them being on the periphery of society, although it is difficult to ascertain if 
this was caused or contributed to by cannabis use. 
“Family relationships breaking down.” (Participant 2; female) 
“How it affects me is I can’t see my family now...” (Participant 11; male) 
 
4.3.3.13 Effects of consequences of use and their influence on use behaviour and outcomes 
The next section contextualises the experiences and outcomes young people reported about their 
cannabis use.  This ranged from the positive experiences they associated with cannabis, to how their 
use escalated, and how the escalation of use altered their perception and experiences with cannabis.  
Many participants reported that as their use continued they experienced increasing negative 
consequences, which outweighed the positive effects of their use: 
‘Well, I say there were positives from when I first started smoking weed.  It helped me forget what 
was going on at home and so that was a positive because, ya know, when I was really young and I 
seen a lot at home and mainly just for that I say it was positive….but as you get older it gets pure 
negative…more bad has happened in my life than fucking good from doing drugs. I’ve hurt my 
friends, I’ve hurt my friends and all that…’. (Participant 1; male) 
“It’s changed. It’s more different now. Because when I first started, it’s like you pull so many because 
you get stoned, and like you’re here just you’re like happy like because you just started doing it, but 
now it’s gets boring because it’s a habit, and like you’re constantly like ‘I need a spliff, I need a spliff’ 
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constantly it just takes over you, it changes you, and you can’t do nothing about it, unless you’re 
willing to change, but it’s hard, like nowadays I know you say there’s jobs out there, but there isn’t, 
some people don’t, but since I’ve been smoking cannabis but I’ve been nicked for it so I’ve got a 
record off that, so if I hadn’t started smoking I wouldn’t have the record, it’s doesn’t change ya, it 
makes ya different, people call you pothead, people say oh look at him he smokes week don’t talk to 
him, that’s what some people are like.” (Participant 4; male) 
“What am I doing with my life?  Why am I sitting here doing this when I smoked it about 7 years to 8 
years non-stop? Why am I still doing this? How much money have I got when you accumulate? When 
I don’t think about how much I spent, I just roll with it and with whatever is going on that day?” 
(Participant 8, male) 
It should be noted that some of the reported negative outcomes were related to the 
outcomes of a ‘cannabis lifestyle’ and not specifically acute cannabis use.  The criminal justice 
consequences related to cannabis can lead to social stigma and create obstacles in obtaining 
employment. Furthermore, of those participants who reported significant negative opinions about 
their own use behaviour, most were involved in the sale of cannabis (all who reported dealing 
cannabis were male).  Additionally, two of the four participants who reported dealing cannabis had 
quit using cannabis at the time of interview.  Other participants, however, reported that as their use 
of cannabis continued, they did not experience significant problems associated with their use 
behaviour.  Although they experienced problems/consequences as a result of their use, they 
reported that their use was largely, a positive aspect of their life. 
“I don’t think you’ll ever get the same as when you first try it when you’re only sixteen. It’s like a buzz 
then.  Now, it’s just like more chilling me out when I use it now. I like to have it after me tea, say, and 
just chill and watch and film and chat with mi mates or something.” (Participant 2; female) 
“It’s just like, I just like it, like I don’t even know, it doesn’t give me any bad side effects, I’ve recently 
come off anti-depressants and all my friends will go out and just like get really drunk or take coke or 
ecstasy or whatever and I can’t do that because it just sends me weird, whereas weed I can go just 
smoke spliff after spliff after spliff and be fine and it never does anything bad to me. It’s just Larry.” 
(Participant 6; female) 
“It’s not like a major part of my life, don’t get me wrong, it’s not something I’m addicted to, but I do 
enjoy it, it’s there, it’s something I enjoy, and if I enjoy it I’m going to do it.” (Participant 10; male) 
4.3.4 Cannabis use behaviour and knowledge 
The Cannabis Use Behaviour and Knowledge section of the interview guide was designed to 
ascertain how participants acquired cannabis, and the social facilitation of use through dealers and 
friends.  Furthermore, this section aimed to gain a better understanding of the knowledge users 
possessed about the cannabis they typically purchased, and how purchasing decisions were made.  
  
129 
 
Lastly, this section sought to outline patterns of use and how they were negotiated, both in 
purchasing cannabis and how and when they used it.  
4.3.4.1 Cannabis frequency of use 
Cannabis frequency is difficult to assess and interpret.  Due to varying quantities used in joints, 
different strengths of cannabis strains, the ways in which cannabis is often used and shared in a 
social environments, among other factors, traditional estimates of number of days, or number of 
joints do not provide a clear picture of use behaviour.  Therefore, participants were asked to 
describe their frequency of use generally and how their own use behaviour varied.  
“It depends. I’m up and down at the moment with my cannabis use.  One week I could be smoking 
every day, and then I could two weeks without it, and then I could go a month on it, It’s up and down 
really.” (Participant 2; female) 
“In a day, at most like 12 spliffs, so like a 10, like an eighth a day.” (Participant 6; female) 
 
“Once a week maybe, if that.” (Participant 10; male) 
 
“I use less weed, that’s what makes people paranoid when you put loads of weed in that’s why I only 
put a little bit in.” (Participants 11; male) 
 
4.3.4.2 Negotiation of use with responsibilities 
The ways in which cannabis use negotiated their use in their daily lives provided insight into how 
they managed their experiences and balanced this with their other responsibilities.  Most 
participants reported that their use was negotiated with their other responsibilities, like work and 
school.  The negotiation of cannabis use behaviour around responsibilities does not, as reported 
below, necessarily indicate that use was considered any less problematic.  However, participants 
who had fewer responsibilities tended to describe more intensive daily use sessions.  Some 
participants also described how their cannabis changed from a social activity, to one that they 
engaged in to relax, or help them sleep. 
“After work, or college or uni, yeah.” (Participant 2; female) 
 
“It’s mostly, when I wake in the morning I have one, and then it’s like after 12 o’clock, after midday, 
it’d be like in between 1 and 3 in the morning, one after another all the way through.” (Participant 4; 
male) 
 
“Yeah, definitely, when I first started it was during the day when we was chilling out, now if I have 
spliff it will be before I go to bed and go sleep.” (Participant 7; male) 
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“Yeah, apart, because I’m like in college Monday, Tuesday, Wednesday, so I don’t smoke it, like if I 
get up in the morning, I’ll have a ciggie and then go to college I know I can’t smoke it,  erm, but as 
soon as I’ve got back, I’ve got it on my mind when I’m in college, but then as soon as I get back, the 
first thing I do is buy a bag of weed or have a spliff.” (Participant 9; female)  
4.3.4.3 Cannabis purchasing frequency 
Most respondents reported purchasing cannabis nearly every day, and often from friends or dealers.  
Cannabis purchasing behaviour provides insight into their use environment, and how use decisions 
are made and how, in an unregulated market, knowledge of cannabis content is negotiated.  
Participants described the frequency of their purchasing behaviour and from whom they purchased.  
Most participants reported frequent cannabis purchase, with daily or every few days, and purchased 
from the same few, trusted sources.  The information presented on cannabis purchasing frequency 
was also informed by cannabis ‘knowledge’ and potency preferences. 
 “Yeah, because it was like, only when…when I first started I only had a couple of drags, then I started 
like smoking more like, getting a 10 bag. A 10 bag would last me before about a week and then I 
went up to, I was smoking about 60 pounds worth a day.” (Participant 2; female) 
“Every few days, 10 bags.” (Participant 3; female) 
“The weed I was getting, you know when I first started smoking weed it gets you stoned quicker, 
doesn’t it? But then, gradually, after a while you been smoking, you need more of a spliff, so you’d 
get more weed to put in the spliff.  Every week, I’d be spending like 300 quid every two weeks…..” 
(Participant 4; male) 
“Every day, 10 pounds worth a day, at least, if I can get my hands on more, I’d get more, I smoke it 
with other people as well, so I’d smoke my 10 pounds, and then obviously, I’d smoke it with other 
people so I’d be consuming more than just my 10 pounds.”(Participant 9; female) 
 
In addition to reporting frequent purchasing of cannabis, most participants reported that 
they typically used the same few, trusted sources, while a minority of participants reported an 
expansive cannabis network. 
“Quite a lot, well 10 people or something like that.” (Participant 3; female) 
“Different. Sometimes, like, when I used to do it kind of thing I’d always just take mine, but then I  
stopped it for good reason, because I’ve seen so many of my mates getting nicked and they asked me 
to put tents [for the growing of cannabis] in me flat and set up and I was like no. But then, umm, I go 
to the same one usually, but then sometimes he doesn’t have like good weed in, so umm after going 
to the same dealer mostly, but it’s just weird like I could leave here and go to the same person if he 
has nothing and go down the street and go to another one street and just keep knocking and 
knocking until I find one.” (Participant 4; male) 
“I’ve got like four, but it’s always the same four people.” (Participant 6; female) 
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4.3.4.4 Cannabis knowledge and preference 
The participants described their knowledge about the cannabis they purchased, and though they 
described having ‘options’, there seemed to still be uncertainty about quality and the degree to 
which the cannabis may have been tampered with some participants being more discerning than 
others in the quality of strain of cannabis they purchased: 
‘Well, you know sol, that’s like pure mixed with all stuff.  The green is occasionally sprayed and stuff 
it’s not good is just like chemicals really, proper weed it’s good….Yeah, you have options. But like, I 
still normally go through a friend and say ‘do you have like decent skunk? And go like, ‘what do you 
think is the best?’’ (Participant 2; female) 
‘I’m not fussed about what cannabis I’m getting. If I know what it is, and I have an option for going 
somewhere and getting a different thing, I’ll go for the better one, but I’m not 100% on it myself, I 
don’t look too much in it.’ (Participant 3; female) 
‘You have to go with it don’t you.  If the smell of it smells like cheese then it’s a good one. If you get it 
and it doesn’t smell of nothing then you don’t know what’s in it and you’re just risking your own 
health and for something that could be a load of shit.’ (Participant 4; male) 
“I try not to get skunk, but I do prefer green. But if someone offers me like pollen or whatever I won’t 
be like no”. (Participant 6; female) 
When asked to describe what would constitute ‘good quality’ cannabis, it was suggested 
that stronger, more potent cannabis was desired, but that the quality of cannabis they received was 
quite variable.  Furthermore, participants noted that the main two strains available in their area 
were Haze and Cheese, with most having a preference towards one or the other. 
“Like, you don’t need as much in a joint as, you know….it’s enough to not choker [fill] it out.” 
(Participant 2; female) 
 
That you get stoned better….. ridiculous, it’s constant, sometimes it’s stronger, sometimes it’s shit, I 
think it depends on how dry kind of thing.” (Participant 4; male) 
 
“Yeah, like haze I’d rather, I’d prefer to get haze then cheese you know what I mean, because haze 
was nicer than cheese you know what I mean, but it got to the extent where I wasn’t asked what I 
got it didn’t matter what I got.” (Participant 5; male) 
 
“So say I was to get haze or the cheese, I’d prefer to smoke the cheese because the haze one makes 
me feel a bit whoa you know what I mean it makes me angry then I get paranoid pretty quick off 
haze then I would cheese but there’s the two differences but I prefer cheese because I’m more 
mellowed and relaxed then all you’re not constantly paranoid on what’s being said or who’s gonna 
say something to you so you just say the same with cheese depending on how much THC is in it.” 
(Participant 11; male) 
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4.3.5 Cannabis motivations and cessation 
The last section of the interview asked participants about their motivations and reasons for using 
cannabis, whether they would like to decrease or discontinue use, and their reasons for any desired 
behaviour change.  There were the most varied responses by participants in this section of the 
interview.   
4.3.5.1 Motivations of behaviour change 
Some participants were happy with their use, others wanted to use less, and others had either quit 
using or hoped to. Other people, family members and friends, and a desire for a ‘normal’ life were 
reported as reasons for a desired change in cannabis use behaviour. 
‘My mom, really, like I wanted it for myself obviously, I wanted it for myself for years, but like I said I 
couldn’t change my life’. (Participant 1; male) 
‘Because I don’t want to be dead when I’m older, I don’t want to be wasting away look, ya know with 
my face, and just I don’t want to waste my life away with spliffs, do you know what I mean? I want to 
go out there and do something why I’m still young, instead of sitting around wasting years smoking 
weed, wasting everything aren’t I?’ (Participant 4; male) 
Even though some participants reported wanting a change in their cannabis use behaviour, 
some of them believe only certain experiences with cannabis, like a ‘scare’, or pregnancy would be a 
catalyst for a change in their behaviour. 
“I know the only way to do it was my, obviously my own baby if I was pregnant or if that happened or 
something scary like that or my like family reasons or something like that but not for a job, because 
obviously it is important and I need it for money and for rent, and stuff like that, but weed is a part of 
my life, so I can’t just cut weed out for a job or you get me, that’s how I feel.” (Participant 9, female) 
4.3.5.2 Barriers to behaviour change 
Although many participants expressed a desire to decrease or discontinue use, participants 
described many barriers to achieving this desired outcome.  Participants noted that they had 
triggers, or that they just weren’t confident altering their use. 
‘I tried so many times, see down there I had so many triggers for me, so many triggers, for me now, 
my coping mechanism if I have a bad day I’ll come to here I’ll go see good people, my coping 
mechanism back then was I’ll run straight to drugs’ (Participant 1; male) 
‘Erm, it’s difficult to stop all together, but it’s not difficult not to stop when life’s going ok, if you 
understand…’ (Participant 2; female) 
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‘Yeah,  it’s just like when I feel settled with myself, because I’m still having issues with mi self-esteem 
and stuff like that, when I feel settled, I feel like I’ll be able to stop’. (Participant 3; female) 
 
 ‘Because there’s nothing there in place to replace it.  Like there’s nothing there now which I can think 
of that would make me stop it at the moment, so like if I stopped it now and I had something to 
occupy my mind, but there’s nothing there at the moment, so I have to get that sort of first level of 
do stuff, got stuff to do constantly, the more stuff you have to do the better you are to get off it, cuz 
if you don’t time to break.’ (Participant 4; male) 
For participants who had no current desire to modify they use, they did note that if their use 
behaviour changed or began to have a negative impact on their life, this would change. 
“If it affected me in a bad way, if like because I do have psychosis, if it negatively impinged on that I’d 
stop using it straight away, like I’m using it to help me, not to not help me.”  (Participant 6; female) 
‘An effect form the weed to scare me off of it, like happen on me that would shock me.” (Participant 
8; male) 
Other participants had a much more relaxed, nonchalant approach to cannabis behaviour 
change.   When asked how they would cut down, most described a ‘cutting down’ period that would 
lead to complete cessation.  This transition from frequent cannabis use was described as a natural 
progression. 
‘Erm, at the moment, if I was to stop now, it would be drastic, but if it was over a period of time, I 
reckon it’d bet it’d be a lot better for me, that’s what I’m trying to do….cut down and then eventually 
stop when I’m ready to.’ (Participant 3; female) 
 
“I don’t think it’ll be too different from I am now because I don’t smoke weed too often it’s just I’ll be 
around different people who don’t smoke weed rather than being around people who do smoke 
weed.” (Participants 10; male) 
 
“Yeah, I just think it’s going to happen. Like I’ll just stop being around them when they’re high. And 
things like that.  I’ll decide to just be around them when they’re sober and things like that. But I don’t 
think it’s going to be choice, it’s just things happen.” (Participant 11; male) 
 
Of the participants who had already ceased using cannabis described that although there 
previously had been a desire to discontinue use, there wasn’t a commitment to the process. 
‘Because I knew what lifestyle I live, I wasn’t going in it wholeheartedly, yeah, you gotta do 
something, you want to get an achievement out of something, you got to put your whole heart 
behind, and you’ll be allowed to do it ya know what I mean, when my mom, this time around, my 
mom cried to me, and I know what you mean, it hit me, it hit home to me, and that was the drive for 
me, I tried so many times, I had to take myself out of the situation and put myself in this sort of 
situation I’m in in this recovery I’m standing here now, I still have a long way to go.’ (Participant 1; 
male) 
  
134 
 
 
Of particular concern was how several participants described that they were ‘addicted’ to 
cannabis.  Although they didn’t describe features of ‘addiction’, they described how cannabis was a 
critical part of their life  and their ability to function. 
 
“It’s a apart of mi, I think it’s a part of my life, like I can’t live without it I feel like basically it’s like a 
limb like you can’t like you know what I mean chopping off my arm if I cut cannabis off it’d be like 
chopping off mi arm, that’s what it feels like I need it in my life to live like to make me function 
sometimes I know it makes me dozey at the same time but it makes me feel normal if I’m not stoned 
and I’m just normal to everyone else I’m font feel normal to myself I like to feel that stoned or just 
that mellow feeling just that feeling off the weed you know what I mean, even though I don’t get 
stoned like I used to in the day, there’s still something you know what I mean, I’m not normal, like 
now I haven’t had a spliff you know what I mean, I just woke up half asleep, but I haven’t had a spliff 
so I feel normal and I don’t like that feeling, I like to feel stoned.” (Participant 9, female) 
 
4.3.5.3 Tools for cannabis behaviour modification 
In addition to asking about future or current interest in cannabis behaviour modification, 
participants were asked how they would go about change.  While some participants noted that they 
felt the change would happen naturally as they got older, most suggested that they would employ 
the use of a support service, or were already actively engaged with a support service to modify their 
cannabis use.  Despite all participants being in touch with support services, the levels of engagement 
and intentions varied widely. 
“I come here though to [name of service], they try and get you off it as well. But it’s more about what 
you want in your life. So like, that’s what I want to do, so hopefully in the next couple of months, I’ll 
be able to reduce it right down and be off it.” (Participant 4; male) 
“I’d go to [name of service] and say I want to quit then probably be like cold turkey, but when I don’t 
smoke weed I tend to start smoking cigarettes, to like counteract kinda thing, I’d rather smoke 1 
spliff a day or like 2 spliffs a day then smoke 10 cigarettes, you know what I mean, because I think 
they’re worst for you.” (Participant 6; female) 
 
Although some had already engaged in support work, the process of modifying or altering 
behaviour was considered to be a relatively long process.  Changes in use behaviour could also be 
due to changes in responsibilities, and use could subsequently be adjusted to fit around those 
demands. 
“….(my) support worker here, just phoned him up and started speaking to him and that, I was still 
smoking it then though, I wasn’t as bad and just went down and down and down, and on new year, I 
was with him, say about 2 years, 2011 I think it was, or 2010, and I just….in 2012 going to 2013 I cut 
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down totally then, I was only having like the end a 10 bag or something, and like 2 months into that 
or 3 months into that just swerved it off altogether, been off it like now 2 and a half years.” 
(Participant 5; male) 
 
“umm, I am, I have cut down lately, well over the last 6 months I’d say I cut down a bit, only because 
I’m coming at it with *support service* I’ve got a worker, so I’m, I wouldn’t say because of that it is 
helping a bit, but I’m just trying myself because I’m in college  so half the day I’m in college so I’m not 
smoking it where before I wasn’t in college so I was smoking all day, so bits like that that’s how I’m 
stopping” (Participant 9; female) 
 
Even when cessation occurs for a considerable period of time (for example:  6 months), 
participants noted that when they began using again, it was not to the same frequency as before. 
 
“I got one of those electric ciggies and I just decided to up and quit and I did quit for about 6 months 
but I started smoking weed again and that started me getting high again.” (Participant 10; male) 
 
4.4 Discussion 
The results of this study are discussed in relation to the four themes: Cannabis History; Cannabis 
Experiences; Cannabis Use Behaviour and Knowledge; and Cannabis Motivations and Cessation.  
Particular emphasis will be put on use intentions and how they influence behavioural outcomes, and 
how this information may inform indicated prevention.  Following the trajectory of use behaviour 
from initiation to problematic use outcomes, these results will be contextualised with consideration 
of drug normalization and drug instrumentalization frameworks (Parker, Aldridge & Measham, 1998; 
Müller & Schumann, 2011).   
The results of the interviews indicated that initiation of cannabis use was facilitated by social 
interaction, generally with friends.  These were broad social experiences in which initiation was 
invited by friends or peers and was not considered to be a planned event, but rather a casual, 
spontaneous experience.  Following the initiation of use, however, most interviewees reported a 
relatively rapid escalation to regular and self-defined problematic use and for many of the 
participants in this study, the escalation of use was quite rapid and that their use environment and 
experiences changed concurrently.  This suggests that specific risk factors may create a vulnerability, 
for some individuals, that leads to a propensity for the development of problematic use outcomes, 
and that these may be identifiable and inform future prevention efforts.  This discussion will explore 
the results of this study in regards to the ways and reasons for cannabis use, and how this 
information may inform indicated prevention. 
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4.4.1 Cannabis history  
4.4.1.1 Initiation of cannabis use 
Among participants in this study, cannabis initiation occurred in early adolescents and was mediated 
by social relationships with friends or partners.  Cannabis initiation, for example, has been 
associated with attending bars and not having organised leisure time for males, and cannabis-using 
friends in females (e.g. Perez et al., 2010).  These assertions are aligned with the results of this study, 
in which males reported general deviant behaviour prior to use as well as unorganised leisure time, 
while most female respondents reported having friends that were cannabis-users, often being the 
ones who facilitated the initiation of use.  The context of use, as described by participants, suggested 
an environment in which cannabis use was not, however, considered particularly deviant, although 
some references to ‘wrong crowds’ were made.  Additionally, the atmosphere of use was detailed as 
a causal initiation by friends, often at a house or in a park, with a group of friends.  The ways in 
which use occurred, casually and in situations in which the participant would frequently find 
themselves in, suggests that the development into frequent, habitual use was easily facilitated.  
Furthermore, as most participants reported positive, enjoyable experiences of use, it would further 
encourage the continuation of cannabis use behaviour with their social group. 
4.4.1.2 Cannabis development 
The development of use following initiation is an important factor in prevention, and how to identify 
and design interventions for those most likely to develop problematic cannabis use behaviours.  
Although a few participants noted that they did not adopt frequent, problematic cannabis use 
behaviours directly following initiation, the majority of participants discussed that they immediately 
began using cannabis frequently.  The rapid development of use frequency from initiation is an 
important factor for consideration.  The shift from initiation to frequent, habitual use suggests that 
there may be particular vulnerabilities that require intervention prior to use, or early in use 
trajectory.  Alternatively, in an environment of normalization, if social groups have access, resources 
and time to engage in cannabis use and report their experiences as positive, it is likely that use will 
become more frequent, especially if they have a lack of other commitments or responsibilities.  
However, although research on drug normalization for non-problematic users is needed 
(Hammersley, 2005), it is important to understand why the participants in this study developed 
problematic use behaviour, and how particular vulnerabilities or environment contributed.  
Furthermore, the identification of risk factors is important to the development of cannabis 
prevention efforts (Stone et al., 2012). Particularly, the differences among users with frequent, 
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habitual cannabis use, to those with infrequent, inconsistent cannabis use, which is less associated 
with problematic outcomes, and how social groups may facilitate the development of frequent, 
habitual cannabis use (Lee et al., 2007). 
The development of use behaviours highlights the importance of context of use on 
outcomes and consequences, and how social groups and environment can influence initiation and 
use development (Connell et al., 2010; Staff et al., 2010; Tucker et al., 2013).  However, as use 
developed, many interviewees reported that they began to use cannabis on their own, often before 
bed or to relax at the end of their day at school or work.  Understanding how cannabis use 
transitions from social to solitary use may be useful in evaluating use outcomes, with some research 
evidencing the association of solitary cannabis use and problematic use (Tucker et al., 2006; Noack, 
Höfler & Lueken, 2011; van der Pol et al., 2013c).  Both the participants with the most severe and 
least severe reported consequences associated with cannabis use, reported habitual, solitary use, 
thus solitary use shouldn’t be considered an indicator of problematic use.  Participants who reported 
the least severe of consequences and used cannabis in a solitary context, discussed that their use 
was ‘goal-oriented’ relaxing, a sleep aid or to improve their cognitive ability for tasks.  Furthermore, 
those participants often described use sessions that were, although frequent, less frequent and less 
intense than their peers, with a more clearly expressed intended outcome.  Other participants, who 
used in a solitary context but experienced self-described severe consequences due to their use of 
cannabis, tended to describe use that was throughout the day, albeit mediated by responsibilities, 
and often their primary focus.  This highlights the important of context, intentions and environment 
on use outcomes.   
 
4.4.2 Cannabis experiences   
4.4.2.1 Cannabis intentions 
In this study, the ‘over-instrumentalization’ of psychoactive drugs seemed to be an occurrence that 
happened quite quickly within the study population following the initiation of use.  Participants 
reported high frequency of use and a large financial burden of use from the onset.  Financial 
problems were associated with interest in cannabis treatment in previous research (Buckner, Ecker 
& Cohen, 2010).  Based on their self-reported lack of cannabis knowledge and intentions prior to the 
initiation of use, it is likely that the participants were ‘naïve users’ and would have lacked the drug 
knowledge to participate in ‘goal-directed’ use (Müller & Schumann, 2011).  In particular, the 
responses of the participants suggest that ‘recovery from and coping with psychological stress’ and 
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‘self-medication for mental problems’ were proximal mechanisms for which use was continued by 
respondents.  Unsurprisingly, cannabis is often associated with the reduction of stress (Boys et al., 
1999; Boys et al., 2001; Müller & Schumann, 2011) and cannabis is thought to contain chemicals that 
control the emotional impact of stimuli and aid in the reductive of aversive memories (Mechoulam 
et al., 1998; Marsicano et al., 2002).  It is likely that those with a predisposition of extreme 
psychological stress, and with little social resources to ameliorate their stress, may be especially 
vulnerable to exhibiting ‘over-instrumentalization’ of cannabis in order to assuage these stressors.  
Respondents noted that cannabis helped them to ease the psychological stress of memories, as well 
as make them feel ‘relaxed’ and relieved from the stresses they were under. Furthermore, although 
they didn’t specifically report any clinical diagnoses related to anxiety, depression or any other 
clinical mental health disorders, participants suggested that the use of cannabis was helpful in 
alleviating feelings of sadness and other symptoms associated with poor mental health.  This 
suggests that the participants were unable or unwilling to pursue any other options to ameliorate 
psychological stress, or had difficulty in carrying them out previously.  As a result, the 
instrumentalization of cannabis to mitigate the effects of psychological stress was over-
instrumentalized, with most participants expressing how important and useful cannabis was for this 
purpose.  Although there is still ambiguity regarding links between mental health, particularly 
around causality, the evidence does support an association between them, and how early initiation 
and frequency of use is associated with mental health outcomes (Van Ours & Williams, 2010; Van 
Ours & Williams, 2012; Copeland, Rooke & Swift, 2013; Degenhardt et al., 2013; Yuraseck & Hadley, 
2016).  More research focusing and how mental health, stress, and cannabis use are negotiated is 
needed.  
In addition to alleviating psychological stress, participants noted many other intended 
outcomes for cannabis use, and reported nearly all the described intentions in the 
‘instrumentalization’ framework apart from sexual facilitation.  Three participants noted how they 
used cannabis specifically to enhance their perception for artistic, creative endeavours. This is 
aligned with previous research in which self-reported creativity and cannabis use are described 
(Green, Kavanagh & Young, 2003; Hammersley & Leon, 2006), although evidence from laboratory 
experiments dispute this claim (Kowal et al., 2015).  Creativity through expanded perception horizon, 
along with self-medication and stress, and social facilitation seemed to be the most prominently 
described instrumentalized goals.  ‘Goal-directed’ cannabis use, however, was not constant for all 
participants.  All participants described use that was both ‘goal-directed’ and ‘over-
instrumentalized’, however when the goal of cannabis use was alleviation of psychological stress or 
self-medication of mental health issues, there was more likely to be a tendency for over-
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instrumentalization.  Further research is needed to understand the mechanisms for use in these 
‘goal-directed’ categories, particularly around cannabis use and creativity where there is 
substantially less evidence. 
4.4.2.2 Cannabis use outcomes and consequences 
Cannabis use motivations are often linked with use outcomes, and enjoyment/fun, conformity, 
experimentation, social enhancement, boredom, and relaxation are reported as some of the most 
common reasons for use (Lee et al., 2007).  It is important to consider motivations of use, because 
the ways in which use occurs is linked to use outcomes, and it also informs the ways in which 
prevention interventions can be disseminated.  Stress, as both a risk factor and a motivation for 
cannabis use, and stress-related factors are associated with cannabis consumption (Hyman & Sinha, 
2009).  Many participants described cannabis use behaviour motivation influenced by a desire to 
ameliorate stress and other psychological issues.  Although cannabis may be used to alleviate issues 
of psychological stress and other issues, like depression and anxiety, it seems that there may be a 
bidirectional relationship in which cannabis also exacerbates these issues.  Stress and coping models 
of addiction support this claim (Will & Hirky, 1996), as chronic cannabis use among young adults who 
use cannabis as a coping strategy are more likely to experience poor mental health, greater 
pathology, and distress than peers who use predominately for social reasons (Brodbeck et al., 2007). 
There does, however, seem to be a variety of both acute and long-term problems related to 
cannabis use (Karila et al., 2014), with this sample reporting acute effects related to outcomes 
directly from use and the ramifications of use related to continued use behaviour, including financial 
and social issues.  Although cannabis may help to assuage psychological stresses acutely and aid in 
sleep (Bonn-Miller, Babson & Vandrey, 2014; Kevorkian et al., 2015; Moitra et al., 2015), it seems 
that the ramifications of frequent use can contribute to additional issues around relationships, 
stigma and financial circumstances that result in psychological stress (Dahl & Heggen, 2014; Duff & 
Erickson, 2014; Liebregts et al., 2015).  It appears that individuals who are already in a vulnerable 
position due to their age and interaction with drug and homelessness services, are already more 
likely to have stressful lives, and that although cannabis is used to cope with stress, it also creates 
additional stressors.  It is likely that young people with more social capital, and less life stressors, 
would not experience the same degree of consequences due to their use of cannabis.  Although 
frequent cannabis users that are middle-class experience negative social and financial consequences 
related to use, it appears they do so to a much lesser degree than the participants in this study 
(Osborne & Fogel, 2008). 
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4.4.3 Cannabis use behaviour and knowledge 
4.4.3.1 Cannabis use frequency 
Frequency of cannabis use, particularly around the ways in which use is quantified and evaluated in 
young people, is critical to understanding cannabis use behaviour and its outcomes.  The 
identification of problematic cannabis users is often based on frequency of use, a technique that has 
been criticized as an oversimplified approach to assessing use behaviour, which largely ignores daily 
consumption and the context of use (Temple, Brown & Hine, 2010; Copeland, 2011; Patton, 2011; 
Earleywine, 2011; Hammersley, 2011; Andréasson, 2011; Asbridge et al., 2014).    Although the 
majority of users were habitual, daily users of cannabis (two participants quit cannabis, or used an 
alternative drug, like the legal high, ‘spice’), their patterns of use were varied, both by the degree of 
cannabis they consumed, as well as the amount of times they used per day.  In describing their 
cannabis use, there seemed to be considerable variation in use to the extent that it was difficult for 
the participant to gauge their own use.  Additionally, because users often share the cannabis they 
purchase with their friends, and also share cannabis offered to them by their friends (Coomber & 
Turnbull, 2007), it was difficult to estimate daily use.  Furthermore, because cannabis use frequency 
is often oriented around responsibilities and social factors (Hughes et al., 2014), use is quite variable.  
Although users discussed their daily use of cannabis, they also described fluctuations in the amount 
they purchased and used, and factors which contributed to these changes, including daily stressors 
and the amount of cannabis needed to achieve their desired level of intoxication, which is influenced 
by the intensity of their cannabis use (i.e. more intense use requires more cannabis to achieve the 
desired level of high).  The ‘over-instrumentalization’ of cannabis was not a constant among 
participants, but rather for most, something that intensified occasionally when dealing with 
particularly stressful situations or circumstances, or when they were without many responsibilities. 
4.4.3.2 Cannabis strains 
In addition to the frequency and intensity of use, the strain of use was important in the desired high 
and intended acute outcome of cannabis use.  Little research has been done investigating strain 
preference and use outcomes, although one study has shown preference among medical cannabis 
use for sleep problems (Belendiuk et al., 2015).  Participants frequently cited two strains of cannabis, 
Haze and Cheese.  Most, but not all, participants had preference for one or the other, with Haze 
being desired more frequently for perception enhancement and Cheese being desired more for 
relaxation.  Participants described that they initially sought out cannabis generally, but as they used 
more frequently and gained more cannabis knowledge and more experience, they developed 
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preferences and relationships with dealers who they believed would deliver the cannabis necessary 
to achieve their desired cannabis outcomes.  Some participants were more particular with what they 
desired, while others more willing to use cannabis even if it wasn’t the type they were originally 
seeking to purchase.  It appears that some users have very explicit rules that govern their cannabis 
use, including how they use and which strain they will use, while others maintain more flexibility and 
openness in their use behaviour.  
4.4.4 Cannabis motivations and cessation 
4.4.4.1 Motivations and barriers to behaviour change 
Although nearly all participants were in contact with drug services to modify their cannabis use, the 
level of commitment differed greatly between participants.  Some participants expressed that they 
were content with their current cannabis use behaviour, or expressed that they had already 
modified their use to a level that they believed was appropriate.  Other participants described 
intense use behaviour in which use modification or cessation seemed unlikely, yet desired, some 
described an ‘addiction’ or ‘dependency’ to cannabis.  Two participants ceased cannabis use with the 
assistance of local drug support services.  Evidence has highlighted the issues regarding drug 
treatment for cannabis in the UK, with type of treatment delivered, pathways to treatment, 
perceptions of cannabis risk by staff, and greater cannabis knowledge by clients all cited as issues 
(Monaghan et al., 2016). Most participants reported varied use histories, including times when they 
had cut down significantly, or used to a much greater extent, while one participant noted that they 
had completely quit, but eventually began using again, albeit to a much lesser degree.  Some 
participants noted that their use was more reflective of the stage of their life, and that they believed 
they would likely cut down and cease using when they had more responsibilities, like work and 
family.  Evidence has shown that cannabis use patterns are mitigated by work and leisure and often 
shift between dependent and non-dependent use (Osborne & Fogel, 2008; Liebregts et al., 2015).  
Acknowledgment of gender differences, particularly for female cannabis users, is an area in which 
development is needed.  Although some male and female participants discussed how adult 
responsibilities and family life would lead to cannabis use modification, the gendering of drug roles, 
and the specific differences experienced by female drug users is largely ignored (Measham & 
Williams, 2011).  In this study, for example, one female participant believed that only pregnancy and 
motherhood would lead to cannabis behaviour change/modification. 
A theme that emerged amongst participants was that a ‘scare’ that occurred from acute use 
would be a catalyst for cannabis use behaviour change (Ogdon & Hills, 2008).  This suggests that the 
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lack of immediate consequences as a result of acute use was a barrier to behaviour change.  
Alternatively, this explanation may be used by cannabis users in order to rationalise why they are 
unable to modify their use behaviour.   
4.4.5 Informing indicated prevention 
The results of this study aim to provide a better understanding of the shifting types of cannabis use 
and use transition among young people.  In addition to reporting cannabis to aid with feelings of 
psychological distress and self-reported mental health difficulties, the respondents of this study 
reported changes in the circumstances in which they used cannabis.  Rather than public, social 
circumstances of use, cannabis use behaviour eventually included ritualised, private use behaviour.  
Several participants discussed that use was necessary for them to feel well enough for them to 
engage in their day-to-day life.  Although many participants used cannabis in the morning if their 
responsibilities for the day allowed for it, only one described that this was imperative only a daily 
basis  This supports emerging evidencing linking solitary cannabis use and problematic use 
outcomes, although better understanding of the mechanisms of this relationship are needed 
(Buckner, Ecker & Dean, 2016; Creswell et al., 2015).  In addition to solitary use, the increased 
frequency of use to chase the ‘high’ experienced when one first starts using was described.  The 
‘buzz’ that inexperienced users feel when cannabis use is initiated eventually dissipates, yet 
interviewees had vivid memory of this experience and the chasing of this feeling encouraged their 
continued use of cannabis.  One participant noted, however, that thought this is experience of ‘high’ 
was sought the use of cannabis eventually evolved to one in which the intention was simply to ‘chill 
out’ or relax.  Use instrumentalization seemed to evolve from seeking a ‘high’ to a relaxation or 
alleviation of psychological stressors.  Although the motivation for enhancement (high) was not 
related to dependence in young, frequent cannabis users, parallels were found among boredom 
motivations and young people in other studies (Lee et al., 2009; Benschop et al., 2015) 
Recognising the potential vulnerabilities in the respondents of this study, and how their 
cumulative experiences are representative of the transition from non-addictive to problematic use is 
a key element in informing prevention programs.  This research provides evidence to suggest that 
psychological stress and mental health deficiencies may be a pathway for individuals to transition to 
problematic cannabis use, a shift that appears to be rapid.  Evidence from dependent and non-
dependent users has shown that while non-dependent users have similar mental health to the 
general population, mental health is worse for dependent users (van der Pol et al., 2013b).  
Instrumentalization frameworks suggest that a key function in the prevention of the transition from 
regular, non-addicted psychoactive drug users to addictive problematic use is to focus on ‘over-
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instrumentalization’, or a dependence on the drug to achieve major life goals (Müller & Schumann, 
2011).  Furthermore, it suggests that an overview of instrumentalization patterns and the use of 
psychoactive drugs to achieve life goals should be reviewed (Müller & Schumann, 2011).  Under the 
guise of this framework, one would need to look at three major aspects the psychoactive drugs users 
life course: the environmental and social factors, the personal factors associated with propensity for 
use (personality factors, mental health, beliefs and attitudes), and previous use behaviours, including 
the underlying intentions for their use, and the development and evolution over time.  Firstly, as 
residents of the UK, the respondents in this study were associated with an environment of 
normalization in which there was relatively easy access to and availability of cannabis, and initially 
indicated perceived public social acceptability.  Secondly, participants noted feelings of psychological 
stress and beliefs that their cannabis use aided them in alleviating psychological harms that they 
were experiencing.  Thirdly, the respondents reported that their use behaviour escalated to the 
point of frequent use, in which a large financial burden was placed on them, and that use behaviour 
resulted in problematic and unwanted outcomes, and more perceived stigma.  This suggests that in 
an ‘environment of normalization’ the keys to preventing the ‘over-instrumentalization’ of use is to 
focus on education and how to safely use psychoactive drugs similarly to how public health 
education encourages safe, responsible alcohol consumption. 
The instrumentalization framework postulates that psychoactive drug users need to be 
‘educated’ and ‘informed’ with specific intended outcomes for their use and titrate and negotiate 
their use accordingly.  This component is reflective of the ‘drug normalization’ theory which suggests 
youth and adolescent drug use is an interplay of human agency and social structure (Measham and 
Shiner, 2009).  The social structure, and the background for which ‘drug normalization’ exists, is 
evidenced by the growing landscape of drug availability in the UK (Downey & Verster, 2015).  Albeit 
drug use may be related criminal behaviour, drug gangs, and influence from gender, ethnicity, age 
and socio-economic background, the initiation of drug use is not bound by a deviant, low-
socioeconomic background, but permeates through all classes of society (Monaghan et al., 2015).  
Despite data that suggests many cannabis users will eventually transition, or ‘grow out’ of use as 
they age, a proportion of those who use cannabis may develop problematic/dependent use 
behaviours (Lopez-Quintero et al., 2010).  Applying the human agency element of the ‘drug 
normalization’ theory ties in with the emphasis in the instrumentalization framework that suggests 
that users must be ‘educated’ and make decisions regarding their use behaviour accordingly.  
However, although cultural perceptions of drug use may be normalized, the public health 
approaches and education provided for young people are largely based on the prevention of use and 
abstinence aims which lack information regarding the ‘safe’, ‘informed’ use of drugs.  This results in 
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a system in which drug availability and experimentation is frequent and ‘normal’, but information 
detailing the ways in which psychoactive drug use are safely used are not readily available or 
disseminated to young people.  This subsequently results in ‘naïve, uneducated’ drug users who 
initiate use based on information from other, unreliable sources. 
The implication of the intersection of the instrumentalization framework and ‘drug 
normalization’ theory for indicated prevention is the acknowledgement of specific vulnerabilities for 
the development of problematic drugs use and dependency and that human agency and ‘informed’ 
drug use behaviour may help to prevent the overinstrumentalization of use.  In both aspects, 
acknowledgement of human agency is critical in the development of indicated prevention.  In the 
context of ‘drug normalization’, particularly for cannabis which has the highest rates of use among 
young people, a large proportion of young people will experiment with cannabis and should be 
educated on the ways in which drugs are used and how to use them in a safe way.  Unlike education 
campaigns that focus on the dangers and pitfalls of recreational drug use, focus should be placed on 
allowing young people information that enables them to adopt and adapt to ‘healthy’ ways to use 
drugs, similarly to some alcohol education programs.  Furthermore, individuals with perceived 
vulnerabilities regarding the increased likelihood of developing problematic use behaviours, like 
individuals with high levels of psychological distress or mental health difficulties, may receive 
targeted prevention efforts tailored towards the risks associated with use and advice on how to best 
navigate the environment of ‘drug normalization’.  The interviewees in this study reported initiation 
into cannabis use and increasingly frequent use behaviour that was far from ‘goal-oriented’, but 
rather used as a tool to aid in coping with the stresses of life and to ‘escape’ from reality.  Although 
many of the users reported prolonged, frequent use of cannabis, when asked what they knew about 
the drug, and specifically about the cannabis they purchase, they often gave uninformed, unknowing 
responses.  Bridging the information gap among cannabis knowledge in an environment of 
‘normalization’ is likely to help prevent problematic use outcomes. 
In addition to lack of information regarding cannabis, respondents in this study 
demonstrated key vulnerabilities related to their problematic cannabis use behaviour and over-
instrumentalization.   Key vulnerabilities, like mental health factors and psychological distress, were 
likely to account for the overinstrumentalization of use by participants.  While most participant 
discussed that their use initiated with their peers as a social experience, this quickly shifted to a 
more solitary and increasingly frequent endeavour used to curb mental distress and as a coping 
strategy for difficulties, which eventually led to the creation of additional difficulties caused by 
excessive use.  Additionally, when respondents discussed their experiences of use behaviour, they 
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discussed several different reasons and resulting outcomes from their use.  Despite these differing 
circumstances, they were consistent in their accounts of a need for repeated and excessive use in 
order to relax or merely ‘exist’ and that in response to their use they experienced negative and 
problematic outcomes. 
Although vulnerabilities associated with over-instrumentalization of use as described by 
participants may be a promising avenue for indicated prevention, it is important to consider the 
context and environment of cannabis use among users, particularly among users who could be 
considered to be at the fringes of society.  In particular, participants in this study were in contact 
with homelessness services for young people and engaged in social programs are considerably more 
vulnerable than the general population.  
4.4.6 Risk factors suitable for targeting in the development of indicated prevention 
The association between psychological distress and cannabis use is not undocumented in the 
academic literature.  A systematic review of longitudinal general population studies assessing the 
relationship between illicit drug use and young people and psychosocial harms were inconclusive in 
finding a causal link between cannabis use and psychosocial harm (Macleod et al., 2004).  This 
research, however, looked specifically at the causal relationship of cannabis use that leads to the 
development of psychosocial harms.  Furthermore, the authors postulate that psychosocial 
problems are likely to be a precursor to problematic patterns of illicit drug use and that the use of 
cannabis may exacerbate pre-existing harms (Macleod et al., 2004).  More recent work has 
investigated the relationship between moral disengagement, psychological distress, resistive self-
regulatory efficacy and cannabis and alcohol use among young people in Australia and found 
evidence to suggest that higher moral disengagement and lower resistive self-regulatory efficacy 
were associated with initiating cannabis use, although psychological distress was not associated with 
cannabis initiation (Newton, Havard & Teesson, 2012).  The findings support theory that in an 
environment of ‘drug normalization’, high levels of moral disengagement and lower resistive self-
regulatory efficacy are associated with initiation of cannabis use.  However, the initiation of cannabis 
use in and of itself is a generally common and unlikely to be associated with problematic outcomes.  
Although preventing the initiation of use is certainly purposeful in preventing harms, based on 
prevalence data, preventing the escalation of problematic use is associated with more burden.  
Building on the association between psychological distress and substance use, an internet-based 
universal prevention campaign aimed at the harm minimisation of young people effective at 
reducing alcohol and cannabis use (Newton et al, 2009; Newton et al., 2010) was also found to 
reduce factors associated with use, including truancy, psychological distress and moral 
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disengagement (Newton et al,. 2014).  This provides evidence that prevention work has the potential 
to both curb excessive, or over-instrumentalized use, as well as the factors that may predate or 
exacerbate use behaviour.  Furthermore, this suggests that more tailored indicated prevention work 
for young people with increased vulnerability for developing problematic cannabis use behaviours 
may help to cease the transition to problematic dependent use while focusing on the underlying 
mechanisms to those behaviours. 
Levels of psychological distress may be an important factor in assessing whether individuals 
have vulnerability in developing problematic cannabis use outcomes.  Research looking at the 
relationship between self-harm, psychological distress and substance use found an association 
between current cannabis use and past year self-harm (Moller et al., 2012).  Although this research 
does not provide evidence to a causal relationship between cannabis and psychological distress, or 
the degree and frequency of cannabis use, it suggests that there may be association between 
cannabis and psychological distress.  Self-medication hypotheses and model pathways suggest that 
psychological distress, often stemming from trauma, may be often a precursor to substance misuse 
as well as exacerbate outcomes of use (Garland, Pettus-Davis, & Howard, 2013).  Although this 
research suggests that the outcomes of extensive and often violent traumatic events lead to more 
extreme substance misuse, it is likely that lesser perceived trauma and psychological distress could 
lead to more extreme, problematic levels of substance misuse as well.  In alignment with the ‘drugs 
as instruments’ framework, this suggests that the use of illicit substances to cope and deal with 
psychological stresses may become ‘overinstrumentalized’ to the degree to which use behaviour 
becomes problematic.  This evidence suggests that honing in on key vulnerabilities related to 
problematic illicit drug use outcomes and how these vulnerabilities evolve and intersect with use 
behaviour is critical in the development of indicated prevention work aimed at the reduction of 
harm and problematic use outcomes. 
4.4.7 Determining problematic use in an environment of normalization 
An environment, in which drugs are normalized, facilitates access and social acceptability of use.  
Cannabis use has reached the point of normalization in much of the western world, with the 
legalisation of use becoming increasingly more commonplace and as a result led to initiation and 
recreational use that is to a greater degree than other illicit drugs.  Perhaps as a result of the greater 
prevalence of cannabis use in relation to other illicit drugs, cannabis use is no longer considered a 
widely stigmatised behaviour.  By nature, this makes the differentiation between 
experimental/recreational use and problematic/dependent use difficult to ascertain.  Furthermore, 
this makes it difficult for prevention work, even within the context of a harm reductionist 
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perspective, difficult to maneuverer; determining harm of use, in a research environment in which 
all use is usually deemed problematic, unlike, for example alcohol, provides difficulty in sorting out 
problematic and unproblematic cases of use.  Furthermore, disseminating information, often to 
young people under the 18 years of age, about the ‘safe, healthy’ ways to use illicit drugs proves to 
be a moral conundrum.  Due to the cultural and social normalization of cannabis use in the United 
Kingdom, prevention work geared towards licit substances like alcohol and tobacco may be more 
relevant in adapting prevention work for cannabis consumption. Prevalence data suggests that the 
majority of cannabis users discontinue use as they age, likely due to growing responsibilities of 
family and professional lives, or possibly because frequent may be considered more stigmatised as 
one ages.  In order to provide appropriate education and prevention campaigns, research must work 
towards identifying and defining problematic cannabis use and designing programs that are oriented 
towards the prevention of problematic use outcomes.  Specifically, prevention work is saddled with 
the responsibility of creating programs that identify young people most at risk of graduating from 
experimental/recreational use to dependent/problematic use.  In an environment in which nearly a 
third of people under 25 years of age will initiate cannabis use, prevention work needs to 
acknowledge that use is likely among young people and equip them with the information and 
knowledge needed for them to make healthy, effective choices regarding their decisions and 
behaviours with cannabis. 
4.4.8 Conclusions 
Although this research was exploratory in nature, it provides a contextualisation to existing theories 
regarding the development of problematic cannabis use behaviour.  This research provides evidence 
to suggest that psychological stress and mental health are factors that may influence cannabis use 
outcomes, and create specific vulnerabilities in young people.  Further research investigating how 
young people navigate use in an environment where illicit cannabis consumption is illegal, yet 
relatively common, and how young people gain knowledge about how they use is needed.  This 
evidence would help to provide prevention work to limit and prevent problematic/dependent 
cannabis use behaviour among young people. 
4.4.9 Limitations 
Although this research did not specifically assess whether or not the participants of this study were 
clinically dependent on cannabis, participants were in contact with drug services and self-reported 
problematic cannabis use and a desire to cease, alter or receive assistance in continuing to be 
abstinent.  As a result, it is important to understand the association between problematic cannabis 
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use and mental health factors.  Specifically, to develop a better understanding of how cannabis use 
and mental health interact, and unravel the pathways of the development of both cannabis and 
mental health issues.  A systematic review of the evidence of cannabis use and the development of 
psychotic or affective mental health outcomes suggests that there is an increased risk for psychotic 
outcomes for cannabis use, but the evidence for affective mental health outcomes is less strong 
(Moore et al., 2007).  Reporting lifetime cannabis use had a dose-response effect with psychosis, 
while the findings for depression, anxiety and other clinical affective disorders were less consistent 
and addressing causality in those instances was more tenuous (Moore et al., 2007).  The comorbidity 
of substance use and mental health problems is becoming increasingly apparent, with research 
demonstrating that self-reporting last year substance use increasing the likelihood of having a co-
occurring mental health problem (Chan, Dennis, & Funk, 2008).  Additionally, young people (aged 
18-25) were the most vulnerable to co-existing substance use and mental health issues (Chan, 
Dennis, & Funk, 2008).  A more comprehensive understanding of how the mental health of the 
interview participants, and the state of their mental health prior to these interviews, would have 
provided a better understanding of how cannabis use affected use and how the two factors 
interacted. 
Research on young people, university students, suggests that of those who engage in 
cannabis 9.4% meet the criteria for cannabis use disorder (CUD) (Caldeira et al., 2008).  Furthermore, 
young people defined as at-risk (smoking cannabis more than 5 times in that past year), reported 
high levels of problems (Caldeira et al., 2008).  This provides further evidence that contextualising 
the instrumentalization of use among young cannabis users, both the frequency to which they use, 
the social circumstances around their use, and the intentions behind their use behaviour is needed.  
Furthermore, research regarding the life course of cannabis use for young people needs to be 
addressed.  Research suggests that although young people report frequent use, and even meet 
clinical levels of dependency, this might not translate into continued dependent use based on the 
dips of prevalence data that are reported.  This research focuses specifically on frequent, 
problematic users of cannabis, but the ‘frequent’ aspect of their use should not be considered 
synonymous with all cases of cannabis use behaviour.  Both frequent and infrequent cannabis use 
can be associated with problematic outcomes, and research addressing the circumstances and 
intentions around problematic outcomes is needed. 
This research provides evidence that cannabis use problems among young people can cause 
problematic use outcomes and exacerbate existing self-reported problems among young people.  
This research, however, focuses specifically on young people in touch with drug services who are 
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likely to have experienced greater cannabis-related problems than the majority of other users.  
Although this does not provide generalizability of ‘cannabis experience’, it does provide insight into 
how use may develop into problematic use.  Further research is needed on cannabis experiences of 
young people, particularly of young people who ‘instrumentalize’ use and experience limited 
problematic outcomes from their use.  Additionally, research on problematic outcomes for non-
frequent users would help to provide evidence of how information regarding ‘healthy, safe’ use 
could be disseminated. 
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Chapter 5 
General discussion 
The studies described in this PhD have sought to provide evidence to inform the feasibility of 
adapting current prevention programs for targeted, indicated prevention for those most vulnerable 
to developing problematic/dependent cannabis use.  This discussion will firstly review the studies 
conducted in this PhD and how they cumulatively add to our understanding of cannabis use, and 
prevention, particularly around risk factors associated with cannabis use behaviour.  Next, this 
discussion will briefly discuss the evidence that supported this research and what new insights this 
research has provided.  Lastly, this discussion will then provide recommendations for future 
directions for prevention work and research that will inform, and the best ways to negotiate these 
within the current framework of UK drug policy. 
5.1 The measurement of cannabis behaviour and factors associated with use 
A main topic addressed in Study 1 of this PhD was the exploratory analysis of factors 
associated with cannabis use outcomes, the measurement of these outcomes, and the relationship 
between associated factors and cannabis use outcomes. Longitudinal research has identified a 
multitude of factors associated with substance use (Beato-Fernandez et al., 2005; Belcher and 
Shinitzky, 1998; Beyers et al., 2004; Bränström, Sjöström, & Andréasson, 2008; Challier et al., 2000; 
Costa, Jessor & Turbin, 1999; Donovan, 2004; Hawkins, Arthur & Catalano, 1995; Hawkins, Catalano 
& Miller, 1992; Kandel et al., 1986; Kliewer & Murrelle, 2007; Labouvie & McGee, 1986; Newcomb & 
Felix-Ortiz, 1992; Oman et al., 2004; Ostaszewski & Zimmerman, 2006; Stone et al., 2012; Thompson 
& Auslander, 2007; White, Pandina & LaGrange, 1987). The results of this initial study indicated that 
factors predicting cannabis use outcomes such as measures of lifetime use, frequency of use, 
severity of dependency and problems associated with use behaviour varied significantly.  This 
indicates that cannabis use outcome measures, which provide insight to different aspects of 
cannabis use behaviour and user profiles, and the factors associated with them, are different.  Thus, 
when using evidence from studies to inform prevention, the consideration of cannabis use 
measurement in identifying the population in which interventions should be aimed, and the factors 
appropriate for targeting that population is critical.  Cannabis use measurement is currently a hotly 
debated topic (Temple, Brown & Hine, 2010; Copeland, 2011; Patton, 2011; Earleywine, 2011; 
Hammersley, 2011; Andréasson, 2011; Asbridge et al., 2014).  Emerging research on cannabis use 
behaviour has sought to use new strategies for measuring cannabis use, including more detailed 
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assessments of intoxication, potency and frequency (van der Pol et al., 2011; van der Pol et al., 
2013a; van der Pol et al., 2013b; van der Pol et al., 2013c; van der Pol et al., 2014; Hughes et al., 
2014; Ansell et al., 2015; Asbridge et al., 2014).   This study and the corresponding review of the 
analysis provided the basis for additional studies completed in this PhD and highlighted the 
importance in considering cannabis use measurement when extrapolating evidence to inform 
indicated prevention interventions.   
One of the key aims of this PhD was to provide evidence to potentially inform indicated 
prevention for cannabis use among young people at-risk for developing problematic and/or 
dependent use behaviour.  By looking at multiple cannabis use outcomes, the work examined how 
factors associated with use were related to different outcome measures.  Thus, factors that were 
related to assessment of cannabis use (lifetime use history, frequency of use, and problems related 
to use) differed within the same population of users, although some of the factors were associated 
with multiple assessments of cannabis use behaviour.  Results indicated that cannabis use outcome 
measures most associated with problematic behaviour, including assessment of problems associated 
with use, severity of dependence, and frequency of use, indicated the mental health symptomology 
was a potential pathway for targeting problematic users in this sample. 
Based on the results of study 1, psychopathological symptomology was considered an 
avenue to explore in the development of indicated prevention approaches, although the relationship 
identified within the research did not suggest causality.  However, additional analysis, a latent class 
analysis of the population grouped by severity of mental health symptomology, showed that in 
groups reporting greater severity of mental health symptomology, there was an association with 
(non psychopathological) problems associated with cannabis use behaviour.  It is possible that 
greater use of cannabis leads to greater mental health problems; however, it is more likely that 
there is a bidirectional relationship between mental health and cannabis use.  The association 
between mental health and cannabis use is well-documented, although issues regarding causality 
and confounding factors make interpretation difficult (Degenhardt et al., 2012; Copeland, Rooke & 
Swift, 2013; Schubart et al., 2013).   Regardless, the relationship between mental health 
symptomology and cannabis use suggests that these constructs interact and influence each other, 
and although there is large literature on the relationship psychopathology and cannabis, a greater 
understanding of how mental health effects use behaviour and the implications for the development 
of prevention interventions are needed (Degenhardt, Hall & Lynskey, 2003;Macleod et al., 2004; 
Jané-Llopis and Matytsina, 2006; Moore et al., 2007; Lev-Ran et al., 2014). 
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5.2 Implicit cognition measures and cannabis use behaviour 
Following the completion of Study 1 for this PhD, an additional experimental study was 
designed, further developing on the conclusions derived regarding cannabis use outcomes 
measurement and mental health symptomology.  In order to refine the model of cannabis use 
behaviour measure and mental health symptomology, implicit cognition measures were assessed 
and the relationship between mental health symptomology, implicit cognition measures and 
cannabis use behaviour was explored.  Implicit cognitions are unaware, uncontrollable, fast 
mechanisms that underlie behaviour, and the measurement of this allows to researchers to examine 
the beliefs and feelings that cannot be wholly expressed by explicit, self-report measures which rely 
on participant introspection (Nisbitt & Wilson, 1977; Roefs et al., 2011).  The relationship between 
implicit cognitions and substance use has been documented (Rooke, Hine & Thornsteinsson, 2008; 
Stacy & Wiers, 2010; Wiers et al., 2015), although research on implicit cognitions and cannabis use is 
less extensive (Ames, Zogg & Stacy, 2002; Field, Mogg & Bradley, 2004; Ames et al., 2005; Field, 
2005; Field et al., 2006; Dekker et al., 2010; Cousijn, Goudriaan & Wiers, 2011; Beraha et al., 2013; 
Cousijn et al., 2013; Schmits et al., 2015).  Results have shown varied results with cannabis users 
showed lesser negative implicit associations with cannabis-related words than non-users (Field, 
Mogg & Bradley, 2004), heavy cannabis users have demonstrated a stronger implicit positive-arousal 
association with cannabis (Beraha et al., 2013), no correlation between implicit cannabis association 
and cannabis use in young adulthood (Dekker et al., 2010) and negative implicit expectancies with 
cannabis having a negative relationship with cannabis frequency and problems in adolescents 
(Schmits et al., 2015). 
The population for this study, unlike the general student population of the first, consisted of 
weekly cannabis users.  This sample was chosen in order to understand differences among frequent 
cannabis users and to try and identify which users might be most likely to develop problematic use 
behaviours, and to apply more sophisticated measurements of cannabis use behaviour.  In other 
studies looking at dependent and non-dependent cannabis users, factors, including current 
problems and mental health, had a stronger association with dependence and problematic use than 
the current study (van der Pol et al., 2013a; van der Pol et al., 2013b).  Two additional components 
were added to the design for Study 2: additional measurements of cannabis use behaviour and tests 
of implicit cognitions and cannabis-related stimuli.  Additional measurements of cannabis use 
behaviour were used in order to get a better understand of behaviour, and how other dimensions of 
use, such as the amount of cannabis used per joint, related to factors associated with use and other 
measures of cannabis consumption.   
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The addition of implicit measures aimed to provide evidence regarding cannabis use 
decision-making and how use was related to cannabis stimuli among frequent cannabis users.  As 
evidenced by the Study 1 of this PhD, the measurement of cannabis consumption and behaviour 
provides is crucial in understanding the development of problematic use behaviour.  To provide a 
better understanding of how cannabis is used, amongst the population that reported use of cannabis 
joints, participants were asked to roll joints (a cannabis substitute was provided) to estimate the 
amount of cannabis and tobacco typically consumed.  Additionally, participants were asked 
questions about their joint rolling behaviour, including: who rolls their joints and the variability 
amongst the joints they smoke.  This provided evidence of the variation of cannabis use behaviour 
among frequent cannabis users, and emphasised the need for more evidence regarding decision-
making and use behaviour amongst frequent cannabis users.  This is important in differentiating 
cannabis user profiles and identifying characteristics of frequent cannabis users most vulnerable to 
developing problematic outcomes due to their use.  Although the variation among cannabis use 
behaviours did not indicate differences in problematic outcomes or composite measures of use, 
results indicated that there were considerable differences amongst use patterns and behaviours in 
this study.   The rationale for this study was to provide evidence leading to inform better ways to 
identify and target individuals who may be appropriate for indicated prevention interventions. 
Subsequently, this evidence would address the potential of new, emerging methods in disseminating 
prevention interventions like bias modification (Boendermaker, Prins & Wiers, 2015; Boffo et al., 
2015; Wiers et al., 2015).   
In addition to the development of cannabis measurement, implicit cognition tests were used 
in an attempt to assess the use of new measurement techniques to inform prevention efforts.   This 
work examined how frequent cannabis users responded to cannabis stimuli, their association to that 
cannabis expectancies, and their ability to regulate implicit cognitions.  Although the results 
indicated that implicit measures used in this study did not add to previous models of cannabis 
consumption and associated factors of use, this avenue of research should not be discontinued.  The 
relationship between implicit associations and drugs has been well-documented, with links identified 
in a range of populations (Ames, Franken & Coronges, 2006; Rooke, Hine & Thornsteinsson, 2008; 
Stacy & Wiers, 2010).  Despite advances in our understanding of neuroadaptive changes resulting 
from drug use (Bechara, 2005; Bechara, Dolan & Hindes, 2002; Everitt, Dickinson & Robbins, 2001; 
Everitt et al., 2008; Volkow & Fowler, 2000; Adinoff, 2004), implicit cognitive measures and their 
influence on processes of addictive behaviour are still new and underdeveloped (Ames et al., 2013).  
Research using fMRI and implicit association tests showed neural activity consistent with dual 
processes framework in a sample comparing non-users and users of cannabis (Ames et al., 2013). In 
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the sample for this study, cannabis users were not compared to non-users, unlike other studies 
which have used the SC-IAT for cannabis expectancies (Dekker et al., 2010; Beraha et al., 2013)  
Differences in results might therefore have been due to the lack of an external drug naïve control 
group to compare with cannabis users.  In both of those studies, significant negative implicit 
associations were shown in both cannabis users and controls (Dekker et al., 2010; Beraha et al., 
2013), while higher weekly cannabis use was associated with negative implicit associations in 
(Beraha et al., 2013).  Methodological issues could explain differences in results, including the ‘figure 
ground effect’, the noticeability salience of stimuli as the cause of IAT effect not implicit attitudes 
(Rothermund & Wentura, 2004).  Results in other similar studies (Dekker et al., 2010; Beraha et al., 
2013) may be the results of ‘figure ground effects’, although alcohol-arousal effects could not be 
explained by ‘figure ground effects’ in one study (Houben & Wiers, 2006).  Furthermore, the 
relationship between extra-personal associations, like cultural norms, may, at least in some part, 
contaminate the IAT effect (Houben & Wiers, 2007).  Furthermore, it is possible that the homogeny 
in cannabis use behaviour did not warrant significant differences in implicit expectancy association 
and affect regulation, although differences were detected in explicit expectancy measures.  Further 
development of the measurement of implicit cognitions may provide better tests, and it is possible 
that the ways in which cannabis influences brain behaviour, including memory and reaction times, 
might muddy the ability for these test to accurately assess the construct.  Regardless, this evidence 
shows that there are considerable differences amongst frequent cannabis users, and evidence is 
needed to understand how these differences contribute to different use trajectories and the 
development of associated problems. 
5.3 The experiences of young problematic cannabis users in services 
Evidence provided in the first two studies of this PhD indicated that a focus on more detailed 
cannabis use behaviour measures to better identify and understand problematic cannabis use 
development in young people is needed.  The strengths of using assessment of psychopathological 
symptomology as a tool for targeting those most vulnerable was identified in those studies.  An 
additional study was designed to contextualise these results and gain a better understanding of how 
problematic use developed and evolved in young people.  The final study of this PhD consisted of 
interviews with young people in contact with drug and housing services, and identified by staff as 
young people with current or previous problems due to their use of cannabis.  The aim of this study 
was to provide an understanding of use behaviour and its development over time, and was framed 
in references to normalization and instrumentalization theories.    
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As described in Section 4.1.4, according the normalization thesis, the UK cannabis 
environment posits a culture in which cannabis use is not particularly stigmatised for many young 
people (Parker, Aldridge & Measham, 1998).  Cannabis has a significant cultural presence, with 
considerable references in TV, film, music and literature (Manning, 2007).    In fact, a large minority 
of young people will use cannabis casually and will never develop problems from their use (Lopez-
Quintero et al., 2010).  This climate of normalized cannabis use makes it important for prevention 
researchers to identify those most likely to develop problems as a result of their use, and develop 
and design interventions to target those individuals and respond to their specific vulnerabilities.  The 
normalization framework, however, is not without criticism.  The normalization framework has been 
described as the conflation of ubiquitous drug experimentation with less common use (Shiner & 
Newburn, 1999), an oversimplified framework that ignores socioeconomic status among other 
factors (Shildrick, 2002), and while others have pointed its reliance on multidimensional factors of 
drug taking and cultural norms (Perreti-Watel, 2003).  Despite public opinion of cannabis that is 
increasingly liberal and pragmatic (Gould & Stratford, 2002), the perceived perception of use seems 
to effect cannabis users.  Parker, Aldridge & Measham (1998) argued that drug decisions are based 
on a cost-benefit system, in which enjoyment is weighed against potential risks and harms, like social 
disapproval, criminal justice sanctions and health issues (Aldridge, Measham & Parker, 2011; Shiner 
& Winstock, 2015).  Several studies have examined how this cost-benefit system is experienced, and 
how the stigma associated with use is negotiated and managed by cannabis users through various 
means (Shiner & Newburn, 1997; Sandberg, 2012; Järvinen & Ravn, 2014; Duff & Erickson, 2014; 
Hathaway et al., 2015).  This work highlights that despite increasing liberal public opinion, stigma 
and perception of cannabis use still impact on users. 
Interviews with young people identified as problematic, or former problematic users of 
cannabis, detailed their use history and their development of problematic use behaviours.  These 
results indicated that cannabis was readily available to most young people and that for most who 
developed problematic use behaviours, their use quickly developed into self-described problematic 
use.  The development of use, as described by young people in contact with drug and housing 
services, and its problematic nature corresponded with a multitude of contributing factors, including 
self-described stress and mental health symptomology.  Furthermore, the use of cannabis seemed to 
coexist with other deviant behaviour and unstable environments lacking structure.  These 
interviews, however, further emphasised the bidirectional relationship between cannabis and 
mental health symptoms, and a relationship in which cannabis was used to alleviate these 
symptoms, yet also contributed to them.  The interviews with young people provided insight into 
how cannabis was negotiated in their life, and as well as the types of problems experienced because 
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of use.  Of particular note was how the participants described few problems as a result of acute use, 
but rather noted how the lifestyle of being a cannabis user was one of the most disruptive elements, 
particularly regarding finances, employment and relationships.  This suggested that perceived 
normalization may not exist for the participants in this sample. 
The perceived normalization the participants experienced is highlighted by the mixed 
messages of cannabis use by UK drugs policy and media reports.  In the United Kingdom, there is 
currently increasing debate regarding drug use, and to a large extent the use of cannabis, and the 
public policy framework that dictates the rules and regulations on its use, production and 
distribution.  A general review of the past 20 years of cannabis research outlined dependence and 
the physical and mental harms that could result from its use (Hall, 2014).  This review of 
epidemiological data on cannabis use and its effects suggested that cannabis use likely increases the 
risk of physical, particularly cardiovascular health, can produce dependence, and is likely cause or 
exacerbate mental health and other psychosocial harms (Hall, 2014).  Although this evidence was a 
collation of previous evidence supporting these claims, these results were sensationalized in the 
media, with a Daily Mail article titled, ‘The terrible truth about cannabis: Expert's devastating 20-
year study finally demolishes claims that smoking pot is harmless’ (Daily Mail, 2014). In addition to 
this article, general media representations presented an image of the dangers of cannabis, and 
likening its use to other, potentially more harmful illicit drugs, like heroin.  This sensationalism is 
representative of the media perception of cannabis, how it is presented in the media, and why it 
becomes difficult for public health to disseminate accurate information to best inform and advise 
people on health behaviour.   
Despite the majority of mainstream media publications comparing cannabis use to heroin, 
the Guardian has produced several articles recently discussing drug policy and its effects on use 
behaviour, and the Observer recently printed a spotlight on drugs that invited academic researchers 
to highlight current issues and trends regarding illicit drug use in the United Kingdom.  ‘The Guardian 
view on drugs policy: time for the politicians to study the evidence’ highlights recent data from the 
home office that suggests drug policy has little effect on use behaviour of illicit drugs, but does effect 
costs, while The Observer ‘Drugs Uncovered 2014’ provided current public perceptions of drugs, 
current emerging trends, and data that paints an accurate depiction of current use behaviour in the 
UK (The Guardian, 2014; The Guardian, 2014a).  The contrasting information, the misinformation, 
and the differing ways in which cannabis knowledge is presented in the media provide a very 
confusing message about illicit drug use, particularly that of cannabis.  The ways in which the media 
present knowledge about drug use and perception will surely influence young people’s drug use 
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behaviour.  Recognising the conflicting and confusing messages disseminated by the media is an 
important aspect in considering how to proceed with prevention efforts, especially in an 
environment where cannabis use is so prevalent among young people. 
The current UK Drugs Strategy aims to reduce demand and restrict supply of illicit drugs 
while building recovery in communities.  To achieve these goals, the strategy aims to reduce illicit 
and other harmful drug use and increase the number of people recovering from drug dependence 
(Home Office, 2010).  One way in which the UK Drugs Strategy tackles these aims is by the 
classification which designates penalties for possession, supply and use of drugs.  The classification 
of cannabis has undergone changes in recent years, with the Advisory Council for the Misuse of 
Drugs recommending a reduction in the severity to Class C that was followed through, only to be 
overturned under pressure from politicians and reinstated as a Class B substance.  The 
reclassification of cannabis, followed by its return to its original classification, did not produce any 
differences in prevalence rates.  It’s likely that this return to its original classification only produced 
greater effort for police in enforcing drug laws as well as penalising and imposing judicial harms on 
low-level users.  This policy shift also represents a considerable difference compared to the rest of 
global cannabis policy which has been increasingly shifting towards more liberal policies.  The UK 
Drugs policy landscape is a series of confusing and contradictory claims and practices that is likely to 
make decision-making for young people difficult.  Oscillating drug policy coupled with fear 
mongering media assertions in an environment in which ‘drug normalization’ exists, particularly with 
cannabis, sends mixed messages regarding cannabis use. 
The culminating interviews from this study provide considerable insight into problematic 
cannabis users, their relationship with cannabis, and how use-related problems develop.  These 
results, due to the sample of cannabis users in touch with social support services, are not 
generalisable to the general population, but may still provide insight into mechanisms of drug 
instrumentalization and drug normalization.  Most interviewees described cannabis use which was 
oriented around responsibilities, and used to alleviate stressors and relax, and rarely used in an 
indulgent manner or to party.  This is similar to research on socially, integrated cannabis users in 
Canada (Duff & Erickson, 2014).  However, many participants described times when they were 
particularly stressed or dealing with difficulties, they had the propensity to over use cannabis in 
order to escape or cope with their problems.  This, however, was in direct contrast to work on 
socially integrated cannabis users in Canada who reported restricting use during times of stress (Duff 
& Erickson, 2014).  This behaviour tended to exacerbate their current problems because of the 
financial implications, and tensions that arise from perceptions of use from friends or family 
  
158 
 
members.  Thus, it is possible that the ‘rules’ enforced about use by socially integrated cannabis 
users protect them from problematic outcomes, and the development of such ‘rules’ could be 
beneficial to young people.  Furthermore, this is consistent with research that looks at socially 
integrated and disintegrated drug users (Järvinen & Ravn, 2014).  This research has shown that 
among drug-using youth, social interaction is both a motivating factor and protective factor for use, 
although it is possible that use, in and of itself, is the cause of the disintegration (Järvinen & Ravn, 
2014).  A better understanding of how individualised, disintegrated use, and how this develops (as a 
precursor to treatment, or as a result of treatment) and how this effects use development is needed.  
Furthermore, there was a split among participants and their intended future use behaviour, with 
some believing that use would naturally diminish or cease as they develop family or career 
responsibilities, with others believing it would be difficult to stop using and aren’t sure it is 
attainable for them.  This highlights the variation of cannabis users in touch with drug services, 
including varied use intentions and treatment needs (Hamilton et al., 2014). 
5.4 Cumulative results and how they inform indicated prevention 
The culminating evidence from this PhD suggests that a variety of factors are associated with 
problematic cannabis use, particularly environmental factors, cannabis instrumentalization, and 
mental health symptomology.  Although evidence from Study 1 showed associations between 
cannabis use and mental health symptomology and other factors, more in-depth analysis was 
conducted to explore the nuances between cannabis user behaviour and associated factors.  In 
Study 2, emphasis was placed on frequent cannabis users, at least weekly consumption.  Results 
indicated considerable variation among use patterns.   Cannabis use behaviour, however, was not 
associated with implicit cognitions as hypothesised, which did not contribute significantly to 
differences in problematic cannabis use outcomes; explicit expectancies and mental health factors, 
however, were associated with cannabis use outcomes.  In order to develop a better understanding 
of how problematic use developed and how use was negotiated by habitual cannabis users, in-depth 
interviews were conducted with problematic cannabis users in touch with drug and housing social 
services.  Through these interviews, evidence gleaned that problematic cannabis use tended to be 
exacerbated by mental health symptomology, although there was a duality to use, which was often 
used to alleviate mental health symptoms as well.  The results suggested that use often became 
problematic when their environment or life was particularly stressful, and that cannabis use tended 
to become overinstrumentalized as a result.  Participants noted that their cannabis use was quite 
variable, shifting from self-described problematic to non-problematic use tendencies depending on 
personal factors. 
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Indicated prevention for cannabis must be oriented around the targeting of individuals most 
likely to develop dependency or problematic behaviour.  The results of this PhD indicate that mental 
health symptomology may be a suitable construct to target and design such interventions.  However, 
additional evidence is needed to understand the underlying mechanisms for which this relationship 
is bound.  Results suggest that although mental health symptomology may be related, this 
relationship appears to be multifaceted, with cannabis alleviating symptoms and exacerbating 
problematic cannabis use, sometimes simultaneously.  Interviews with young, problematic cannabis 
users suggest that the overinstrumentalization of use leads to problematic outcomes, and that 
anxiety and depressive symptoms, particularly, are often the root of overinstrumentalized 
behaviours.  This result is similar to work looking at coping motivations and distress intolerance and 
cannabis use.  Distress intolerance is conceptualised as substance use that is motivated by the 
avoidance or reduction of negative affect states (Baker et al., 2004).  This coping mechanism is linked 
to more frequent and problematic use (Cooper, 1994; Hides et al., 2008; Johnson et al., 2010), and 
cannabis users with greater distress intolerance are more likely to use cannabis to cope than more 
tolerant individuals (Potter et al., 2011; Simons & Gaher, 2005; Zvolensky et al., 2007).  This 
relationship appears to be more powerful for women than men (Bujarski, Norberg & Copeland, 
2012).  Although coping mechanism and the propensity to adopt coping mechanisms for use may be 
related to problematic use, the results of this analysis of young people in touch with social services 
highlight that cannabis use is variable, and that coping motivations to use cannabis are also variable.  
Prevention efforts targeted around cannabis use and goal-directed use and coping mechanisms must 
address the variability of use intentions and outcomes.  Indicated prevention strategies, akin to 
alcohol based prevention work which proposes limits to drinking, might be useful in informing young 
people and their cannabis use behaviour, particularly those with distress intolerance vulnerabilities. 
In addition to informing prevention efforts, this PhD provided evidence that measurement of 
cannabis is critical in understanding patterns of use and understanding the development of 
problematic user behaviours (Temple, Brown & Hine, 2010; Copeland, 2011; Patton, 2011; 
Earleywine, 2011; Hammersley, 2011; Andréasson, 2011).  Problematic cannabis use, however, 
should be measured not merely by frequency of use, but also by intended outcomes of use, patterns 
of use, and problems experienced as a result.  Frequency of use, although associated with cannabis-
related problems, is too broad to encompass the nuanced characteristics of cannabis use behaviour, 
which should include potency, number of joints, and more detailed patterns of use.  Emerging 
evidence showing differences among non-dependent and dependent frequent cannabis users 
demonstrates the need for a greater understanding of the nuances of cannabis patterns, and how 
they inform user profiles and use outcomes (Hughes et al., 2014; van der Pol et al., 2014; van Laar et 
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al., 2013; van der Pol et al., 2013b).  Particularly when designing indicated prevention, it is important 
to understand how risk factors, which may be used for identifying individuals at risk for developing 
problematic use behaviour, are related to cannabis outcomes measures.  Results from Study 1 of this 
PhD demonstrate that although some risk factors relate to multiple cannabis outcome measures, 
they measure different aspects of cannabis use behaviour.  With evidence suggesting that focusing 
on problematic user may be the most appropriate pathway (Davis et al., 2009; Thake & Davis, 2011; 
Zeisser et al., 2012; Asbridge et al., 2014).  This research suggests that focusing not only on 
problematic users, but on the mechanisms associated with specific problematic cannabis use events, 
may be the best way to inform indicated prevention efforts and advise young people at-risk how to 
negotiate and manage their cannabis use behaviour. 
5.5 Novelty of this PhD 
This PhD provides evidence of risk factors associated with problematic cannabis use in young people, 
and the importance of how cannabis use assessment on the identification of consequences and 
predictors of use.  Specifically, the findings of this work contribute to literature on the relationship 
between psychopathology and problematic cannabis use behaviour, and the importance of use 
incorporating theory and frameworks such as instrumentalization to better understand patterns and 
outcomes of use.  Furthermore, this work shows that implicit association tests do not significantly 
predict cannabis use involvement.  This suggests that implicit association tests, as operationalised 
here, are not suitable for identifying young people at-risk for developing problematic use 
behaviours.  Considering the underlying mechanisms for these patterns and outcomes of cannabis 
use are important in understanding how cannabis use develops, and the potential for harmful 
outcomes.  Finally, it shows the importance of wider societal responses to cannabis use by some 
user groups, and the potential role of stigma in the development of problematic patterns and 
outcomes of use among young people.   
5.6 Policy implications 
 So what does public policy regarding cannabis use mean in relation to the evidence 
produced by this PhD?  Information regarding cannabis use must be particularly confusing for young 
people, as laws regarding its use vary widely by country, with media depictions of medicalised use 
and other legalised use, and wide-ranging media depictions (e.g. Hughes, Lancaster & Spicer, 2011; 
Lancaster et al., 2011).  Varied media representations and perceptions of cannabis use coupled with 
prevention that focuses on harm reduction and abstinence towards cannabis equip young people 
with little information regarding cannabis use and its effects (Rosenbaum, 2016).  Cannabis legality 
  
161 
 
shifts in the United States have opened a discussion about science and reality based prevention 
approach akin to alcohol (Rosenbaum, 2016).  The results of this study indicate that, even among 
problematic users of cannabis, knowledge and cannabis use behaviour and experiences vary widely.  
Furthermore, most young frequent users of cannabis learn about use from their experiences and 
from their peers, with evidence suggesting that cannabis users may have more knowledge than 
those delivering treatment (Monaghan et al., 2015).  Interviews with problematic users 
demonstrated that use could be overinstrumentalized, often in times of extreme stress.  Learning to 
negotiate use to avoid overinstrumentalization seems critical in preventing frequent cannabis users 
from experiencing problematic use outcomes.  Unlike socially integrated users in Canadian samples 
(Dahl & Heggen, 2014; Duff & Erickson, 2014; Järvinen & Ravn, 2014), it appears that young people 
in services lack the ability to moderate their use behaviour to avoid problematic outcomes.  Thus, it 
would seem that educating young people on the effects of cannabis and how to use ‘safely’ use 
might prevent young people from experiencing problematic outcomes.  More research regarding the 
relationship between distress intolerance, coping motivations for use and instrumentalization, and 
patterns and outcomes of cannabis use is needed to inform potential prevention programs. 
In the UK prevention is bound to drug policy and the legality of cannabis.  Particularly in the 
delivery of universal prevention, it is unlikely that informing young people about how to safely use 
cannabis is a potential avenue.  An alternative approach might be reality, science-based education 
for young people on how cannabis effects mental health and the effects of excessive use.  The 
evidence of this PhD showed an association between mental health symptomology and problematic 
cannabis use outcomes.  Acknowledgment of how problematic use develops, in addition to how 
cannabis use works in legalised environments, including medicalised routes, might be helpful in 
informing young people, particularly in highlighting the bidirectional relationship between mental 
health and cannabis.  More evidence, however, is needed regarding the relationship between 
cannabis use behaviours, including more detailed measurement, and mental health.  It is likely that 
prevention focusing on abstinence will be ineffective in preventing problematic use, particularly 
when a large minority of young people experiment with cannabis and never experience problems, 
and global perceptions of cannabis and legal frameworks have an increasingly liberal approach.  
Furthermore, interviews with young people in social services suggest that those with less social 
capital and resources may be more vulnerable to experiencing problematic use outcomes.    
5.7 Recommendations for future research and prevention 
The culmination of this PhD provides evidence to inform the development, design and 
dissemination of indicated prevention for young people in the UK.  Looking at risk factors associated 
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with problematic use outcomes, implicit cognitions and memory associations with cannabis-related 
stimuli contextualised within the environment of drug normalization as described by young people 
identified as problematic cannabis users in touch with drug and housing social services, this evidence 
suggests that there is a need for indicated prevention efforts, and that they need to be adapted 
greatly from current frameworks of prevention (Home Office, 2010, Home Office, 2015b).  In 
identifying young people most at risk for developing problematic cannabis use, looking at risk factors 
that relate to cannabis use outcomes indicative of problematic use, stages of risk, is key (Hines et al., 
2016).  In identifying young people for indicated prevention for problematic cannabis use, factors 
associated with mental health symptomology might be useful, while measures of implicit cognitions 
are likely not appropriate.  Implicit cognitions and the potential of bias modification for young, 
problematic cannabis users, however, is an area of research that needs further exploration.  In 
designing and implementing targeted interventions, consideration of the instrumentalization of use 
may be helpful in identifying how problematic use develops in the context of the use environment, 
particularly around stigma and support, should be addressed. 
 The UK drugs environment is one in which cultural and media representations of use 
fluctuate between normalization to similarities with heroin (Daly & Sampson, 2012).  Furthermore, 
public policy places considerable restrictions on cannabis use and places it as a more serious criminal 
offence than many other similar countries where legalisation for medical and non-medical purposes 
is becoming increasingly common (Hunt & Stevens, 2004; Pacula et al., 2014; Coombes, 2014; 
Monaghan, 2015).  Although prevalence rates for cannabis initiation are high, use diminishes in the 
UK with age and a small portion of those that use cannabis develop problematic, dependent use 
behaviours (Home Office, 2015a; Burton et al., 2014).  Despite this evidence, the majority of 
research and prevention in the UK is focused on universal prevention programs that are aimed at 
both the prevention of initiation and the reduction of harmful use (Foxcroft et al., 2003; Faggiano et 
al., 2008; Lemstra et al., 2010; Norberg, Kezelman & Lim-Howe, 2013; Faggiano et al., 2014).  
Programmes are needed that focus specifically on the most vulnerable groups, those most 
susceptible from developing dependent, problematic use (Tait, Spijkerman & Ripe, 2013).  The 
evidence provided in this PhD suggests that risk factors associated with sub-clinical levels of mental 
health, particularly anxiety, may be suitable for targeted intervention.  Furthermore, young people 
susceptible to ‘over-instrumentalizing’ their cannabis use, possibly as a coping strategy, may be 
particularly vulnerable.  This research also highlights that implicit cognitions regarding cannabis do 
not appear to be a suitable the identification vulnerable young people for prevention.  Rather, 
prevention should focus explicit, self-reported intentions, beliefs and knowledge regarding cannabis 
and its related use behaviour and how young people negotiate these constructs in an environment 
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of normalization.  Additionally, it should be considered that young people that have problematic 
cannabis use may be experience problems due to other vulnerabilities, like mental health difficulties, 
familial problems, or other issues.  Consideration of these vulnerabilities and unthreading the 
interaction between cannabis use behaviour, mental health outcomes and use environment is 
critical to informing indicated prevention interventions.  Under the guise of the current public policy 
and cultural beliefs regarding cannabis in the United Kingdom, it is difficult to disseminate 
prevention programs that effectively deal with the real circumstances within which young people 
are likely to engage.  Future prevention aimed at specific vulnerabilities associated problematic 
cannabis use may be adaptable and feasible within this current framework, but it seems unlikely that 
this will prevent many young people from graduating to problematic cannabis use.  
5.8  Limitations 
In interpreting the conclusions derived from this work, it is important to consider the limitations of 
this work.  Specific limitations exist for each of these studies, in addition to limitations corresponding 
to the totality of this work.  This section will specifically address the limitations regarding the totality 
of this work.  This PhD encompassed three research studies with distinctly different methodological 
approaches and population samples.  Although the inclusion of these different methodologies and 
samples provides a broad understanding of cannabis use and development, caution and 
consideration should be used when interpreting and building on conclusions derived from their 
totality.  The mixed-methods approach used in this PhD was employed due to the exploratory nature 
of this work and the influence interpretation of these conclusions (Fetter, Curry & Creswell, 2012).  
This work collectively provides evidence regarding cannabis behaviour as it relates to informing 
indicated prevention, and should interpreted this way as it is the substantive focus.  As a result, the 
varying methodological approaches employed do not allow for the direct comparison on cannabis 
use behaviour and limit the interpretation of these results beyond that substantive scope. 
The population samples for each of these studies were different, with a general population, 
weekly cannabis users, and a frequent cannabis group in touch with support services used.  The 
varying sample characteristics limit the ability to compare and contrast results from the studies 
undertaken.  Results of the research undertaken informed the design of subsequent studies and 
helped to identify areas in which research was needed.  This exploratory process, although 
highlighting issues critical to understanding of the development of cannabis use and informing 
indicated prevention, requires the acknowledgment of these varying techniques and limits the 
interpretation of comparing the results. 
  
164 
 
The concept of problematic cannabis use and dependence and its representation and 
measurement within this work and the academic literature places limits the conclusions derived 
from this work.  Although attempts at consistency in cannabis use measurement were considered, 
the measurement of cannabis in each study differed.  Although this contributed to a greater 
understanding of cannabis use behaviour generally and was employed to better inform indicated 
prevention, it limits to a great extent to the ability to draw any conclusions when directly contrasting 
the results of cannabis use behaviour between studies.  Furthermore, the time frames in which this 
research took place are bound by changing drug environment, including an increase in legal highs, 
and cultural perceptions of drug use which may affect the interpretation of these results and their 
corresponding conclusions (Measham & Newcombe, 2015).  Lastly, the majority of the data collected 
was from young people in the NorthWest of England and may be influenced by culture of this 
environment and consequently limit the generalisability of this data to the wider population.  
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Appendix 1. Interview Guide.  Cannabis use behaviour and problems among young people in 
services. 
Determinants of Cannabis Use 
Qualitative Interview Schedule 
 
 
I’m Nathan and I am a researcher from Liverpool John Moores University.  
 
I am working on a project that is interested in finding out about people’s use and experiences 
with cannabis. We are talking to people from the North West, such as yourself, and are 
interested in your experiences with cannabis.  We’ll talk about what you about how you’ve 
used cannabis, what you think about it, and what you know. 
 
This interview is confidential and no one outside this research team (me and Professor Harry 
Sumnall) will read what you have said. Staff members in this service or any others (such as 
the police) won’t be able to see any of your answers.  
 
I am not here to judge anything that you say as there are no right or wrong answers.  It’s 
important that you tell us what you really think and not what you think we want to hear.  
 
The session will be recorded but no one will hear the tape recording other than me.  Everything 
that is said will be typed up into written notes. Your name will not be on any of the notes or 
research reports that are printed. Is that ok with you? (Press recorders). 
- 
 
We need you to sign a consent form to show us you have agreed to take part. If you decide 
you don’t want to take part in this interview then you can drop out at any time, thats fine. If 
you decide you don’t want anything you have said to be used after you have taken part you 
can contact me using the details printed on the information sheet I’ll give you at the end. 
 
You will also receive a £10 high street voucher for taking part.  
 
Are you happy to take part in this interview? If no, stop interview session.  
 
Give out consent forms and collect.  
  
 
To begin, please fill out this short questionnaire. (If not give out questionnaires to be 
completed and explain that they are confidential). 
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Section 1: Cannabis History 
Firstly I am going to ask you some questions about your history with cannabis. 
1.  Please tell me how you first began using cannabis.   
a. At what age did you begin using cannabis?   
b. Who introduced you to cannabis?  
c. What method did you use for smoking?  Joint? Pipe? Bong? Vaporizer? 
d. How did you feel when you first began using cannabis (including effects of using 
cannabis and effects of the experience)?   
e. Did you use other substances with cannabis like alcohol, tobacco, or other drugs? 
f. What sorts of activities do you associate with first experiences using cannabis? 
Music? Film? Hanging out? 
2.  Please describe your use of cannabis during the past year. 
a. How much cannabis do you use during a typical use session?  Has this changed 
since you first began using cannabis? 
b. What method do you use cannabis (joint, pipe, bong, vaporizer, etc.)?  Has this 
changed since you first began using cannabis? 
c. Do you use other substances with cannabis like alcohol, tobacco, or other drugs?  
Has this changed since you first began using cannabis? 
d. Whom do you use cannabis with?  Has this changed since you first began using 
cannabis? 
e. When do you use cannabis (in the morning, after work/school/college, only at 
parties, etc.)? Do you smoke at different times compared to when you first began 
smoking? 
 
 
 
Section 2: Cannabis Experiences  
Now I’m going ask you some questions about your experiences with cannabis. 
1. What types of experiences do you usually have when you use cannabis? 
a. What are the positive feelings that you associate with cannabis?  Are these 
positive feelings the same as when you first began using cannabis? If not, how have 
they changed? 
b. What do you enjoy most about using cannabis?  Has that always been the most 
enjoyable part of the experience? 
c. How much variation is there in your experiences with cannabis?  Have these 
experiences changed since you first began using?  Are they more or less intense? 
d. Do you think the cannabis you use is different from when you first began using 
cannabis?  If not, how do you think it is has changed? 
d. What problems (social, criminal justice, mental, financial, etc.) have you 
encountered due to your use of cannabis?  Have you experienced more or less of 
these problems since you began using cannabis? 
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Section 3: Cannabis Use Behaviour and Knowledge 
Now I’m going ask you some questions about how you get cannabis and what you know 
about it. 
1.   How do you get your cannabis? 
 a. If you purchase it, how often do you purchase cannabis? 
 b. What quantity of cannabis do you purchase?  
 c. Who do you get your cannabis from?  Is it always the same source? 
 d. Do you share your cannabis with other people? 
 e. Do you ever use cannabis by yourself? 
 f. How has the ways in which you get cannabis changed over time? 
  
2. What do you know about the cannabis you’re purchasing? 
a. Do you have options in the types cannabis you purchase (resin, skunk, herbal)?  
Different potency or different qualities (street names)?  If so, how do you decide 
which to purchase? 
b. What does “good quality” cannabis mean to you?  What makes a type of cannabis 
better than another? 
c. How much variation do you believe there is in the ‘quality’ of the cannabis you 
use? 
d. Are there particular cannabis types (street names) that you prefer, or types that 
you don’t like? 
e. Do you purchase different types of cannabis based on how or why you’re using it? 
f. Do you think you know more about the cannabis you use than when you first began 
using cannabis?  Please explain. 
g. What did you know about cannabis when you first started? What have you learned 
about cannabis since? 
 
 
Section 4. Cannabis Motivations and Cessation 
I’d know like to ask you some questions about why you smoke cannabis and how you would 
feel about stopping your use of cannabis... 
1. Why do you enjoy smoking cannabis?  
a. How does cannabis make you feel about yourself?  Do you feel more relaxed?  
More fun, or exciting?  
b. Tell me a bit about your thoughts about the lifestyle of a cannabis user.  Do you 
think people who smoke cannabis are different to those who do not?  What do you 
enjoy about cannabis culture?  
c. What do you think your life would be like if you didn’t smoke cannabis?  What kind 
of effect would not using cannabis have on your life?   
 
2. Do you think you would ever like to stop using cannabis? 
 a. What would make you want to stop using cannabis? 
b. Do you think you would find it difficult to stop using? 
 b. How would you quit using cannabis? 
d. Would you seek help from drug services, online resources, or from anywhere else 
to help you stop using cannabis? 
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e. Have there been any periods of time, after you first began using cannabis, that you 
stopped using cannabis?  Why did you stop using cannabis?  What was that like?  
Did you replace cannabis with another substance (alcohol, tobacco, etc.)? 
 
 
Section 5. Concluding questions 
And just to finish... 
1. Is there anything about cannabis, or your experiences with cannabis that you would like to 
share? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GIVE OUT PI FORM AND VOUCHERS AND THANK YOU 
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Appendix 2. Coding Scheme. Cannabis use behaviour and problems among young people in services.  
Drug Normalization Theory (Parker et al., 1998, 2002) 
1. Availability and accessibility 
2. Drug trying rates 
3. Recent and regular drug use (prevalence) 
4. Social accommodation of ‘sensible’ recreational drug use (friends views of drug use) 
5. Cultural accommodation of recreational drug use (media) 
6. State responses in legislation and ‘anti’-drug strategies 
Drugs as Instruments Framework (Muller & Schumann, 2011) (Parker et al., 1998, 2002) 
7. Improved social interaction 
8. Facilitated sexual behaviour 
9. Improved cognitive performance and counteracting fatigue 
10. Facilitated recovery from and coping with psychological stress 
11. Self-medication for mental problems 
12. Sensory curiosity –expanded perception horizon 
13. Euphoria, hedonia, high 
14. Improved physical appearance and attractiveness 
Cannabis Behaviour 
Patterns of use 
15. Frequency of use 
16. Times when I use cannabis 
17. Intensity of use 
18. Other substances used with cannabis 
19. How has use changed over time 
Contexts of use 
20. Who I use cannabis with 
21. Situation in which we use 
Method of cannabis consumption  
22. Pipe, bong, joint, vaporizer 
23. Purchase behaviour 
Cannabis Outcomes 
Consequences of Use 
24. Health-related consequences 
25. Social consequences 
26. Mental health consequences 
27. Financial consequences 
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28. Criminal just consequences 
Acute Effects 
29. Relaxation 
30. Laughter ‘a good laugh’, Fun Time 
31. Stress-free 
32. Felt high 
Perceptions of Cannabis use 
33. Cannabis Lifestyle 
34. Societal Perceptions of Use 
35. Cultural/media perceptions of use 
36. Community perception of users 
37. Peer perceptions of users 
Motivations for Use Change or Cessation 
38. Cannabis importance in lifestyle 
39. Cannabis cessation 
40. Quit attempts 
41. Change in use behaviours 
42. Use of services or other resources to help quit or manage use 
Cannabis Varieties 
43. Type of cannabis 
44. Addiction 
45. The taste/smell 
 
 
 
 
